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Adult skeletal muscle contains a population of tissue-specific stem cells (satellite 
cells) that are essential for effective growth, repair and regeneration. Normally 
maintained in a state of metabolic and proliferative quiescence, satellite cells 
become activated in response to growth stimuli or damage and proliferate to 
provide progeny that differentiate to augment, repair or generate new functional 
muscle fibres. In addition to producing differentiated cells, satellite cells also self-
renew to maintain or replenish the stem cell compartment retain regenerative 
capacity. The precise mechanism by which this occurs remains uncertain, although 
several recent studies have implicated the Notch signalling pathway, an 
evolutionarily conserved system involved in determining cell fate behaviour and 
fate in a wide range of developing and adult tissues. 
This thesis presents an investigation of the role of Notch signalling, specifically 
Notch3 activity, in the regulation of the adult skeletal muscle stem cell phenotype 
using an in vitro model of satellite cell self-renewal during regeneration. When 
mouse skeletal muscle precursor cells are induced to differentiate, most form 
myotubes (immature muscle fibres), whereas a small minority within the same 
culture adopt a reversible, quiescent, undifferentiated phenotype comparable to 
that of a satellite cell. This phenotype was shown to be dependent on the 
expression of the Notch3 receptor and its activation by a specific ligand, Delta-like 
4, which is expressed by the nascent myotubes. Furthermore, studies in which 
isolated reserve cells were reactivated from the quiescent state revealed that 
Notch3 is rapidly inactivated and subsequently down-regulation prior to re-entry 
into the cell cycle, consistent with a role in maintaining the stem cell phenotype.  
Together, data presented in this thesis suggest that satellite cells can be recruited 
for differentiation at different stages of activation and how once activated, muscle 
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MB    myoblasts 
MCS     multiple cloning site 
MESV     Murine Embryonic Stem Cell Virus 
MyHC     myosin heavy chain 
Mg2+     magnesium ion 
Mib     Mind bomb 
mig      acronym for pMSCV-IRES-eGFP 
MNF     myocyte nuclear factor 
MPCs     myogenic precursor cells 
M phase    mitosis phase 
MRF     myogenic regulatory factor 
mRNA     messenger ribonucleic acid 
MSCV     Murine Stem Cell Virus 
mSP    muscle side population 
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MT     myotubes  
Neur     Neuralised 
NEXT    Notch Extracellular Truncation 
NIC     Notch1 intracellular domain 
NLS     nuclear localisation signal 
NRR    negative regulatory region 
NT     N-terminal 
N-terminal    amino-terminal 
oligo     oligonucleotide 
PFA     paraformaldehyde 
PBS     phosphate-buffered saline 
PBS-T     phosphate-buffered saline with Tween 20 
PCAF    P300/CBP-associated factor 
PCMV     PCC4-cell-passaged myeloproliferative sarcoma virus 
PCR     polymerase chain reaction 
Pfu     Pyrococcus furiosus 
PGK     phosphoglycerate kinase 
pofut1    protein O-fucosyltransferase 1 
poly-A     poly-adenine 
poly-T     poly-thymidine 
PPGK     phosphoglycerate kinase promoter 
PTB     phosphotyrosine binding 
Puror     puromycin resistance 
p value    probability value 
PVDF     polyvinylidene difluoride 
qRT-PCR   quantitative real-time polymerase chain reaction 
RC     reserve cells 
RE/AC     repression/activation 
RIP     regulated intramembrane proteolysis 
RIPA buffer    radioimmunoprecipitation buffer 
RNA     ribonucleic acid 
RNase     ribonuclease 
rpm     revolutions per minute 
rRNA     ribosomal RNA 
 20 
 
RT-PCR    reverse transcription polymerase chain reaction 
S1     site 1 
S2     site 2 
S3     site 3 
SAP30    Sin3A-associated protein 30kDa 
S-DMEM    supplemented DMEM 
SDS     sodium dodecyl sulphate 
SDS-PAGE    SDS-polyacrylamide gel eletrophoresis 
Sel1h     (Suppressor of lin-12) 1 homologue 
Shh     Sonic hedgehog 
SKIP    ski-interacting protein 
SMRT silencing mediator for retinoid or thyroid-hormone 
receptors 
SP    side population 
ST    slow twitch 
S phase    synthesis phase 
Su(dx)     Suppressor of Deltex 
Su(H)     Suppressor of Hairless 
SV40     simian virus 40 
T0     Time 0 (i.e. 0 hours) 
TACE     TNF- α- converting enzyme 
TAD     transactivation domain 
Taq     Thermus aquaticus 
TBE     Tris-borate/EDTA 
TBS     Tris-buffered saline 
TBS-T     Tris-buffered saline with Tween 20 
TE     trypsin/EDTA 
TE buffer    Tris-EDTA buffer 
TEMED    N, N, N’, N’-tetramethylethylenediamine 
TGF-β    transforming growth factor- β  
Th1     T helper cell type 1 
Th2     T helper cell type 2 
TNF-α     tumor necrosis factor-α  
VCAM1    vascular cell adhesion molecule 1 
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VSMC     vascular smooth muscle cells 
-W     width 
































Chapter 1: Introduction 
 
1.1 An overview of adult mammalian skeletal muscle structure and 
function 
Skeletal muscle is required for several essential physiological processes including 
maintenance of posture, locomotion, breathing and whole body metabolism. It is 
the most abundant tissue in adult mammals, constituting about one-third to one-
half of the total body mass (Collins et al., 2005; Sloper et al., 1978; Zierath & 
Hawley, 2004). The muscle fibre is the functional cellular unit of skeletal muscle, a 
syncytium containing many post-mitotic nuclei (myonuclei) that form during 
development by the fusion of muscle precursor cells (myoblasts).  
Mature muscle fibres are highly specialised for the primary function of force 
generation and contain a registered array of myofibrils each composed of an “end-
to end” series of contractile sarcomeres. 
Sarcomeres are the contractile units of striated muscle, consisting predominantly of 
myosin-rich thick filaments and actin-rich thin filaments. Each sarcomere is 
demarcated by Z-discs, into which thin filaments are anchored by α-actinin: the thin 
filaments are directional and at each end of the sarcomere, the “plus” end is 
associated with the Z-disc with the “minus” end orientated towards the middle of 
the sarcomere. The bidirectional thick filaments are maintained in the centre of the 
sarcomere by titin molecules and in the region of overlap, each thick filament can 
interact with five adjacent thin filaments via cross-bridges, the N-terminal domains 
of the type II skeletal muscle myosin heavy chains which function as motor proteins 
with both actin binding and ATPase activities. During contraction, cross-bridges 
attach to the thin filaments and utilise energy from ATP- hydrolysis to undergo 
rotational power strokes that pull the thin filaments (and therefore the Z-discs) 
towards the centre of the sarcomere, before detaching and then reattaching to 
another binding site towards the “plus” end of the thin filament. The cross-bridges 
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cycle independently, generating force by increasing the overlap between the thick 
and thin filament and shortening the sarcomere (Huxley, 1957; Huxley, 2000). 
Each muscle fibre is surrounded by a layer of connective tissue (endomysium), 
groups of muscle fibres, termed fascicles are surrounded by a perimysium and these 
are clustered into bundles to form a skeletal muscle, enveloped by the epimysium 
(Figure 1.1). Through their attachment to the skeleton via myotendinous junctions, 
myofibre contraction is transformed into movement. 
When a myofibre matures, it is contacted by a single motor neuron and expresses 
distinctive molecules (e.g. myosin heavy chain) for contractile function. An 
individual muscle fibres contractile properties depends on its muscle fibre 
composition, including the slow-contracting/fatigue-resistant (slow twitch, ST) 
fibres and fast-contracting/non-fatigue-resistant (fast twitch, FT) fibres. 
 
 
Figure 1.1 Structure of skeletal muscle 
Skeletal muscle is formed hierarchical bundles of structures: bundles of myofibres 
contained by the perimysium, which is in turn contained by the epimysium. 
Myofibres cross the entire muscle lengthwise and attach to the bone through 
myotendinous junctions at both ends. Myofibres are multinucleated single cells 
made up of an array of stacked myofibrils. The myofibrils consist of thick and thin 
filaments organized into a contractile unit called a sarcomere. The myofibres are 
surrounded by a basal lamina. A population of quiescent muscle progenitor cells 
(satellite cells) are located underneath the basal lamina. A rich network of blood 
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vessels and nerves weaves between and within the myofibres. (Diagram taken from 
Scime et al., 2009). 
 
1.2 Skeletal muscle development 
Skeletal muscle originates from embryonic somites. The formation of committed 
skeletal muscle precursor cells in the myotome is stimulated by paracrine factors 
from the surrounding tissue (dorsal ectoderm, neural tube, and notochord), that 
induce the expression of MyoD (Maroto et al., 1997; Tajbakhsh et al., 1997). The 
precursor cells migrate to form specific muscle groups: for example, the deep back 
muscles are formed from cells migrated from the medial portion of somite, whilst 
the body and the limb muscles are formed from the lateral somites (Bischoff, 1994; 
Hauschka, 1994).  
In the lateral somites, surrounding environment factors induce the transcription 
factor Pax3 that turns on the muscle-specific transcription factors, Myf5 and MyoD, 
although in the medial somites, MyoD is induced through an alternative pathway. 
Both MyoD (Davis et al., 1987) and Myf5  (Braun at al., 1989) are members of the 
basic helix-loop-helix (bHLH) family and myogenic regulatory factors (MRFs) that 
bind to specific sites on DNA and activate muscle-specific genes. MRFs are also 
called the MyoD family, consisting of MyoD (Tapscott et al., 1988), Myf-5 (Braun et 
al., 1989), myogenin (Wright et al., 1989), and MRF4 (Rhodes and Konieczny, 1989). 
Furthermore, MyoD also directly activates its own expression. The proliferative 
myotomal cells that express MyoD or Myf5 are termed myoblasts and eventually 
fuse and form multinucleated myotubes. Myoblasts proliferate without 
differentiating until specific growth factors are depleted. The myoblasts then exit 
the cell cycle and secrete fibronectin which is bound to the extracellular matrix by 
α5β1 integrin (Menko & Boettiger, 1987; Boettiger et al., 1995). Once aligned into 
chains, the myoblasts fuse to form myotubes, a process mediated by a group of 
metalloproteinases called meltrins (Yagami-Hiromasa et al., 1995). The primary 
myotubes formed by the fusion of embryonic myoblasts are thought to serve as a 
framework on which foetal myoblasts proliferate before fusing to form secondary 
myofibres during fetal development (Kelly & Zacks, 1969). During embryogenesis, 
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each of the bHLH MRFs (MyoD, Myf5, myogenin and MRF4) is expressed in a 
distinct temporal and spatial distribution pattern, relecting their unique roles in 
muscle development. Studies of knockout mice have demonstrated the critical roles 
of the MRFs in skeletal myogenesis in the embryo, yet reveal some degree of 
functional redundancy in the control of the skeletal myogenic development. In 
single MyoD or Myf5 knockout mice, skeletal muscle develops with no apparent 
abnormalities (Rudnicki et al., 1992; Braun et al., 1992). However, double 
MyoD/Myf5 knockout mice die shortly after birth with a complete absence of 
skeletal muscle (Rudnicki et al., 1993), implying that MyoD and Myf5 can substitute 
each other’s activities. In contrast, single knockout mice lacking myogenin die soon 
after birth with a severe reduction in skeletal muscle bulk (Hasty et al., 1993). 
Furthermore, the muscle tissue that is formed consists of mononucleated, 
undifferentiated myoblasts consistent with an essential role for myogenin in 
terminal skeletal muscle differentiation that cannot be compensated for by other 
MRFs (Nabeshima et al., 1993). Initial studies reported that single MRF4 knockout 
mice are viable and fertile, suggesting that other MRFs can compensate for the 
developmental functions of MRF4, although the muscles contained high levels of 
myogenin, implicating MRF4 in the postnatal down-regulation that normally occurs 
in skeletal muscle (Zhang et al., 1995). However, subsequent studies have shown 
that when MRF4 is compromised, skeletal muscle does not develop in the 
MyoD/Mfy5 double knockout mouse (Kassar-Duchossoy et al., 2004), revealing a 
crucial role for MRF4 during early muscle development. Together, these studies 
have established a definite relationship between the MRFs with Myf5/MRF4 acting 
upstream of MyoD to direct the development of embryonic cells into myogenic 
lineage and myogenin acting downstream to induce terminal myoblast 
differentiation. 
 
1.1.1 Studying satellite cells 
Using enzymatic digestion, myofibres could be isolated from muscles together with 
satellite cells beneath the basal lamina (Beauchamp et al., 2000; Bischoff, 1975; 
Bischoff, 1986; Konigsberg et al., 1975; Rosenblat et al., 1995; Yablonka –Reuveni 
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and Rivera, 1994; Zammit et al., 2004). Satellite cells are mononucleated cells that 
reside between muscle fibres and basal lamina, and thus can be isolated together 
with single muscle fibers. They are responsible of assuming post-natal growth of 
muscle fibres, by adding new myonuclei to maintain the nuclear domains 
functional, but they are also responsible for nuclear turnover and, more 
importantly, muscle fibre regeneration after trauma in the adult (reviewed in 
Morgan and Partridge 2003) 
There are two ways these isolated fibres can be studied; when cultured normally 
the satellite cells start to proliferate, differentiate into satellite-derived myoblasts, 
migrate off the isolated fibres onto their substrate and fuse to produce 
multinucleated myotubes (Zammit et al., 2006a); if they are maintained in a 
suspension culture (Zammit et al., 2004), they will similarly become activated, 
proliferate and differentiate while still being exposed to signals from the myofibres 
(Beauchamp et al., 2000). The latter allows the fate of the satellite cells to be 
studied without selection bias (Zammit et al., 2006a) and without interference from 
potential exogenous sources of myogenic cells such as connective tissue and 
vasculature (Ferrari et al., 1998; LaBarge and Blau, 2002; Tamaki et al., 2002).  
In this thesis, satellite cell-derived myoblasts and the mouse myogenic cell line 
C2C12 (Yaffe and Saxel, 1977) were used to further investigate the role of Notch 
signalling. C2C12 cells have been chosen as they are much more manipulable in 
tissue culture than primary cells (Morgan et al., 1992). Furthermore, they are well-
charecterised and have been used extensively in muscle cell differentiation studies 
(Cossin et al., 2002; Nofziger et al., 1999; Shawber et al., 1996). 
The C2C12 cell line was subcloned from the C2 line, which was derived from the 
thigh muscle of an adult female C3H mouse after a crush injury (Yaffe and Saxel, 
1977; Blau et al., 1983). They are able to differentiate rapidly and forming extensive 
contractile myotubes producing characteristic muscle proteins. In the presence of a 
high concentration of serum, C2C12 cells proliferate as undifferentiated myoblasts 
(Yoshida et al., 1998). Serum depletion induces differentiation in 40-60% of cells 
withdraw from the cell cycle and fuse to form myotubes. 
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These cultures are maintained as proliferating myoblasts in high serum growth 
media. However, differentiation can be induced by serum depletion, giving rise to 
multinucleated myotubes. Not all of the myoblasts differentiate and a small 
proportion exits the cell cycle and remains as mononucleate MyoD-ve reserve cells. 
The reserve cells are quiescent mononucleated and undifferentiated cells. They 
retain the ability to be activated and proliferate after which they can be induced to 
differentiate (Kitzmann et al., 1998; Lindon et al., 1998; Yoshida et al., 1998); 
leading again to a new mixed population of myotubes and reserve cells. The reserve 
cells have been found to express M-cadherin, Myf-5 and CD34 (Beauchamp et al., 
2000).  
This system is therefore a potentially useful in vitro model of satellite cells and may 
be used as a model of both myogenic differentiation and satellite cell specification. 
 
1.3 Skeletal muscle Skeletal muscle regeneration 
Normal adult skeletal muscle has low turnover of the postmitotic myonuclei (Decary 
et al., 1997). Daily wear and tear only produces a slow turnover of skeletal muscle 
fibres and it is estimated that no more than 1-2% of myonuclei are replaced every 
week in normal adult rat muscle (Schmalbruch & Lewis, 2000). Nonetheless, adult 
skeletal muscle retains the capability to complete a rapid and extensive 
regeneration in response to severe muscle damage. Two main phases characterise 
adult skeletal muscle regeneration: a degenerative phase and a regenerative phase 
(Charge & Rudnicki, 2004). When triggered by the disruption of myofibres, adult 
skeletal muscle enters the degenerative phase, which is accompanied by activation 
of inflammatory cells and myogenic cells. This is then followed by the regenerative 
phase of muscle repair, which begins with the activation and proliferation of 




1.3.1 Skeletal muscle regeneration capability depends on satellite cells 
The regenerative capability of skeletal muscle is attributed to satellite cells, a 
relatively small population of adult stem cells occupying a specific niche of adult 
skeletal muscle. Each satellite cell is closely associated with an adult myofibre (see 
Fig. 1.1), residing in an interstitial layer between the sarcolemma and basal lamina 
(Mauro, 1961). After birth, 20-30% of the sub-laminar muscle nuclei in neonatal 
hind limb skeletal muscle are satellite cells (Bischoff, 1994). Satellite cells are 
generally in a non-proliferative, mitotically quiescent state in normal adult muscles 
(Schultz et al., 1978). However, satellite cells become activated in response to 
growth signals or myotrauma, start to express a sequence of MRFs myogenic 
markers and begin to proliferate and produce myoblasts, which ultimately 
differentiate and fuse to repair existing myofibres or form new fibres (Grounds and 
McGeachie, 1987; Rantanen et al., 1995). The regenerated tissue eventually 
becomes indistinguishable both morphologically and functionally from undamaged 
skeletal muscle (Charge & Rudnicki, 2004). 
 
1.4 Identification of satellite cells 
1.4.1 Satellite cell morphology 
Adult skeletal muscle satellite cells are different from both the embryonic and 
foetal myoblast populations that are responsible for developmental myogenesis in 
all organisms analysed to date, including human (Cossu et al., 1985), mouse (Cossu 
& Molinaro, 1987), birds (Hartley et al. 1992 and Feldman & Stockdale, 1992) and 
reptiles (Kahn & Simpson, 1974). Quiescent satellite cells are primarily identified by 
their morphological characteristics. They are located between the plasma 
membrane of the muscle fibre and the basement membrane within the basal 
lamina surrounding the myofibres. The major morphological features of satellite 
cells include a relatively high nuclear-to-cytoplasmic ratio, lack of organelles, small 
nucleus and large amount of nuclear heterochromatin (Schultz & McCormick, 1994). 
After activation, satellite cells lose some of these characteristics and they become 




1.4.2 Satellite cell molecular markers 
A number of molecular markers have been identified which have helped the 
identification of satellite cells by immunostaining at the level of light microscopy. 
Some of these markers, such as MyoD (Davies et al., 1987; Tapscott et al., 1988), 
are expressed by both satellite cells and myoblasts (Zammit et al., 2004), whilst 
others are restricted to one or more phases of the myogenic pathway. For example, 
myocyte nuclear factor-β (MNF-β) normally expressed by quiescent satellite cells 
are down-regulated during activation, whereas MNF-α is expressed by proliferating 
myoblasts (Hawke & Garry, 2001). The most common and effective identification 
markers for satellite cells are M-cadherin and Pax7. M-cadherin, a calcium-
dependent homotypic cell adhesion molecules, is not present on all quiescent 
satellite cells but its expression is upregulated during activation (Cornelison & Wold, 
1997). The transcription factor Pax7, expressed by both quiescent and activated 
satellite cells and by myoblasts, is down regulated during differentiation. Pax3, a 
paralogue of Pax7 is also expressed by both quiescent and activated satellite cells. 
Studies of skeletal muscle from the Pax7 knockout mouse initially suggested that 
Pax7 is an essential factor in the specification of the satellite cell population (Seale 
et al., 2000). Indeed, in vitro studies have shown that when satellite cell progeny are 
induced to differentiate, a proportion retain Pax7 expression and enter a state of 
undifferentiated quiescence, in a process akin to reconstitution of the satellite cell 
pool (Zammit et al., 2004; Olguin & Olwin, 2004). However, a later study revealed 
that satellite cells are initially present in Pax7 null mice, but are progressively lost 
during the early postnatal development in both Pax3 +ve and Pax3 –ve muscle 
suggesting that Pax7 has an apoptotic function that cannot not be substituted by 
Pax3 (Oustanina et al., 2004 and Relaix et al., 2006). When Pax7 is not present, 
growth and regeneration is greatly compromised, leading to a rapid of loss of 
myofibres (Kuang et al., 2006). Recently, Lepper et al. (2009) showed that Pax7 is 
required for the maintenance of the satellite cell population in limb skeletal muscle 
in the immediate postnatal period but not beyond.  
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Several other satellite cell markers are less useful as their expression is not 
restricted to myogenic cells. For example, Cornelison et al. (1997) identified the 
tyrosine kinase receptor c-Met as a quiescent satellite cell marker and it has also 
been shown that most quiescent satellite cells express CD34, a hematopoietic stem 
cells marker (Beauchamp et al., 2000). Several cell adhesion molecules present on 
satellite cells, such as vascular adhesion molecule-1 (VCAM-1) and neural cell 
adhesion molecule (NCAM) have also been identified. VCAM-1 is widely expressed 
during embryogenesis, but it is present only in quiescent satellite cells in adult 
muscle (reviewed in Hawke & Garry, 2001; Covault, & Sanes, 1986), whereas NCAM 
is expressed in proliferating satellite cells and newly form myotubes but not in 
mature myotubes (Rosen et al., 1992).  
During development, mammalian myogenesis occurs in two phases termed primary 
and secondary myogenesis. First, the primary myoblasts fuse to form primary 
myotubes that express the integrin receptor α4β1, but not VCAM-1. During 
secondary myogenesis, a second generation of α4β1-negative/VCAM-1-positive 
myoblasts interact with primary myotubes via α4β1, arrange themselves along the 
primary myotubes and fuse to form secondary myotubes. Most adult muscle fibres 
are derived from such secondary myotubes (Rosen et al., 1992; Jesse et al., 1998). 
 
1.5 Dynamics of Satellite cells distribution 
Satellite cells are present in all skeletal muscles but their distributions vary between 
species and even among different muscle fibre types within the same species. For 
example, in the mouse, there are more satellite cells in the soleus muscle than in 
the extensor digitorum longus (EDL) muscle, whilst more satellite cells are found in 
slow muscle fibres than the fast muscle fibres within the same muscle (Gibson & 
Schultz, 1982). 
The underlying regulatory mechanism for satellite cell distribution remains largely 
unknown. In addition, the size of the satellite cell pool also varies with age, for 
example, the percentage of satellite cells relative to myonuclei was shown to slowly 
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decline with age in mouse soleus and EDL muscles. On the other hand, between 1 
and 12 months, the absolute number of satellite cells increases significantly, in 
contrast to a significant decline in EDL muscle (Gibson & Schultz, 1983). During 
postnatal growth, satellite cells proliferate and fuse with growing muscle fibres, 
dramatically increasing the number of myonuclei associated with each fibre 
(Bischoff, 1994); some also form new satellite cells (reviewed in Morgan and 
Partridge, 2003). Yet the number of satellite cells rapidly declines with age to 
approximately 5% two months postnatally (Bischoff, 1994). Once sexual maturity is 
reached, it has been suggested that satellite cell numbers continue to decrease, 
albeit not as dramatically (reviewed in Chargé and Rudnicki, 2004). Adult skeletal 
muscle uses a mechanism that compensates for the turnover of terminally 
differentiated cells to maintain tissue homeostasis. 
The latter proportion remains relatively constant throughout adulthood (Bischoff, 
1994), but eventually declines at a slow rate (Bockhold et al., 1998; Gibson & 
Schultz, 1983; Schultz & Lipton, 1982). This continuous decline in the number of 
satellite cells has been proposed as a contributory factor in the decline in muscle 
bulk and regenerative ability observed with advancing age (Collins et al., 2005). 
However, the true extent of the variation in satellite cell number due to age 
remains unclear because of contradictory observations by various studies which 
have reported a decline, maintenance or even increase with age (Gibson & Schultz, 
1983; Schultz & Lipton, 1982; Nnodim, 2000; Roth et al., 2000). Intriguingly, it has 
been reported that the number of Pax7-expressing satellites (i.e. the phenotype 
associated with self-renewal) declines with age, but that their intrinsic myogenic 




Figure 1.2 Schematic of markers during myogenesis 
CD34, Pax7, and Myf5 are expressed in quiescent satellite cells. Once satellite cells 
are activated (MyoD upregulate), and produces myoblasts that further proliferate, 
before committing to differentiation (Myogenin) and fusing to form myotubes 
which then mature into myofibre (Diagram taken from reviewed in Zammit PS et 
al., 2006a). 
 
1.6 Molecular regulation of satellite cell proliferation and differentiation 
1.6.1 Pax proteins 
Several studies have suggested that Pax proteins play an important role in the 
regulation of adult myogenesis. Pax3 levels are regulated by mono-ubiquitination 
and proteasomal degradation during satellite cell activation, a process as shown by 
the inhibition of myogenic differentiation by sustained expression of mutant Pax3 
(Boutet et al., 2007). On the other hand, although Pax7 is normally down regulated 
during myogenesis, sustained expression of Pax7 only delays the onset of myogenin 
expression without preventing myogenic differentiation and fusion. The presence of 
Pax7 is compatible with myogenic differentiation and its down-regulation is not a 
prerequisite for this process. Furthermore, the constitutive expression of Pax7 in 
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Pax7-null C2C12 sub-clones increases the proportion of cells expressing MyoD, 
suggesting that Pax7 can act upstream of MyoD (Zammit et al., 2006). This conflicts 
with the earlier studies in which the over-expression of Pax7 was found to suppress 
MyoD and prevent differentiation (Olguin & Olwin, 2004). In a subsequent study, it 
was shown that myogenin directly influences Pax7 expression and it was postulated 
to regulate Pax7 down-regulation (Olguin et al., 2007). When MyoD activity is 
enhanced under certain conditions, myogenin is up regulated and the presence of 
ectopic Pax7 does not prevent terminal differentiation, suggesting that Pax7 is 
incapable of preventing muscle differentiation once myogenin accumulates (Olguin 
& Olwin, 2004). 
 
1.6.2 Myogenic Regulatory Factors (MRFs) 
MyoD is required for skeletal muscle differentiation (Sabourin et al., 1999; 
Cornelison et al., 2000), whereas Myf5 is required to regulate satellite cell and 
myoblast proliferation and homeostasis (Gayraud-Morel et al., 2007; Ustanina et 
al., 2007). Quiescent satellite cells do not express detectable levels of MRFs, but 
activation is accompanied by the rapid up-regulation of Myf5 and MyoD (Grounds 
et al., 1992; Fuchtbauer & Westphal, 1992; Smith et al., 1994; Yablonka-Reuveni & 
Riveria, 1994; Rantanen et al., 1995; Cornelison & Wold, 1997; Cornelison et al., 
2000; Conboy & Rando, 2002; Zammit et al., 2002). Myf5 up-regulation occurs 
within 12h of activation, before the onset of cell division and is immediately 
followed by a period of co-expression of Myf5 and MyoD (Cooper et al., 1999; 
Cornelison et al., 2000; Cornelison & Wold, 1997; Smith et al., 1994).  
MyoD plays an important role in satellite cell differentiation. Megeney et al (1996) 
reported that MyoD-/- mice show reduced regenerative capacity with larger than 
normal population of MPC and a reduction of regenerated myotubes. In addition, 
the expression of M-cadherin was reduced significantly whilst expression of Insulin-
like Growth Factor I (IGF-1) was increased significantly (Sabourin et al., 1999). M-
cadherin is required for myoblast differentiation (Irintchev et al., 1994; Zeschnigk et 
al., 1995), whereas IGF-I promotes myoblast proliferation and inhibits 
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differentiation (Engert et al., 1996; Quinn & Roh, 1993). In contrast, in normal 
satellite cells MyoD serves to up-regulate M-cadherin and down-regulate IGF-I, 
thereby promoting myogenic differentiation. Together, these data suggest that 
MyoD plays an important role in satellite cell differentiation but are not sufficient to 
identify the exact downstream targets of MyoD that are important in the 
regenerative process. 
There is evidence to suggest that Myf5 plays a distinct role from MyoD by 
promoting satellite cell self-renewal (Kuang et al., 2007). Muscle regeneration was 
found to be perturbed in adult Myf5-/- mice in that muscle fibre hypertrophy was 
observed whilst the satellite cell numbers were not significantly changed, although 
others have reported impaired proliferation in vitro (Gayraud-Morel et al., 2007). 
MRF4 is required for myoblast specification in embryonic muscle progenitors. When 
MRF4 expression is disrupted, skeletal muscle does not develop in Myf5:MyoD 
double-null mice (Kassar-Duchossoy et al., 2004). However, in a later study using a 
MRF4 knock-in mouse, expression of MRF4 was only observed during differentiation 
and was not up-regulated in Myf5 null satellite cells, suggesting that Myf5 and 
MyoD are the only MRFs acting in the early stages of satellite cells activation 
(Gayrould-Morel et al., 2007). 
 
1.6.3 Fusion of myogenic precursor cells (MPCs) 
MPCs initiate terminal differentiation after the proliferative phase through the up-
regulation of myogenin and MRF4 expression. They subsequently withdraw from 
the cell cycle, activate muscle specific proteins and initiate fusion to repair damaged 
muscle fibres. M-cadherin has been suggested as a molecule responsible for 
myoblast fusion during embryonic myogenesis and muscle regeneration (Moore & 




1.7 Alternative sources of myogenic regeneration 
The satellite cell population may not be the sole contributing factor in the renewal 
of the satellite cell pool. Multipotent stem cells have been isolated from various 
adult tissues and shown to differentiate into multiple lineages both in vitro and in 
vivo. Such cells with the potential to differentiate into the myogenic lineage have 
been isolated from bone marrow (Bittner et al. 1999; Ferrari et al. 1998; Gussoni et 
al., 1999; LaBarge & Blau, 2002), adult somatic muscle (Asakura et al., 2002; 
Gussoni et al. 1999; Jankowski et al., 2002; Qu Petersen et al., 2002; Torrente et al., 
2001) and various mesenchymal tissues (Young et al., 2001a; Young et al., 2001b).  
Transplantation experiments have further suggested that non-muscle stem cells can 
participate in muscle regeneration. Ferrari et al. (1998) transplanted genetically 
marked bone marrow from transgenic mice into immunodeficient host mice either 
intramuscularly or intravenously and identified bone marrow-derived myogenic 
cells in the host musculature. It was suggested that these donor-derived cells are 
recruited through long-range signals, migrate into the damaged muscle from the 
circulation and take part in the regeneration process, Noteably, the differentiation 
timeline of bone marrow derived cells was different from that of committed adult 
myogenic precursors in that bone marrow-derived cells could only be detected in 
regenerating fibres after 2 weeks-post transplantation. 
Subsequent studies reported that only a specific subpopulation of bone marrow 
cells, termed the side population (SP), was able to generate myofibre nuclei, 
illustrated by the ability to restore dystrophin expression in regenerating mdx 
mouse muscle (Gussoni et al., 1999; Jackson et al., 1999). Bone marrow-derived 
cells (BMDC) have also been shown to be able to contribute to the satellite cell pool 
(LaBarge & Blau 2002). In this study, mice were grafted with GFP+ve BMDC and the 
endogenous satellite cells ablated from the muscle stem cell niche following 
irradiation-induced damage. GFP+ve cells were observed in the satellite cell position 
and when triggered by exercise-induced damage, were able to self-renew and 
participate in muscle regeneration, giving rise to proliferative myoblasts and the 
expression of skeletal muscle specific proteins both in vivo and in vitro. 
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It has also been reported that adult skeletal muscle contains a resident muscle side 
population (mSP), identified by a similar Hoechst staining technique to that used to 
isolate bone marrow SP and can repopulate the ablated hematopoietic niche of 
lethally irradiated mice after intravenous injection (Gussoni et al., 1999; Asakura et 
al., 2002). The mSP is distinct from satellite cells as it does not express the satellite 
cell markers Myf5, Pax7 or desmin (Asakura et al., 2002). Furthermore, mSP isolated 
from the muscles of the Pax7 -/- mice lacking satellite cells were unable to undergo 
myogenesis but had significantly increased hematopoietic potential in vitro, 
suggesting that mSP may contain satellite cell progenitors (Seale et al., 2000). The 
mSP can be further classified into phenotypically distinct subpopulations with 92% 
expressing Sca-1 and 16% positive for CD45, a haematopoietic lineage marker 
(Asakura et al., 2002). In vitro, 9% of CD45+ve and 5% of CD45-ve mSP underwent 
myogenic conversion when co-cultured with myoblasts, although the CD45-ve mSP 
appeared to have greater myogenic potential after intramuscular injection 
(McKinney-Freeman et al., 2002). In a later study, the CD45+ve/Sca-1+ve mSP cells 
isolated from uninjured muscle were found to have no myogenic potential, whereas 
a large fraction of the CD45+ve/Sca-1+ve cells isolated from regenerating muscle 
underwent myogenic differentiation in vitro or when co-cultured with Wnt protein 
expressing cells (Polesskaya et al,. 2003).  
Both Camargo et al. (2003) and Corbel et al (2003) transplanted mice with single 
hematopoietic stem cells (HSCs). It was shown that CD45+ve, but not CD45-ve HSCs 
could generate muscle when irradiated mice following regeration. However, there 
was no evidence of HSC-derived muscle precursors suggesting that the CD45+ve 
cells had become incorporated during regeneration without preceding myogenic 
conversion. It was therefore hypothesized that CD45+ve cells that reside in muscle 
can give rise to myogenic precursors, but that HSC cannot (Camargo et al., 2003; 
reviewed in Rudnicki, 2003).  
Other studies have also identified cells with myogenic potential both within or 
associated with the vascular system. For example, a subpopulation of circulating 
human blood–derived cells expressing the hematopoietic stem cell marker AC133 
also express myogenic markers and can undergo myogenesis when co-cultured with 
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myogenic cells or Wnt-expressing cells in vitro or when delivered directly into the 
musclse of transgenic scid/mdx mice or through the arterial circulation (Torrente et 
al., 2004). Pericytes, present in adult skeletal muscle but phenotypically distinct 
from satellite cells, have also been shown to have myogenic potential, possibly 
equal to that of satellite cells (Dellavalle et al., 2007). These adult cells, derived from 
blood vessels, express the pericyte markers NG2 proteoglycan and alkaline 
phosphatase (ALP), but not endothelial markers. Dellavalle et al. (2007) showed that 
pericyte-derived cells could efficiently colonise dystrophic mouse muscle and 
generate skeletal muscle fibres after transplantation. Strikingly, this myogenic 
differentiation is approximately one order of magnitude higher than other types of 
stem cells. 
 
1.8 Satellite cell self-renewal 
In adult skeletal muscle, the satellite cell pool has an inherent capacity for self-
renewal as shown by the fact that the population of quiescent adult satellite cells 
remains largely constant even after numerous cycles of degeneration and 
regeneration (Gibson & Schultz, 1983; Schultz et al., 1985). Evidence of satellite cell 
self-renewal was obtained by transplanting purified populations of satellite cells 
into irradiated host mice, which showed that these cells can both regenerate new 
myofibres and repopulate host muscle with new satellite cells. This demonstrated 
that satellite cells are able to self-renew and replenish their niche and generate 
progeny capable of efficient regeneration (Collins et al., 2005; Montarras et al., 
2005; reviewed in Le Grand, & Rudnicki, 2007). Fate tracing experiments have 
further suggested that not all satellite cells are equivalent in this respect with 80% 
dividing rapidly and contributing myonuclei to growing fibres, whilst the remaining 
20% divide more slowly and have been suggested to be responsible for replenishing 
the satellite cell pool (Schultz, 1996; Gussoni et al., 1997; Gross & Morgan, 1999; 
Heslop et al., 2001). These observations are compatible with the view that only a 
small proportion of satellite cells have true stem cell potential, specifically in terms 
of the capacity for self-renewal (Baroffio et al., 1995; Baroffio et al., 1996; 
Beauchamp et al., 1999; Schultz, 1996; Yoshida et al., 1998). 
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Also consistent with this view, are two alternative (but not necessarily mutually 
exclusive) models for satellite cell self-renewal. In the ‘stochastic’ model, the 
progeny of each activated satellite cell are generated by symmetric divisions and, 
after a period of proliferation, one or more of the progeny return to quiescence 
while the remainder differentiate. A minority of the progeny then exit the cell cycle 
and return to a quiescence state, presumably due to extrinsic cues, thereby 
renewing the satellite cell niche (Zammit et al., 2004; Olguin & Olwin, 2004). In an 
alternate model, the activated satellite cell divides asymmetrically and generates 
two distinguishable daughter cells: one daughter cell then divides symmetrically to 
generate myoblasts that progress along to the myogenic lineage for muscle 
regeneration, whereas the other daughter exits the cell cycle and returns to 
quiescence, maintaining the satellite cell pool (Dhawan & Rando, 2005; Chargé & 
Rudnicki, 2004). Evidence supporting the second model was obtained by the lineage 
tracing experiments of Kuang et al. (2007). These studies suggested that the 
Pax7+ve satellite cell pool contains a subpopulation of ‘true’ stem cells that never 
express Myf5 and that are capable of dividing asymmetrically to generate a Myf-ve 
daughter cell that replenishes the niche and a Myf5+ve daughter cell that is 
committed to proliferate symmetrically and undergo myogenesis. Furthermore, 
prospective isolation and transplantation of both types of daughter cells suggested 
that the Myf5-ve population was far more effective in its ability to contribute to the 
satellite cell pool compared with Myf5+ve cells which were restricted to muscle 





Figure 1.3  Two models of satellite cell self-renewal. 
A. In this model, injuring the muscle causes the quiescent (Pax7+) satellite cells to enter an 
activation and proliferation (Pax7+/MyoD+) stage. The majority of the cells from this 
transitory proliferating population undergo terminal differentiation. The remaining cells 
return to a Pax7+/Myf5− stage thereby renewing the quiescent satelite cell pool. B. In a 
second model, Pax7+/Myf5− satellite ‘stem’ cells co-exist with Pax7+/Myf5+ ‘committed’ 
satellite cells. Pax7-only cells undergo symmetric or assymetric cell division to amplify or 
maintain, respectively, the stem cell pool. Committed Pax7+/Myf5+ satellite cells, probably 
through symemtric cell division, preferentially undergo terminal differentiation. (Diagram 





1.9 The role of Notch signalling in satellite cell self-renewal 
Several lines of evidence suggest that Notch signalling may be involved in the 
regulation of satellite cell behaviour, particularly in terms of proliferation and cell 
fate decisions. Indeed, the observation that when differentiation begins, satellite 
cell progeny can adopt divergent cell fates either to terminally differentiate or to 
return to quiescence (Zammit et al., 2004; Beauchamp et al., 2000), is consistent 
with some form of the ‘lateral inhibition’ through to cell-cell signalling is involved. 
Given the established roles of the Notch signalling pathway, a conserved cell-to-cell 
pathway that regulates cell proliferation, cell fate determination and asymmetric 
cell divisions during embryogenesis (Artavanis-Tsaknas et al., 1999), it is highly 
probable that Notch signalling may play an important role in the maintenance of 
the satellite cell pool. 
 
1.10 Notch signalling overview 
The development of multicellular organisms requires spatially and temporally 
coordinated cell behaviour (Artavanis-Tsakonas et al., 1999; Schweisguth, 2004). 
Regulation of cell fate, proliferation, growth, migration, survival, apoptosis, 
differentiation and morphogenesis involves cell-cell communication. The Notch 
signalling pathway is an evolutionarily conserved mechanism that facilitates short-
range communication between cells. Under most circumstances, physical contacts 
between cells are required for the transmission of Notch signals for the selection of 
pre-existing developmental programs. Thus, Notch signalling, through regulating 
the activation of differentiation programs, can promote or suppress cell 
proliferation and cell death. Notch signalling is critical throughout development and 
in adult organisms from nematodes to humans, for tissue repair, regeneration and 
the maintenance of the capacity for self-renewal. Indeed, the Notch signalling 
pathway is crucial for neurogenesis (Louvi & Artavanis-Tsakonas, 2006), 
vasculogenesis, angiogenesis (Krebs et al., 2000), somite formation (Artavanis-
Taskonas et al., 1999; Conboy & Rando, 2002; Gridley, 2007; McGrew & Pourquie, 
1993; Weinmaster, 1998; Pourquie, 1999) and lymphogenesis (Kondo et al., 2001). 
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It has also been shown to play a role during postnatal myogenesis (Conboy & 
Rando, 2002; Conboy et al., 2003; Conboy et al., 2005). A distinguishing feature of 
Notch signalling is the mechanism of signal transduction. This mechanism sets it 
apart from other conserved signalling pathways and relies on the ability of a ligand 
to bring about intramembrane receptor proteolysis, which is followed by receptor 
activation with the release of an active intracellular Notch receptor fragment into 
the cytoplasm of the recipient cell. After proteolytic release from the membrane, 
the active Notch intracellular domain (NICD) translocates to the nucleus and 
associates with a DNA binding protein to form a transcription complex. This 
transcription complex then activates downstream target genes. This “canonical” 
transduction pathway is used in most Notch-dependent processes. In addition, the 
amplitude and duration of the Notch activity can be regulated at various points in 





Figure 1.4 Notch signalling pathway 
Notch signalling is initiated by a Notch ligand binding to a Notch receptor (1). This 
binding initiates two subsequent proteolytic cleavages of the Notch receptor by the 
ADAM protease (2) and the γ-secretase, respectively (3). The Notch IntraCellular 
Domain (NICD) is thereby released (4) and translocates to the nucleus and activates 
the downstream target genes including HES/HEY. (Diagram taken from reviewed in 
Ersvaer et al., 2011). 
 
1.11 Modes of Notch signalling 
Notch signalling functions via two distinct modes: lateral inhibition (Lewis, 1996) 
and inductive signalling (Haines et al., 2003). 
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1.11.1 Lateral inhibition 
During lateral inhibition, Notch signalling inhibits all but one among a group of 
equipotent cells from adopting a particular fate during development. Initially, cells 
with equal developmental potential both send and receive Notch signals. Later, a 
small variation of Notch ligand expression occurs in some cells either through a 
stochastic event or by other unknown mechanisms, resulting in a rapid 
amplification of the difference by a transcriptional feedback mechanism. The 
presence of a cell with relatively high levels of surface Notch ligand causes an 
increased level of activation of Notch signal in the neighbouring cells, thereby 
inhibits these neighbouring cells from choosing the same cell fate. The selection of 
Drosophila neural precursors and C. elegans vulva development are classical 
examples of lateral inhibition (Greenwald, 1998; Parks et al., 1997). 
1.11.2 Inductive signalling 
Inductive signalling typically occurs between non-equipotent cell populations when 
one group of cells signal to a distinct adjacent group of cells to promote a new cell 
fate along the interface between the two populations. Instead of repressing a given 
cell fate among equipotent cells, inductive Notch signalling instructs cells to adopt 
cell fate as a result of cell-cell interactions at the boundary between the cell 
populations. This is exemplified by Drosophila wing development and vertebrate 
somitogenesis (Conlon et al., 1995; Couso et al., 1995). In mammals, examples of 
cell fate decisions of bipotential precursor regulated by Notch signalling include T 
lymphoid versus B lymphoid cells, pancreatic exocrine versus endocrine, and 
arteries versus veins (Apelqvist et al., 1999; Pui et al., 1999; Lawson et al., 2001). 
 
1.12 Notch receptor and ligand structure 
Notch was identified by T. H. Morgan (Mohr, 1919) and named from the phenotype 
of mutant flies with notched wings. Artavanis-Tsakonas et al. (1983) cloned the 
Notch locus and showed that it encodes a single pass transmembrane protein 
(Wharton et al., 1985). Drosophila has a single Notch receptor whereas C. elegans 
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has two redundant Notch receptors. Mammals possess four Notch receptors 
namely Notch 1-4 and five Notch ligands namely Delta-like-1, -3, -4 and Jagged-1, -2.  
 
Figure 1.5 Structure of the vertebrate Notch receptors and ligands 
(Diagram taken and adpated from Osborne & Minter, 2007) 
 
The Extracellular Domain (ECD) is composed of between 36 (in Drosophila and some 
vertebrate Notch members) and 10 (in C.elegans) epidermal growthfactor-like (EGF) 
repeats, two extracellular sites of proteolytic processing and two conserved 
cysteine residues and three lin-12/Notch repeats (LNRs) (Schweisguth, 2004). The 
Intracellular Domain (ICD) comprises of a conserved PEST sequences, the RAM23 
domain, six cdc10/ankyrin repeats (ANK), valine residue and three nuclear 
localisation signals (NLS) that sandwich the ANK region (Fleming, 1998; Shimizu et 
al., 2000; Mumm and Kopan, 2000). 
In Drosophila, EGF repeats 11 and 12 in the ECD are necessary and sufficient for 
mediating cellular aggregation with ligand-expressing cells in tissue culture (Rebay 
etal., 1991). Repeats 11 and 12 are conserved in all vertebrate homologues and are 
needed for making productive interactions with ligands presented by nearby cells 
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(Fleming, 1998). Some of the EGF repeats bind calcium ions and play a significant 
role in determining the affinity and structure of Notch within the ligand binding 
(Cordle et al., 2008b) which has the ability to influence signalling efficiency.  
A Negative Regulatory Region (NRR) follows the EGF repeats and plays a significant 
role in preventing receptor activation when ligands are not present. The majority of 
the Notch proteins get cleaved at site 1 (S1) which is located within a shapeless loop 
protruding from the heterodimerization sphere, with the help of a protease 
resembling furin (Blaumueller et al., 1997). Fragments undergoing cleavage then are 
joined together by non-covalent associations between the C and N regions found at 
the terminal ends of the heterodimerization domain. Notch receptor ends have the 
C-terminal stop translocation signal consisting of arginine/lysine residues 3-4. The 
RBP-J Association Module (RAM) domain forms an intracellular binding module 
made up of 12 to 20 of the total amino acids and focussed on a tryptophan-any 
(WxP) design amino acid-proline sequence. A formless linker comprising the nuclear 
localization arrangement binds the RAM sphere to the 7 ankyrin repeats within the 
cdc10/ankyrin repeats (ANK) domain. A nuclear localization bipartite arrangement 
and a loosely defined evolutionary divergent transactivation sphere follow the ANK 
domain. The C terminus of the receptor consists of a conserved proline/glutamic 
acid/serine/threonine-rich (PEST) arrangement which that harbour degradation 
signals known as degrons that regulate the stability of the Notch IntraCellular 
Domain (NICD).  
Notch ligands belong to the DSL family, named after the invertebrate ligands, Delta 
and Serrate from Drosophila and lag2 from C. elegans (Fleming, 1998; reviewed in 
Weinmaster, 1997). The majority of Notch ligands are type Ι transmembrane 
proteins featuring three associated structural regions, namely an N-terminal DSL 
motif, special tandem EGF repeats known as the DOS domain (Komatsu, 2008), and 
EGF-type repeats. The DSL ligands are classified by the absence or presence of the 
cysteine-rich spheres and the DOS domains. Both the DOS and DSL domains 





1.13 Notch receptor activation 
Activation of Notch receptors is facilitated by a series of sequential proteolytic 
events (Bray, 2006) and the major regulatory event is ectodomain shedding. Notch 
activation is triggered by the binding of a transmembrane DSL ligand with the EGF-
repeat domain specific to a Notch ectodomain (Fehon et al., 1990; Weinmaster, 
1997), inducing a proteolytic flow known as Regulated Intra-membrane Proteolysis 
(RIP). The ectodomain is released by an ADAM- facilitated and ligand-induced Notch 
cleavage which is a vital regulatory point within the transduction of the Notch signal 
(Brou et al., 2000; Mumm & Kopan, 2000). A site lying between Val-1711 and Ala-
1710 provides the S2 cleavage site for the metallo-proteases and is located twelve 
amino acids ahead of the transmembrane domain, deeply buried in the NRR 
enveloping the heterodimerization domain and the LNR modules. S2 cleavage is 
essential for subsequent cleavage at S3 by γ-secretase (Kopan & Goate, 2000). The 
addition of monensin which disrupts the transport of the vesicles from the trans-
Golgi network to the surface of the cell, blocks S3 and S2 (Schroeter et al., 1998), 
but not S1cleavage (Blaumueller et al., 1997). These findings are consistent with a 
proteolytic cascade in which Notch pathway is activated when Notch Extracellular 
Truncation (NEXT) is resented on the cell surface and converted to NICD. The main 
function of the NNR is to prevent proteolysis of the Notch when ligands are absent. 
Indeed, studies have shown that if a viral integration (Girard et al., 1996) or point 
mutation (Weng, 2004) disrupts the NRR, “leaky” Notch signalling can result in 
acute T cell lymphoblastic leukaemia in both humans and mice and mutation of the 
LNR domain leads to the Notch phenotype activation in C. elegans (Greenwald et 
al., 1990). 
Notch ectodomain shedding results in a membrane-tethered intermediate known 
as NEXT (Wolfe & Kopan, 2004). γ-Secretase is an Intramembrane CLeavIng 
Protease (I-CLiPs) that progressively cleaves the NEXT in the transmembrane 
domain beginning in proximity to the S3 site and terminating somewhere in the 
centre of the S4 site transmembrane domain. After γ –secretase cleavage, the NICD 
can freely translocate to the nucleus to interact with the protein CSL (an acronym 
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for CBF1, Suppressor of Hairless, Lag1) and bind to DNA via the RAM domain. The 
NICD ANK domain interacts with CSL enabling recruitment of the Mastermind/Lag-3 
co-activator, which in turn recruits the mediator transcription activation complex 
MED, thereby activating expression of downstream target genes (Kovall & Kovall, 
2008). 
Since receptor activation is the result of the interactions between Notch receptors 
and DSL ligands found at the cell surface (Brou et al., 2000), it is conceivable that 
Notch activation could be mediated by ligand expressed by the neighbouring cell or 
on the same cell. However, it has been demonstrated that S3 and S2 proteolytic 
cleavages are made when the receptor-ligand interactions take place in trans, 
presumably because S2 cleavage occurs in the plasma membrane (Mumm et al., 
2000). 
It has also been shown that the protein Mind bomb (Mib), previously thought to be 
involved in protein degradation, also has a primary role in protein trafficking by 
promoting internalization of the DSL ligand Delta which increases the efficiency with 
which Delta activates Notch (Itoh et al., 2003). Mib1 is required for Notch ligand 
endocytosis and is thought to interact with and regulates all DSL Notch ligands (Koo 
et al., 2005). Indeed, ligand endocytosis is critically important for Notch activation 
as it is required for separation of the NECD from the NICD, consistent with the pan-





Figure 1.6 Notch signalling 
Notch receptors are synthesised as full-length precursor proteins that are cleaved 
by a furin-like convertase in the Golgi apparatus before transported to the cell 
surface where they reside as heterodimers. Interaction of extracellular domain of a 
heterodimeric Notch receptor with the extracellular domain of DSL ligands (e.g. 
Delta-like or Jagged) on the adjacent cell, leads to a cascade of proteolytic 
cleavages. The second cleavage is mediated by ADAM/TACE/Kuzbanian family 
allowing to release the receptor ectodomain. The third cleavage mediated by the γ-
secretase activity of presenilins which releases the active Notch ICD (NICD) into the 
cell. The NICD translocates into the nucleus and binds to the transcription factor 
CSL, which displaces the corepressor (CoR) complex and recruits coactivators (CoA), 
leading to transcriptional activation of downstream target genes (e.g. Hes and Hey). 
Downstream target genes can be activated via the CSL-independent Notch signalling 
pathway. Deltex molecules activated the heterodimeric Notch receptor in a ligand-
independent manner and activates its gene targets independently of CSL.  





1.14 Regulation of Notch receptor-ligand interactions 
Temporal and spatial restriction of receptor or ligand expression is potentially the 
simplest way to regulating availability. Different receptors and ligands can have 
distinct (but often overlapping) expression patterns during development and may 
by regulated by distinct pathways (Wu & Bresnick, 2007). However, differences in 
receptor and ligand expression patterns are not sufficient to explain the differences 
observed in signalling activities and several post-translational modifications and 
regulation of trafficking are thought to play crucial roles in controlling controls 
receptor ligand availability and the productive interactions between them. 
1.14.1  Notch receptor and ligand trafficking and endocytosis 
Trafficking and endocytosis of DSL ligands has an important role to play in triggering 
the Notch signalling activity (Borgne, 2006). Ligand endocytosis is enhanced by 
mono-ubiquitination, facilitated by the E3 ubiquitin ligases Mind bomb and 
Neuralized. Endocytosis is followed by a poorly characterized process, which results 
in the presentation of active ligand on the cell surface. The current models of ligand 
modification involve ligand recycling, post-translational modification clustering in 
particular membrane micro-domains (Borgne, 2006; Nichols et al., 2007a). 
Members of the Bearded protein family regulate Neuralized activity in a negative 
manner and minimize the efficiency of Notch activation via Delta (Bardin, & 
Schweisguth, 2006) and are referred to as Notch targeting genes (Lai et al., 2000). 
The negative role of Bearded proteins is modulated by micro RNAs that target 
Bearded mRNAs and the E (spl) mRNA, reducing their half life and mitigating their 
impact on Neuralized (Lai et al., 2005; Stark et al., 2003). MicroRNAs also play a key 
role in regulating the expression of Delta itself (Kwon et al., 2005).  
Various mechanisms also control the turnover of Notch receptors at the cell 
surface, thereby regulating their availability for ligand binding. For instance, the E3 
ubiquitin ligases Cbl, Su (Dx)/Itch, Nedd4 and Deltex can direct Notch receptor 
trafficking towards recycling or lysosomal degradation pathways, regulating 
receptor half-life (Bray, 2006). AP2/Numb-associated Kinase (NAK) and the AP2 
component α-adaptin together with Numb, promote Notch degradation in the 
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daughters of dividing cells following asymmetrical division. Deltex family members 
are thought to be involved in ligand-independent Notch signalling (Kishi et al., 
2001). Notch signaling may be autonomously activated by Deltex proteins (Matsuno 
et al., 1995). 
Although Numb acts as a Notch antagonist in the majority of the systems, it can act 
as a Notch synergist in certain specific contexts, (Range et al., 2008). In cases when 
the lateral Notch signalling takes place among resting cells, Numb is inactive. In 
vertebrates, studies have suggested that Numb is unable to associate with the 
protein ACBD3, which is trapped within the Golgi and that this physical separation 
makes Numb functionally inactive in resting cells (Zhou et al., 2007). Golgi 
fragmentation occurring during mitosis allows formation of an ACBD3/Numb 
complex, which activates Numb to increase Notch activity by an unidentified 
mechanism.  
 
1.14.2 Regulation of Notch-Ligand interaction by glycosylation 
Notch receptors are large glycoproteins and gloycosylation, facilitated by Fringe 
proteins is critical for normal Notch signalling (Okajima et al., 2003). Glycosylation 
of Notch receptors involves the modification of their EGF repeats by two basic types 
of O-glycosylation through O-glucose ond O-fucose (Haines, 2003). When the 
synthesis of O-fucose is disrupted or the addition/removal of O-fucose glycan 
binding sites on Notch receptors occurs it lead to serious defects in Notch signalling 
in mammals and Drosophia (Stanley, 2007). Drosophila and mammalian Fringe 
proteins possess a fucose-specific 1,3 N-acetylglucosaminyltransferase activity (i.e. 
glycosyltransferase activity) that catalyses the addition of N-acetylglucosamine to  -
linked fucose residues in the EGF repeats of Notch receptors, ini a ng their 
elonga on ( r ckner et al., 2000; Moloney et al., 2000; Moran et al., 1999). Such 
modification of the Notch ligand binding domain regulates ligand binding and thus 
receptor activation. Drosophila Fringe enhances Delta-Notch binding and inhibits 
Serrate-Notch binding (dependent of O-fucosylation of EGF repeat 12 of Notch (Lei 
et al., 2003)) ( r ckner et al., 2000; Okajima et al., 2003). Indeed, Drosophila and 
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mammalian Fringe proteins, through the regulation of ligand-receptor activation, 
modulate the formation of compartment borders in the developing embryo (Evrard 
et al., 1998; Johnston et al., 1997; Moran et al., 1999; Shimizu et al., 2001; Zhang 
and Gridley, 1998). 
 
1.15 Downstream target genes of Notch signalling 
The main target genes activated by Notch signalling in mammals belong to the Hes 
(Hairy Enhancer of Split) and Hey (Hes-related protein) families (reviewed in Iso et 
al., 2003). They act as Notch effectors through negative regulation of downstream 
targets such as tissue-specific transcription factors. Seven members of Hes gene 
family (HES1-7) have been identified in mamals. They belong to the basic helix-loop-
helix (bHLH) family of transcription factors and functions as transcriptional 
repressor that influence cell proliferation and differentation in embrogenesis and 
myogenesis. There are three conserved domains in Hes genens that impart 
transcriptional functions: the bHLH domain, the Orange domain and the WRPW 
motif (Kageyama et al., 2007).  
Three members of Hey gene family (HEY-1, -2, -L) have been identified in mammals. 
They shared similar structural elements as Hes family: the bHLH and the Orange 
domain. Although there is high level on sequence conservation within the family, 
there is less conservation amongst the two families. HES has a proline residue in the 
basic region and this is the most remarkable difference that distinguishes HES from 
HEY, which has a glycine at the corresponding position. All HES members share the 
C-terminal tetrapeptide WRPW motif, whereas the HEY family has YRPW or its 
variant. In addition, HEY family has an additional conserved region C-terminal to the 
tetrapeptide motif. 
This divergence in structure may account for the fact of the distinct transcriptional 
mechanisms mediated by the two families. Hes proteins repress transcription by at 
least two mechanisms: active and passive repression. Active repression depends on 
the WRPW domain, interacting with co-repressor TLE/Groucho. TLE/Groucho 
recruits HDACs, which alter the chromatin structure thereby reducing the 
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accessibility of transcription mechanism. Hes can also repress via protein 
sequestration (passive repression) whereby a non-DNA-binding heterodimer was 
formed by, for example, Hes1 and another bHLH factor, E47. Thus reduce the 
availably of E47 to bind to its normal partner and forming functional heterodimer 
(e.g. MyoD-E47 and Mash1-E47) (reviewed in Iso et al., 2003b). Thirdly, the Orange 
terminal may mediate repression via direct recruitment of some co-repressor or the 
regulation of WRPW-mediated repression. 
 
 
Figure 1.7 Domain organisation of Hes and Hey proteins.  
(Diagram taken from reviewed in Fischer and Gessler, 2007). 
 
On the other hand, Groucho/TLE is not a critical component of repression by HEY. 
The bHLH domain of HEY alone is sufficient for recruitment of co-repressor complex 
consists of N-CoR, mSin3A and HDAC1 (Iso et al, 2001). 
Activation of Notch signalling in satellite cells promote their self-renewal via 
upregulation of Pax7, and maintain them in an undifferentiated stage by 
transcriptional repression of MyoD and myogenin via the Hes and Hey family of 
transcriptional repressors (Wen et al., 2012).  Notch targets Hey1 transcriptionally 
represses key myogenic genes, including myogenin and Mef2c, preventing 
differentiation of muscle progenitors into multinucleated myotubes (Buas et al., 
2010). 
Fukada et al. (2007) identified HeyL as one of the most highly expressed genes in 
adult quiescent satellite cells. In a follow up study, both Hey1 and HeyL protein 
were similarly found to be simultaneously expressed in quiescent satellite cells, but 
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HeyL was not detected in activated and proliferating satellite cells whilst Hey1 was 
detected in activated and proliferating satellite cells cultured for 3 days. On the 
other hand, Hey2 was not expressed in quiescent satellite cells and myoblasts 
(Fukada et al. 2011).  
Mourikis et al. (2012) showed that the conditional loss of RBP-J in quiescent satellite 
cells provokes their spontaneous differentiation and contributing to myoblasts, 
eventually leading to severe depletion of stem cell pool and compromised muscle 
regeneration. They noted Hes1 is only slightly induced when Notch signalling is 
activated but it is repressed when Notch pathway is inhibited. With absence of 
detectable RBP-J proteins, HeyL, Hey1, Hes1, MyoD and Pax7 transcripts were 
significantly downregulated, in contrast, Myogenin transcript level increased many 
folds. After the RBP-J depletion, the number of Pax7 cells in resting muscle suffered 
continuous decline and muscle regeneration failed at 32 days post RBP-J depletion 
for the conditional knockout (cKO) mice, indicating prolong blocking of Notch 
signalling resulting in the depletion of satellite cells.  
Buas et al. (2009b) argued that the induction of all downstream targets of MyoD 
should be compromised if Hey1 repress intrinsic MyoD transcriptional activity. But it 
was found that co-expression of Hey1 with MyoD inhibited only one (cadherin-15) 
of the two normally expressed markers (cadherin-15 and myogenin). This specifies 
inhibitory effects of Hey1 on myogenesis suggested Hey1 exerts promoter-specific 
repressing, rather than targeting MyoD protein. Furthermore, Buas et al. (2009b) 
also showed that Hey1 is recruited to the promoter regions of myogenin and Mef2C 
and the expression of Hey1 in C2C12 myoblasts correlates with the reduced 
association of MyoD to these promoters. Thus strongly indicated Hey1 inhibit 
myogenesis through repressing the expression of key myogenic targets.  
Nonetheless, Notch signalling may also influences myogenesis through 
incorporating other signalling pathways. One alternate signalling pathway in which 
Bone morphogentic protein (BMP) signalling induces the proliferation of satellite 
cells and also blocking their premature differentiation (Ono et al., 2011). In 
particular, BMP4/SMAD1 signalling promotes Notch-dependent activation of Hes1 
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and Hey1 to inhibit differentiation of satellite cells and C2C12 myoblasts (Dahlqvist 
et al., 2003). 
 
1.16 Cell cycle regulation by Notch signalling 
Several lines of evidence proposed that the Notch signalling pathway is possibly 
involved in the cell cycle (Cao et al., 2003). This is certainly important with respect 
to the maintenance of the satellite cell population in which some proliferating 
myoblasts exit the cell cycle and return to a quiescent state. Strong evidence has 
been shown that Notch activation promotes survival and inhibits apoptosis (Deftos 
et al., 1998; Jehn et al., 1999; Shelly et al., 1999; Tan-Pertel et al., 2000; Tsai et al., 
2000; Rangarajan et al., 2001). Yet, under certain conditions apoptosis in monocytes 
could be triggered by Dll1-mediated Notch activation, whereas apoptosis in B-cells 
in triggered by constitutively active Notch 1 (Morimura et al., 2000). Notch1 was 
reported to delay S phase entry and reduce proliferation in endothelial cells through 
downregulation of p21 expression (Noseda et al., 2005). In another study, Notch1 
was found to modulate the timing of G1-S progression through p21 and p27 
downregulation thus promoting their degradation (Sarmento et al., 2005). Similarly 
Notch1 affects the apoptotic inhibitor Bcl-xL and the cell cycle via p21 and p27 (Jang 
et al.,2004 ; Campos et al., 2002) showed that a permanent state of cell cycling was 
induced in post-confluent vascular smooth muscle by activation of the Notch3 
receptor. The failure to up-regulate p27 is associated to this lack of cell cycle arrest.  
Cao et al. (2003) observed that p21 and p27 were both up-regulated when C2C12 
was induced to differentiate, with p21 more abundantly expressed in myotubes 
while p27 was more abundantly expressed in reserve cells. Overexpression of the 
metalloprotease disintegrin ADAM12 in C2C12 was found to up regulate p27 and 
leads to cell cycle arrest at the G0 or G1 phase. During differentiation of C2C12 
myoblasts, Adam12 and p27 may be committed during the generation of reserve 




The induction of p21 is essential to irreversible cell cycle withdrawal that precedes 
differentiation (Halevy et al., 1995; SB Parker et al., 1995; Skapek et al., 1995; Wang 
& Walsh 1996; Walsh & Perlman 1997). Furthermore, a correlation was found 
between the induction of p21 and the appearance of an apoptosis-resistant 
phenotype during myogenesis. During differentiation, forced expression of p21 
inhibits apoptosis (Wang & Walsh 1996). Therefore, p21 and p27 appear to 
participate in myogenesis. Notch could potentially regulate myogenesis through 
regulating the cell cycle via both p21 and p27, thereby inducing myoblast terminal 
differentiation or their returning to a quiescent state. 
1.17 The role of Notch signalling during myogenic regulation 
The mammalian Notch 1, 2, 3 and 4 receptors share a number of common 
characteristics (Beatus & Lendahl, 1998). The extra-cellular regions contain tandem 
repeat epidermal growth factor-like motifs and a family-specific Lin Notch Repeat 
(LNR) region (Wharton et al., 1985a; Wharton et al., 1985b) (Error! Reference 
ource not found.). However the extent to which they perform different functions 
remains unclear.  
Mice made homozygous for loss-of-function alleles of Notch1 die between 
embryonic day 10 and 12, and no homozygous embryos can be recovered past 
embryonic day 12 (Huppert et al., 2000). Mutation of human Notch1 is associated 
with early developmental defect in the aortic valve (Garg et al., 2005) and has been 
found to be an important prognostic marker in T-Cell Acute Lymphoblastic 
Leukaemia (Zhu et al., 2006). An inactivating mutation in the ankyrin repeats of the 
Notch2 gene induces early embryonic lethality by day 10.5 in mice, indicating that 
Notch2 also plays an essential role in development (Hamada et al., 1999). Mutation 
of Notch3 can result in CADASIL (cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy). In contrast to Notch1- and Notch2-
null mice, homozygous Notch3-deficient mice develop normally and are fertile. 
Furthermore, whereas Notch1 and Notch2 are thought to share common functions, 
the Notch3 intracellular domain acts as a repressor by blocking the ability of the 
Notch1 intracellular domain to activate through the Hes-1 and Hes-5 promoters 
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(Beatus et al., 1999). These observations support the hypothesis that different 
Notch receptors may perform different physiological and developmental functions. 
In skeletal muscle, regulation of Notch signalling is involved in somitogenesis, 
muscle development, and the proliferation and cell fate determination of muscle 
stems cells during regeneration. During each of these processes, the spatial and 
temporal control of Notch signalling is essential for proper tissue formation (Luo et 
al., 2005). However, the role of these Notch proteins is not yet fully understood. 
A number of studies have suggested that Notch signalling may be involved in 
regulating the satellite cells of adult skeletal muscle during muscle regulation 
(Conboy & Rando, 2002; Luo et al., 2005; Kitzmann et al., 2006) and also during 
embryonic development (Schuster-Gossler et al., 2007; Vasyutina et al., 2007). 
Evidence has been accumulating which demonstrates that Notch signalling could 
function as a switch that activates satellite cells into the differentiation pathway or 
maintains them in an immature stem cell-like stage by preventing their 
differentiation into myofibres (Nofziger et al., 1999; Conboy & Rando, 2002; Conboy 
et al., 2003; Shubert, 2004) when Notch activity is repressed or maintained 
respectively (Kitzmann et al., 2006). Activation of Notch 1 appears to promote the 
proliferation of satellite cells (Numb-/Pax3+/Desmin-/Myf5-/MyoD-), whereas 
attenuation of Notch 1 by its antagonist Numb causes cells to exit from cell cycle, 
express myogenic regulatory factors (MRFs) and commit the progenitor cells to 
amyoblast cell fate (Numb+/Pax3-/Desmin+/My5+) and their myogenic 
differentiation (Conboy & Rando, 2002). 
Adult satellite cells express Notch1, Notch2, and Notch3 (Kuang et al., 2007, Conboy 
et al., 2002, Fukada et al., 2007, Mourikis et al., 2012). Among them, Notch1 is 
targeted by all four Numb isoforms, Notch2 is variably repressed and Notch3 is not 
a target of any Numb protein during myogenesis (Beres et al., 2011). Furthermore, 
various structural and functional differences between Notch3 and Notch1/Notch2 
have been reported (Bellavia et al., 2008).  
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Although several studies have demonstrated that Notch signalling (particularly 
Notch1) plays a critical role in muscle regeneration through promoting proliferation 
and self-renewal of satellite cells, much remains to be determined, especially 
regarding the role of Notch3 during muscle regeneration.  
Mourikis et al. (2012) noted Notch activity declined as cells progressed from stem to 
committed cells, which is linked to simultaneous decreases in Notch receptor 
expression, primarily in Notch3. This paper demonstrated that disruption of the 
Notch Canonical pathway leads to severe depletion of satellite cell pools (Mourikis 
et al., 2012). Although Notch signalling activity had been proposed as being involved 
in skeletal muscle homeostasis and satellite cell renewal, and the role of Notch1 has 
been described in this process, less is known about Notch3 precise involvement and 
how it participates to satellite cell self-renewal in their niche. The hypothesis raised 
in this thesis, and further developed in the next paragraph, is that Notch1 and 
Notch3 plays distinct and specific roles in the process of generating quiescent 
satellite cells located finally in their proper niche. The experimental studies 
conducted during the completion of this thesis aimed at testing this hypothesis and 
deciohering which precise role Notch1 and Notch3 have during the general process 
of generating a regenerating fibre with its satellite cells located under the basal 
lamina, and which ligand may be proposed as active during this process. 
 
1.18 Aims 
The aim of this project is to investigate the role of Notch3 activity in the regulation 
of adult skeletal muscle stem cell behaviour. 
Here, mouse myogenic cell line C2C12 (Yaffe and Saxel, 1977) and satellite cell- 
derived myoblasts were used to further investigate the role of Notch3. These 
cultures are maintained as proliferating myoblasts, but can be induced to undergo 
differentiation into multinucleated myotubes. Not all of the myoblasts differentiate 
and a proportion exits the cell cycle and remains as mononucleate MyoD-ve reserve 
cells. Reserve cells express Myf-5 and CD34 (Beauchamp et al., 2000) retain the 
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ability to be reactivated, after which they proliferate and can then be induced to 
differentiate, leading again to a new mixed population of myotubes and reserve 
cells (Kitzmann et al., 1998; Lindon et al., 1998; Yoshida et al., 1998). This system is 
therefore a potentially useful in vitro model of satellite cells and may be used as a 
model of both myogenic differentiation and satellite cell specification. Using this 
system the expression of Notch receptors and ligands during myogenesis and their 
distribution following differentiation will be investigated. 
In order to assess the hypothesis rised above, the following specific aims were 
defined: 
1. Which Notch receptor is involved during muscle regeneration and for generating 
satellite cells in a proper location? To examine the role of Notch receptors and 
ligands by using stable transfection with full length and constitutively active Notch 
receptors and ligands; shRNA knockdown, RT-PCR and western blotting to analyse 
the role (temporal and spatial) of individual notch receptors and ligands in the 
decision process when skeletal muscle precursor cells are induced to differentiate. 
2. Which ligand of Notch receptors is involved in the process of generating satellite 
cells in their proper niche? Investigate the potential significance of interaction 
between Notch3 receptor and Notch ligands in re-establishing and maintaining the 
stem cell pool during regeneration. 
3. What is the specific role of Notch3 as compared to that described for Notch1 in 
the generation of satellite cells and their location in niches between basal lamina 
and regenerated muscle fibres? Investigate the downstream consequences of 
Notch3 activation in terms of potential interaction with other Notch components 





Chapter 2: Materials and Methods 
2.1 Cell Lines 
The murine and human derived cell lines used in this thesis are described below: 
2.1.1 C2C12 cells 
The skeletal muscle cell line C2C12 was subcloned from the C2 line, which was 
derived from the thigh muscle of an adult female C3H mouse after a crush injury 
(Yaffe and Saxel, 1977; Blau et al., 1983). 
2.1.2 HEK 293T cells 
Human embryonic kidney (HEK) 293 cells are an epithelial cell line derived from the 
embryonic human kidney. 293 cells were generated by the transformation of 
normal HEK cells with sheared adenovirus type 5 DNA (Graham et al., 1977; Louis et 
al., 1997). The HEK293T cell line stably and constitutively expresses the SV40 
(simian virus 40) large T antigen. 
2.1.3 NIH 3T3 cells 
The mouse fibroblast cell line NIH-3T3 was established in the 1960s by George 
Todaro and Howard Green from disaggregated tissue of an embryonic Swiss mouse 
(Green H and Todaro GJ, 1967). These cells are highly contact inhibited, and are 
sensitive to sarcoma virus focus formation and leukaemia virus propagation 
(Jainchill et al., 1969; Andersson et al., 1979). 
 
2.2 Cell culture 
Tissue culture grade plastic surfaces (Nunc) were used to maintain HEK293T, 3T3 
fibroblasts and C2C12. However several additional steps were necessary prior to 
seeding C2C12 and primary myoblast cell cultures. Initially, Permanox (plastic) 8- 
well Lab-Tek chamber slides (Scientific Laboratory Services; SLS) were pre-coated 
with growth factor-reduced Matrigel (BD Biosciences). Matrigel stock solution 
(1mg/ml) was stored at -20°C, thawed on ice to prevent gelling of the components 
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and diluted 1:10 in cold DMEM. The plastic was pre-coated with diluted Matrigel, 
excess liquid was removed and slides were incubated at 37°C in a humidified 
atmosphere with 5% carbon dioxide (CO2) for 30 minutes, to facilitate setting of the 
Matrigel prior to the addition of cells. 
2.2.1 Growth conditions 
All cell cultures were grown at 37°C in a humidified atmosphere, with 5% CO2. All 
media and solutions were pre-warmed to 37°C prior to addition to cell cultures. 
2.2.2 Conditions for cell proliferation 
2.2.2.1 C2C12 cell proliferation 
Proliferating myoblasts were maintained in growth medium, comprising DMEM 
containing 4mM L-glutamine, 100U/ml penicillin, 100μg/ml streptomycin.10% and 
foetal calf serum (FCS; PAA Laboratories), 
2.2.2.2 HEK 293T cell proliferation 
Cells were maintained in growth medium that comprising DMEM supplemented 
with 4mM L-glutamine, 100U/ml penicillin, 100μg/ml streptomycin and 10% foetal 
calf serum (FCS; PAA Laboratories), 
2.2.2.3 NIH 3T3 cell proliferation 
Cells were maintained in growth medium that comprising DMEM supplemented 
with 4mM L-glutamine, 100U/ml penicillin, 100μg/ml streptomycin and 10%  foetal 
calf serum (FCS; PAA Laboratories), 
2.2.2.4 Satellite cell-derived myoblasts 
Proliferating primary myoblasts were maintained in growth medium, comprising 
DMEM containing 20% foetal calf serum (FCS; PAA Laboratories), 10% Horse serum, 
1% chick embryo extract (CEE; PAA laboratories), 4mM L-glutamine, 100U/ml 
penicillin and 100μg/ml streptomycin. 
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2.2.3 Subculture of cells 
2.2.3.1 Subculture of C2C12 cells 
Myoblasts were maintained at a low density in growth medium to prevent terminal 
differentiation. When myogenic cell cultures reached approximately 50% 
confluence, cells were replated at a lower density. Growth medium was removed 
and they were briefly washed in a small volume of trypsin/EDTA (TE) solution. After 
5 min incubation at 37°, cells began to detach. The detachment of the adherent 
cells was monitored under the microscope. Once detached, cells were resuspended 
in DMEM (same volume as TE solution added previously) and centrifuge at 350g for 
ten minutes. Pellet was resuspended in an appropriate volume of growth medium. 
A viable cell count was performed and cells were replated at a lower density, 
around 6.5x103 cells per cm2. 
2.2.3.2 Subculture of HEK 293T cells 
At approximately 70% confluence, the HEK 293T cell cultures were replated at a 
lower density. To remove growth medium without dislodging the cells, a small 
volume as TE was added and the culture vessel was gently tapped to detach cells 
from the surface. The detachment of the adherent cells was monitored under the 
microscope. Once detached, cells were resuspended in DMEM (same volume of TE 
solution added previously) and centrifuge at 350g for ten minutes. Pellet was 
resuspended in an appropriate volume of growth medium. A viable cell count was 
performed and cells were replated at around 5.5x103 cells per cm2. 
2.2.3.3 Subculture of NIH 3T3 cells 
Cells were replated at a lower density when NIH 3T3 cell cultures reached 
approximately 60% confluence, to remove growth medium without dislodging the 
cells, a small volume of TE was added and the culture vessel was gently tapped to 
detach cells from the surface. The detachment of the adherent cells was monitored 
under the microscope. Once detached, cells were resuspended in DMEM (same 
volume as TE solution added previously) and centrifuge at 350g for ten minutes. 
Pellet was resuspended in an appropriate volume of growth medium. A viable cell 
count was performed and cells were replated at around 5.5x103 cells per cm2.  
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2.2.4 Induction of differentiation of C2C12 cells 
C2C12 cells were plated at a confluency of approximately 60%. Before 
differentiation was induced, the cultures were propagated in growth medium for 24 
hours. Growth medium was removed and the cells washed once the following day 
with pre-warmed PBS, then switched to pre-warmed differentiation medium 
(DMEM supplemented with 5% Horse serum, 4mM L-glut, 100U/ml penicillin and 
100μg/ml streptomycin). Cultures were propagated for 5 days unless otherwise 
stated. 
 
2.3 Frozen cell storage 
Subcultures of cells were trypsinised and counted. 5x105 cells was resuspended in 
freezing medium, consisting of growth medium mixed with 10% dimethyl 
sulphoxide (DMSO), and aliquotted into 1ml cryovials (Nunc).  Cryovials were placed 
in a ‘Mr. Frosty’ freezing container (Nalgene) containing isopropyl alcohol which 
provides a -1°C per minute cooling rate, and stored in a -80°C freezer. The next day 
the cryotubes were transferred to a liquid nitrogen storage tank for long-term 
storage. 
 
2.4 Determination of cell viability and proliferation 
To determine if the treatments and stimuli used affected the cells, cell viability 
assays were commenced in Notch3 knockdown or overexpress cultures and growth 
factor treated cells. The Caspase-Glo 3/7 and CellTiter 96® AQUEOUS One Solution 
Cell Proliferation Assay were used to check the response of the cells to different 
agents. 
2.4.1 CellTiter 96® AQUEOUS One Solution Cell Proliferation Assay 
Cell proliferation was determined by the CellTiter 96® AQueous one solution cell 
proliferation assay (Promega, UK). This is a colorimetric based assay for determining 
the number of viable cells in proliferation. The assay involves the bio-reduction of 
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the tetrazolium compound “3-(4,5-dimethylthiazol-2-yl)-5-(3- 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium”, to a coloured formazan 
product, facilitated by dehydrogenase enzymes found in metabolically active cells. 
1.5x103 C2C12 cells were seed in a 96-well plate and were propagated in growth 
medium for 24 hours. Cell number was determined by a colorimetric assay using the 
CellTiter 96® AQueous  ne Solution cell proliferation assay (Promega). 20μL of 
CellTiter 96® AQueous one solution reagent were added into each well of a 96 well-
plate containing 100μL of sample. The plate was incubated for 2 hours at 37°C in a 
humidified atmosphere with 5% CO2. Spectrophotometric analysis of cell 
proliferation was determined at 490nm using a 96-Microplate reader (Biochrom). 
2.4.2 Caspase 3/7 activity assay 
To investigate cell survival on shRNA Notch3 knockdown or Notch3 overexpress 
cultures, 1.5x103 cells of C2C12 myoblasts, shRNA Notch3 knockdown and 
Notch3/mig transfected C2C12 were plated into a 96-well white walled plate. 
Caspase-3/7 activity was analysed after 48 hour in differentiation medium (when 
Notch3 level upregulated). 
For the control purpose, blank reaction (differentiation medium only) also included. 
After 48 hours the cells were subjected to Caspase 3/7 activities measurement with 
Caspase3/7-Glo assay kit (Promega). Briefly, the plates containing cells were 
removed from the incubator and allowed to equilibrate to room temperature for 30 
minutes. 100μl of Caspase-Glo reagent was added to each well, the content of well 
was gently mixed with a plate shaker at 300–500 rpm for 30 seconds. The plate was 
then incubated at room temperature for 2 hours. The luminescence of each sample 
was measured in a Veritas™ Microplate Luminometer (Promega) with parameters of 
1 minute lag time and 0.5 second/well read time. The final values for the activity 





2.5 Separation of differentiated myotubes and undifferentiated reserve 
cells by partial trypsinisation 
2.5.1 Solutions used for separation 
All media and solutions were sterile when purchased or sterilised using a 0.2μM 
filter (Sartorius), and they were pre-warmed to 37°C. 
DMEM containing 4mM L-glut, 100U/ml penicillin, 100μg/ml streptomycin 
PBS 
Sterile PBS (GIBCO) was Ca2+/Mg2+-free and at pH7.4.  
Trypsin 
0.15% trypsin (GIBCO) was prepared in PBS. 
Protein extraction buffer 
1% SDS (sodium dodecyl sulphate) 
1X protease inhibitor cocktail (for general use; Sigma (P2714) 
 
2.5.2 Separation of myotubes and reserve cells for subsequent RNA or protein 
isolation 
C2C12 cells seeded in T75cm2 tissue culture flasks (Nunc) were induced to 
differentiate (section 2.2.4). After 5 days, cultures were separated into 
differentiated myotubes and undifferentiated reserve cells. Differentiation medium 
was removed; cells were washed with 8ml PBS and then incubated in 0.01% trypsin 
(Sigma) in PBS approximately one minute. The detached myotubes were retained 
into suspension and poured into a 25ml universal tube. The adherent cells rinsed 
again with PBS and then subjected to a series of 3 one-minute incubations in 0.01% 
trypsin (with intervening PBS washes) to remove residual myoblasts and myocytes. 
Three washings fractions were released into suspension and poured into a 25ml 
universal tube. Finally 10ml of differentiation medium were added to the remaining 
reserve cells in the flasks and incubate in the incubator for about one hour. 
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2.5.2.1 RNA isolation from myotubes and reserve cells 
Myotubes fraction and washing fractions were centrifuged at 350g for ten minutes. 
The supernatant was aspirated then 1ml TRIzol® reagent (Invitrogen) was added to 
the pellet. Cells were triturated using an RNase-free pipette tip then each fraction 
transferred into an individual RNase-free Eppendorf tube. RNA was purified 
according to the manufacturer’s protocol. 
Medium was removed from the reserve cells and they were washed twice with 
differentiation medium to remove dead cells. TRIzol® reagent (1ml) was added to 
the flask and cells were scraped from the surface using a sterile scraper (Sarstedt), 
triturated and transferred to an RNase-free Eppendorf tube. RNA was purified 
according to the manufacturer’s protocol. 
2.5.2.2 Protein extraction from myotubes and reserve cells 
Following trypsinisation, after myotubes and washings fractions had been 
transferred into a 25ml universal tube, the culture was rinsed twice with 5ml 
differentiation medium.  Myotubes and washing fractions were centrifuged at 350g 
for ten minutes. Each pellet was resuspended in 20ml DMEM and centrifuged again, 
to wash the pellet and remove serum. Each fraction pellet was resuspended in 
300μl protein extraction buffer and transferred in individual Eppendorf tube and 
stored at -80°C.  
Differentiation medium was added to the dish containing reserve cells and it was 
returned to the incubator for an hour, and then rinsed twice with 5ml DMEM to 
remove serum. Protein extraction buffer (300μl) was added to the flask and cells 
were scraped from the surface using a sterile scraper, triturated, transferred to an 
Eppendorf tube and stored at -80°C for subsequent processing. 
2.6 Mice 
C57BL/10 mice were maintained in the Biological Services Unit of the Kings College, 
University of London. Mice were used for single fibre isolation and were 
approximately 8-12 weeks old. 
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2.7 Single fibre preparation 
2.7.1 Solutions for single fibre preparation 
 
Collagenase solution 
0.2% collagenase type I, DMEM, 4mM L-glut, 100U/ml penicillin and 100μg/ml 
streptomycin. Four millilitres of collagenase solution was used to digest one muscle. 
5% BSA solution 
5% bovine serum albumin (BSA) was prepared in PBS and heat-inactivated at 56°C 
for 30 minutes. 
DMEM, 4mM L-glut, 100U/ml penicillin and 100μg/ml streptomycin 
2.7.2 Single fibre isolation 
Mice were culled by cervical dislocation. Single muscle fibres were isolated from 
extensor digitorum longus (EDL) muscles (one in each hind-limb) as described by 
Rosenblatt et al. (1995). Muscles were digested in collagenase solution for 90 
minutes in a shaking waterbath at 35°C. Heat- polished glass Pasteur pipettes were 
also pre-coated with 5% BSA solution. Petri dishes (Marathon) were pre-coated with 
5% BSA solution, to prevent the attachment of myofibres. DMEM containing 4mM 
L-glut, 100U/ml penicillin and 100μg/ml streptomycin was added to the pre-coated 
dishes and incubated for 30 minutes at 37°C and 5% CO2. 
After 90 min digestion, individual muscles were transferred into separate dishes 
containing DMEM with 4mM L-glut, 100U/ml penicillin and 100μg/ml streptomycin 
and incubated for 30 min at 37°C and 5% CO2 incubator. Muscles were triturated 
using the heat-polished glass pipettes to disaggregate into individual fibres. Single 
fibres were transferred into dishes containing fresh DMEM containing 4mM L-glut, 
100U/ml penicillin and 100μg/ml streptomycin and kept at 37°C in a humidified 
atmosphere with 5% CO2 then proceed to section 2.6.3. 
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2.7.3 Isolation and culture of satellite cell derived-myoblasts 
Fibres were plated at 10 fibres per well in a Matrigel coated 6-well plate for 4 days. 
After the 5 day of culture, fibres were removed and cells were trypsinised and 
plated into Matrigel-coated Lab-tek-8 well-chamber slide at 30% cell density. The 
transfection of plasmids into primary satellite cell-derived myoblasts was performed 
24hrs after the plating. 
 
2.8 Plasmids 
Cloning protocols see section 2.12. 
2.8.1 eGFP-NIC/puro vector 
The eGFP-NIC/puro vector was recloned by Dr Josephine Sales by inserting the 
eGFP-NIC fusion protein fragment into pMSCVpuro. The original EGFP-NIC plasmid 
encoded an enhanced green fluorescent protein (eGFP)-NIC fusion protein was a 
kind gift from Dr K Tezuka of Gifu University, Japan (Tezuka et al., 2002). 
2.8.2 2pMSCV-IRES-eGFP (‘mig’) 
mig was an acronym for the pMSCV-IRES-eGFP vector, a gift from Dr P S Zammit 
(Kings College, London, UK). The pMSCVpuro vector was modified to replace the 
puromycin selection gene with an internal ribosome entry site (IRES) and enhanced 
green fluorescent protein (eGFP)(Zammit et al., 2006b). 
2.8.3 Numb/mig 
The Numb/mig was reconstructed by Dr Josephine Sales by inserting the 3.3 kb 
Numb cDNA fragment (which was excised from Numb/pBluescript plasmid) into mig 
vector. The Numb/pBluescriptwas a kind gift from Dr W Zhong of Yale University, 
USA. 
2.8.4 Notch3/mig 
The Notch3/mig was reconstructed by Dr Josephine Sales. The N3IC-HA fragment 
was excised from the Notch3IC-HA/pcDNA3 and inserted into mig vector. The 
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Notch3IC-HA/pcDNA3 was originally from Dr I Screpanti (University “La Sapienza”, 
Rome, Italy). 
2.8.5 MigR1 
MigR1 was a gift from Dr M Bevan (University of Washington, USA). The eGFP- 
expressing retroviral vector, MigR1, was constructed by three-way ligation of a 5kb 
MSCV2.2 vector (Hawley et al., 1994), a 0.5kb IRES fragment from pCITE and a 0.8kb 
eGFP fragment (Pear et al., 1998). Target genes were cloned into the MCS of MigR1. 
This encoded a bi-cistronic transcript for the gene of interest and eGFP, separated 
by an IRES. 
2.8.6 Jagged1 
The Jagged1/MigR1vector was provided by Dr M Bevan. The Jagged1/MigR1 
plasmid was released from the pMSCVpuro vector using EcoRI restriction enzymes 
and the Jagged1 insert was re-cloned into the CIAP-treated linearised pCI-neomycin 
vector. 
2.8.7 Dll4 
The Dll4 /MigR1 provided by Dr A Freitas (Pasteur Institute, France) was released 
from the pMSCVpuro vector using XhoI/EcoRI restriction enzymes and the Delta-
like4 insert was re-cloned into the CIAP-treated linearised pCI-neomycin vector. 
2.8.8 Dll1 
The Dll1/MigR1 plasmid, provided by Dr A Freitas (Pasteur Institute, France) was 
released from the pMSCVpuro vector using Bgl II and Xho I restriction enzymes and 
the Delta-like1 insert was re-cloned into the CIAP-treated linearised pCI-neomycin 
vector. 
2.8.9 mHey1 
mHey1 was provided by Dr Eric Olson (University of Texas, USA) 
A BamHI–MfuI partial-digestion fragment of mHey1 was cloned into the pGL3 basic 




mHey2 was provided by Dr Eric Olson (University of Taxes). EcoRI–NruI fragment of 
mHey2 was cloned into the pGL3 basic luciferase vector, which lacks a promoter 
(Osamu Nakagawa et al., 2000) 
2.8.11 mHeyL 
mHeyL was also a kind gift from Dr Eric Olson (University of Taxes). A BamHI–BamHI 
fragment of mHeyL was cloned into the pGL3 basic luciferase vector, which lacks a 
promoter (Osamu Nakagawa et al., 2000) 
2.8.12 pHes1-luc 
Hes1-luc was a generous gift from Dr Ryoichiro Kageyama (University of Kyoto, 
Japan). The -460 to +46 promoter fragment of Hes1 gene was cloned into the pGV-B 
Vector (Nishimura et al., 1998). 
2.8.13 Hes1 
The Hes1 expression vector was also provided by Ryoichiro Kageyama (University of 
Kyoto, Japan). Full-length eDNA fragments of Hes1 was subcloned into the 
eukaryotic expression vector containing the CMV promoter, pCI-vector (Nishimura 
et al., 1998). 
2.8.14 pHes5-luc 
Hes5-luc was also a kind gift from Dr Ryoichiro Kageyama (University of Kyoto, 
Japan). A SmaI (-800) to SacI(+73) promoter fragment of Hes5 was cloned into pGV-
B Vector (Nishimura et al., 1998). 
2.8.15 Hes5 
The Hes5 expression plasmid was also provided by Dr Ryoichiro Kageyama 
(University of Kyoto, Japan). Full-length eDNA fragments of Hes5 was subcloned 




The Hes7-luc was also provided by Dr Ryoichiro Kageyama (University of Kyoto, 
Japan). A HincII (-926) to BspEI (+70) promoter fragment of Hes7 was cloned into 
the pGL3-Basic vector (Nishimura et al., 1998). 
2.8.17 Hes7 
The Hes7 expression plasmid was provided by Dr Ryoichiro Kageyama (University of 
Kyoto, Japan). Full-length eDNA fragments of Hes7 was subcloned into the 
eukaryotic expression vector containing the cytomegalovirus promoter, pCI-vector 
(Hiromi Hirata et al., 2004). 
2.8.18 pSV-β-Galactosidase 
The pSV-β-Galactosidase Control Vector (Promega) is a positive control vector for 
monitoring transfection efficiencies of mammalian cells. The SV40 early promoter 
and enhancer drive transcription of the lacZ gene, which encodes the β-
galactosidase enzyme. The pSV-β-Galactosidase Control Vector can be transfected 
individually or co-transfected with DNA of interest. 
2.8.19 pmaxFP-Green-N 
pmaxFP-Green-N vector is an eukaryotic (mammalian) expression vector encoding 
green fluorescent protein maxFP-Green obtained from Amaxa Biosystems. The SV40 
early promoter provides neomycin resistance gene expression to select stably 
transfected eukaryotic cells using G418. 
2.8.20 shRNA plasmids 
Four shRNA plasmids (P1-P4) designed to knockdown expression of mouse Notch3 
were obtained from SuperArray Bioscience Corporation, together with a control 
shRNA plasmid containing an irrelevant scrambled sequence (P5). 
The shRNA sequences were as follows: 
P1: GGCTGTCTTTCTACTCATCAT  
P2: TCAGAGTGCTGCTGACTACTT 





All shRNA plasmids also encoded GFP and for stable transfection, were linearised 
with the restriction enzyme Sca1. The neomycin resistance plasmid pCINeo was 
obtained from Promega and was linearised with DraII. 
 
2.9 Transfection 
2.9.1 Preparation of transfection complexes 
For each 10cm dish, the transfection complex consisted of: 
A: 5μg DNA into OptiMEM I (final volume of 250ml) 
 : 10μl Lipofectamine 2000 (Invitrogen) into 240ml  ptiMEM  
 
This was prepared in  ptimMEM I medium (GI C ) to give a final volume of 500μl, 
according to the description below. 
First, the appropriate volume of Optimem I medium was placed in a sterile cryovial. 
To avoid adversely affecting transfection efficiency, Lipofectamine was added 
directly to the medium. The tube was flicked gently to mix the contents and 
incubated at room temperature for five minutes. Plasmid DNA was added, the tube 
was flicked to mix and then the complex was incubated for a further 20 minutes at 
room temperature. The dish was gently swirled while 500μl transfection complex 
was added in a drop-wise manner. The dish was incubated at 37°C in a humidified 
atmosphere with 5% CO2. 
2.9.2 Transient Transfection of HEK 293T cells 
HEK 293T cells were seeded at a density of 5.3x103 cells per cm2 in a 10cm 
propagated for 24-48 hours in growth medium. Growth medium was removed and 
transfected with transfection solution describe above. Cells were returned to the 
incubator for four hours, to allow the DNA to infect the cells and transmit the target 
gene into them. The supernatant was removed and replaced with fresh growth 
medium. Transfected cells were incubated for about 48 hours. 
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2.9.3 Transient transfection of C2C12 cells 
C2C12 were seeded at a density of 8x102 C2C12 cells per cm2 and propagated for 24 
hours in growth medium. Growth medium was removed and cells were briefly 
rinsed with OptiMEM I transfection complexes then added to the cells. Cells were 
returned to the incubator for four hours, to allow the DNA to transfect the cells and 
transmit the target gene into them. The supernatant was removed and cells were 
washed with growth medium. Fresh growth medium was added and the transfected 
cells were incubated for approximately 48 hours. 
2.9.4 Stable Transfection of C2C12 (shRNA Notch3 knockdown) 
Cultures of C212 myoblasts were grown to 60-70% confluence in growth medium 
and co-transfected one of the ScaI linearised shRNA plasmids (5μg) together with 
pClNeo linearised with DraII (0.5μg) at a ratio of 10:1, using Lipofectamine 2000 
(Invitrogen) diluted in OptiMEM. Growth medium was removed and cells were 
briefly rinsed with OptiMEM I transfection complexes then added to the cells. Cells 
were returned to the incubator for four hours, to allow the DNA to transfect the 
cells and transmit the target gene into them. The supernatant was removed and 
cells were washed with growth medium. Fresh growth medium was added and the 
transfected cells were incubated for approximately 48 hours. After 48 hours in 
growth medium, 600 g/ml Geneticin (G418; GIBCO) was added to the growth 
medium and the cells were selected for at least 10 days before. The concentration 
of G418 was chosen as the minimum required to kill untransfected cells within 6 
days and was added to all transfected cultures. 
2.9.5 Stable Transfection of NIH 3T3 
Cultures of 3T3 fibroblasts were grown to 60-70% confluence in growth medium. 
Growth medium was removed and. cells were briefly rinsed with OptiMEM I, 
transfection complexes then added to the cells. Cells were returned to the 
incubator for four hours, to allow the DNA to transfect the cells and transmit the 
target gene into them. The supernatant was removed and cells were washed with 
growth medium. Fresh growth medium was added and the transfected cells were 
incubated for approximately 48 hours. After 48 hours in growth medium, 600 g/ml 
Geneticin (G418; GIBCO) was added to the growth medium and the cells were 
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selected for at least 10 days before. The concentration of G418 was chosen as the 
minimum required to kill untransfected cells within 6 days and was added to all 
transfected cultures. 
2.9.6 Transient transfection of satellite cell-derived myoblasts 
Cultures of primary myoblasts were grown to 60% confluence in growth medium 
overnight. Primary cultures growth medium (20% FCS; 1% CEE; 10% HS) was 
removed and cells were briefly rinsed with OptiMEM I transfection complexes then 
added to the cells. Cells were returned to the incubator for four hours, to allow the 
DNA to transfect the cells and transmit the target gene into them. The supernatant 
was removed and cells were washed with growth medium. Fresh primary culture 
growth medium (20% FCS; 1% CEE; 10% HS) was added and the transfected cells 
were incubated for approximately 48 hours. 
 
2.10 Co-culture of ligand-expressing 3T3 cells with reserve cells 
Co-culture of Reserve Cells with DSL-Ligand-expressing 3T3 cells full-length murine 
Dll4 and Dll1 (de la Coste and Freitas, 2006) and Jagged 1 (Lehar et al., 2005) cDNAs 
were each cloned into pCI-neo (Promega) and transfected into 3T3 fibroblasts using 
Lipofectamine 2000. Transfected cells were selected by using G-418 and expression 
of the relevant ligand confirmed by RT-PCR and Western blotting (no endogenous 
expression of Dll1, Dll4 or Jagged 1 was detected). 
For co-culture, 3T3 fibroblasts were grown to confluence in LAB-TEK® PermanoxTM 
8-well chamber slides (for analysis by immunofluorescent staining) or 10cm-
diameter dishes (for Western blot analysis) prior to the addition of reserve cells. 
C2C12 myoblasts were transfected with pmaxFP-Green-N (Amaxa) using 
Lipofectamine 2000 and transfectants selected with G- 418. Cultures of GFP+ve 
myoblasts were allowed to differentiate for 5 days; the reserve cells were isolated 
and then applied to the fibroblast monolayers (4000 reserve cells/well; 2 x 105 
reserve cells/dish) an approximate ratio of 1:3 (reserve cell: fibroblast). Co-cultures 
were maintained for 24 hour in growth medium prior to analysis. Co-cultures 
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maintained in chamber slides were pulsed with BrdU (section 2.15) for 1 hour and 
analysed by immunostaining; co-cultures in dishes were used to produce protein 
and RNA for Western blotting and RT-PCR. 
 
2.11 Transfections and luciferase assays 
C2C12 myoblasts and primary myoblasts were co-transfected one of the reporter 
plasmid together with β -galactosidase plasmid at a ratio of 10:1 according to the 
Lipofectamine 2000 protocol (see section 2.9). 
For luciferase assays, cells were seeded at a density of 1.5X103cells per well in 96-
well white walled plates and transfected with a total of 200 to 300 ng DNA. Cultures 
were maintained for 1 day in growth medium post-transfection and then switched 
to differentiation medium for 24 hours prior to the assays. Reporter activity was 
assayed using the Dual-Light system (Applied  iosystems) and was normalised to β-
galactosidase activity to control for transfection efficiency variation among different 
wells according to the manufacturer's instructions. Luminescent signal was 
quantified by the Veritas™ Microplate Luminometer (Promega). All reporter assays 




2.12.1 Amplification of plasmids 
2.12.1.1 Transformation of the plasmid into bacteria 
Plasmids received were either sent in solution in a tube, or dehydrated on a piece of 
filter paper. Plasmids sent in solution could be used directly for transformation. 
However, those on paper required rehydration. The paper was first soaked in 1X TE 
(Tris-EDTA) buffer and incubated at room temperature for one hour. Chemically-
competent XL1 Blue E. coli cells (Stratagene) were transformed using the solution 
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containing plasmid DNA as per the manufacturer’s instructions. Transformed 
bacterial cells were grown overnight on LB (Luria Bertani) agar plates containing 
100μg/μl ampicillin appropriate for selection of colonies in the specific plasmid. 
2.12.1.2 Amplification and purification of the plasmid 
A cooled sterile inoculating loop (SLS) was used to scrape colonies from the plate 
and transfer them into a sterile flask. The sterile flask was filled with 200ml LB broth 
containing the appropriate antibiotic, which has the same final concentration as 
used in the LB agar. Colonies were then grown overnight at 37°C in a shaking 
incubator. Bacteria were harvested and the QIAGEN Plasmid Purification Maxi Kit 
was used to purify the plasmid as per the manufacturer’s protocol. 
2.12.2 Restriction digestion of plasmids 
Restriction digestion of plasmids to isolate a specific the DNA fragment or to 
linearise a vector in preparation for ligation was carried out using the restriction 
endonucleases specified in section 2.7.1. Between 2-5μg plasmid DNA was digested 
in a 50μl reaction, using restriction endonucleases with 1X reaction buffer, 3mM 
spermidine hydrochloride and 1X  SA if required according to the manufacturer’s 
instructions. 
2.12.3 Filling in 5’ overhangs to form blunt ends 
Isolated DNA fragments were blunt-ended prior to ligation into the appropriate 
vector was specified in section 2.7.1. Restriction digestions (50μl reactions) were 
treated with Klenow, a proteolytic product of E. coli DNA polymerase I, which fills in 
5’ overhangs to form blunt ends (Sambrook et al., 1989). One micro litre of Klenow 
and 1.65μl 1mM dNTPs (deoxynucleotide triphosphates; Invitrogen) was added. The 
reaction buffer was already incorporated in the digestion reaction and therefore no 
additional buffer was required. This reaction was incubated for a duration of 15 
minutes at room temperature and the blunt-ended DNA was subsequently purified. 
2.12.4 CIAP-treatment of linearised vectors 
Calf intestinal alkaline phosphatase (CIAP; Promega) catalyses the hydrolysis of 5’ 
phosphate groups in DNA and RNA. Treatment with CIAP is required to prevent 
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recircularisation and religation by removing phosphate groups from both 5’ termini 
in all linearised vectors whether blunt- or sticky-ended. 
2.12.4.1 CIAP-treatment of linearised vectors with blunt-ends 
The restriction digestion reaction (50μl), containing linearised plasmid DNA, was 
mixed with 1μl CIAP, 6μl 10X CIAP reaction buffer (Promega) and 2μl dH2 . The 
reaction was incubated at 37°C for 15 minutes and then at 56°C for a further 15 
minutes. Another 1μl CIAP was added to the reaction and the above incubation 
protocol was repeated. The higher temperature potentiates blunt end-accessibility 
(Perbal, 1988). Subsequently the CIAP-treated linearised DNA was purified. 
2.12.4.2 CIAP-treatment of linearised vectors with sticky-ends 
The restriction digestion reaction (50μl) was mixed with 1μl CIAP, 6μl 10X CIAP 
reaction buffer and 2μl dH2 , and incubated at 37°C for 30 minutes. Another 1μl 
CIAP was added to the reaction and the incubation process was repeated. CIAP-
treated linearised DNA was then purified (section 2.8.5). 
2.12.5 Gel purification 
Gel purification is needed to remove enzymes in Klenow-treated blunt-ended DNA 
fragments, restriction-digested DNA fragments with sticky ends and CIAP-treated 
linearised DNA. An agarose gel (0.75%) was prepared and samples were run on the 
gel and purified using the QIAquick Gel Extraction Kit (QIAGEN) according to the 
manufacturer’s instructions. 
2.12.6 Ligation 
T4 DNA ligase is the most commonly used DNA ligase which catalyses the formation 
of a phosphodiester bond between juxtaposed 5’ phosphate and 3’ hydroxyl termini 
in duplex DNA or RNA (Sambrook et al., 1989). Therefore, this enzyme was used to 
join purified DNA fragments of interest (either ‘sticky’ or blunt ends). Purified 
samples were run on an agarose gel (0.75%) beside a low mass DNA ladder 
(Invitrogen), to approximately quantify the DNA. In general, the following reagents 
materials were used: Ten micro litre ligation reactions were prepared, containing 
1μl 10X T4 DNA ligase reaction buffer, 1μl recombinant T4 DNA ligase (400 units of 
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enzyme) and variable quantities of linearised vector DNA, insert DNA and dH2O. 
The ligation mix was incubated overnight for approximately 16 hours, at 16°C, and 
then stored at -20°C until it was required for transformation into bacteria. 
2.12.7 Transformation of ligated plasmids 
According to the manufacturer’s instructions, Plasmid DNA from ligation reactions 
(5μl) was used to transform XL1  lue subcloning grade chemically-competent E. coli 
cells (Stratagene), Transformed bacterial cells were grown overnight on LB agar 
plates containing ampicillin, to select for colonies containing the plasmid of interest. 
2.12.8 Amplification of correctly ligated plasmids 
2.12.8.1 Amplification of plasmid DNA from individual colonies 
Twelve colonies were selected individually using sterile tips and transferred into 
sterile tubes (Fisher), each filled with 3ml LB containing the appropriate antibiotic at 
the same final concentration as used in the LB agar. Colonies were grown overnight 
at 37°C in a shaking incubator. Bacteria were harvested and the QIAGEN Plasmid 
Purification Maxi Kit was used to purify the plasmid. Approximately 1.5ml bacterial 
cell suspension was transferred into an Eppendorf tube and centrifuged at 14,000g 
for 30 seconds at 4°C to pellet the bacteria. The supernatant was discarded 
followed by adding 100μl P1 buffer to the pellet and cells were thoroughly 
resuspended by vortexing. A 100μl P2 buffer was added to lyse cells. The samples 
were mixed by several inversions then incubated at room temperature for five 
minutes, which ensured that nuclei did not lyse. To neutralise the alkaline P2 buffer, 
100μl cold P3 buffer (stored at 4°C) was added and mixed by several inversions. The 
tube was centrifuged at 14,000g for five minutes at 4°C. The supernatant which 
contained plasmid DNA was removed. It was then transferred into a new Eppendorf 
tube with 750μl cold absolute ethanol (stored at -20°C) to remove salt from the 
DNA. This was centrifuged at 14,000g for five minutes at 4°C, the supernatant was 
discarded and the pellet was washed with 1ml cold 70% ethanol (stored at -20°C). 
The pellet, containing purified plasmid DNA, was air-dried and resuspended in 30μl 
1X TE buffer. 
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2.12.8.2 Confirmation of plasmid DNA sequences and plasmid amplification 
To determine whether the vector contained the inserted DNA and if the inserted 
fragment was the correct size and orientation. Purified plasmid DNA isolated from 
individual transformed bacterial colonies was analysed by several diagnostic 
restriction digestion reactions. A colony containing correctly-ligated plasmid DNA 
was then chosen for amplification. 200μl of this bacterial cell suspension was 
transferred into a sterile flask filled with 200ml LB broth containing the appropriate 
antibiotic. Bacteria were grown overnight at 37°C in a shaking incubator, harvested 
and the QIAGEN Plasmid Purification Maxi Kit was used to purify the plasmid as per 
the manufacturer’s protocol. 
 
2.13 Fixation of C2C12 cell cultures or primary cultures 
4% Paraformaldehyde (PFA) was prepared in PBS and aliquots were stored at -20°C. 
PFA was thawed and pre-warmed at 37°C prior to use.  
2.13.1 Fixation of C2C12 cell cultures 
Medium was removed from cell cultures in 8-well chamber slides. 200μl/well of PFA 
was added and cultures were incubated at room temperature for 5-10 minutes. PFA 
was removed and cultures were washed twice with PBS. PBS was added and 
cultures were either immunostained immediately, or stored at 4°C with the slides 
covered in Parafilm to prevent evaporation. 
2.13.2 Fixation of primary cultures 
Primary cultures were cultured in 8-well chamber slides. Approximately half of the 
medium (100μl) was removed from each well to fix the cultures, 200μl PFA was 
added and slides were incubated at room temperature for ten minutes. PFA was 
removed and cultures were rinsed twice with PBS. PBS was added and cultures 
were immunostained immediately, or slides were covered with Parafilm and prior 




2.14 Immunostaining C2C12 cell cultures or primary cultures 
2.14.1 Solutions used for immunostaining 
0.1% Triton 
0.1% Triton X-100 was prepared in PBS. 
5% HS 
5%  horse serum (HS; GIBCO) was diluted in PBS. 
0.025% PBS-T 
0.025%  Tween-20 was diluted in PBS. 
 
2.14.2 Immunostaining of C2C12 cell cultures or primary cultures 
Fixed cells were permeabilised in 0.1% Triton for 10 min. Triton was removed and 
cultures were rinsed twice with PBS. Cells were blocked in 20% serum (DAKO) 
diluted with PBS for 30 minutes, to prevent non-specific antibody-binding. The 
serum used for blocking was from the same species that the secondary or tertiary 
antibody was raised in. Primary antibodies (see Table 2.1) were diluted in 5% HS 
and incubate overnight at 4°C. Slides were covered with Parafilm to prevent 
evaporation. Cultures were rinsed three times with 0.025% PBS-T after primary 
antibodies were removed. Fixed cell cultures were incubated with secondary 
antibodies (Table 2.2) diluted in 5% HS for 60 min at room temperature. Secondary 
antibodies were removed and cultures were washed three times with 0.025% PBS-
T. Excess liquid was tipped off slides, cultures were mounted in DakoCytomation 
fluorescent mounting medium (DAK ) containing 100ng/ml 4’,6-diamidino-2-
phenylindole (DAPI) and a glass cover slip (SLS) was added. 
 
2.15 BrdU pulsing, fixation and immunostaining of C2C12 cells 
Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) is a synthetic nucleoside, 
which is an analogue of thymidine and commonly used to identify cell proliferation 
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(Zhang and McLennan, 1999). A BrdU-specific antibody was used to detect 
incorporated BrdU and hence indicate cells that were actively replicating their DNA. 
The DNA was denatured using acid to allow the antibody to bind effectively. 
2.15.1 Solutions BrdU 
The 4mM stock solution was stored in aliquots at -20°C and thawed at room 
temperature for use. 
DMEM 
DMEM was pre-warmed to 37°C prior to use. 
PFA 
4% PFA was prepared in PBS and aliquots were stored at -20⁰C. PFA was thawed 
and pre-warmed at 37°C prior to use. 
PBS 
PBS was pre-warmed to 37°C before use. 
70% ethanol 
70%  ethanol (Fisher) 
0.5% BSA 
0.5%  BSA was prepared in PBS. 
2M hydrochloric acid 
Concentrated hydrochloric acid (BDH) was diluted using PBS. 
0.1M borate buffer 
0.1M sodium borate required heating to dissolve in dH2O. The solution was altered 
to pH8.5 using hydrochloric acid. 
5% HS 




0.025%  Tween-20 was diluted in PBS. 
0.1% Triton 
0.1%  Triton X-100 was diluted in PBS. 
2.15.2 BrdU-pulsing and fixation of C2C12 cell cultures or Co-cultures 
BrdU was added to cell cultures in 8-well chamber slides, at a final concentration of 
40μM in the existing medium. Cultures were returned to the incubator for two 
hours to allow BrdU incorporation. The medium was later removed from the each 
well and cells were washed with PBS. Cells were then fixed with 4% PFA for 10 
minutes and rinsed twice with PBS. PBS was added and cultures were 
immunostained immediately, or Parafilm® was used to cover the slides prior to 
storage at 4°C. 
2.15.3 Immunodetection of BrdU incorporated into C2C12 cell cultures 
Prior procced to the BrdU-detection protocol, cultures were co-stained to identify 
expression of another protein in addition to BrdU if they were first immunostained 
for that protein. Cultures were firstly incubated in 70% ethanol for 10 min then 
washed with 0.5% BSA and incubated with 2M hydrochloric acid for 15 min. 
Followed by 2 min wash with in 0.1M borate buffer. Cells were then permeabilise by 
Triton for 10 min and followed by two rinses with PBS. A 20% goat serum (DAKO) 
diluted in PBS blocking solution was added for 30 minutes. Cultures were incubated 
(covered in Parafilm® to prevent evaporation) overnight at 4°C with monoclonal rat 
anti-BrdU antibody (Abcam) diluted 1:500 in 5% HS. The primary antibody was 
removed and cultures were rinsed three times with 0.025% PBS-T. Alexa Fluor 488- 
or 594 conjugated goat anti-rat secondary antibody (Molecular Probes, Invitrogen) 
diluted 1:200 in 5% HS, was added for one hour at room temperature ( at dark). 
Antibodies were removed and cultures were washed three times with 0.025% PBS-




2.16 Lysenin treatment of C2C12 cell cultures 
Lysenin, a protein isolated from the earthworm Eisenia foetida (Sekizawa et al., 
1997) can be used to detect Sphingomyelin. Sphingomyelin is an integral lipid 
component of mammalian cell membranes. Reserve cells express high levels of 
sphingomyelin in their plasma membranes to bind lysenin, but not proliferating 
myoblasts and differentiated myotubes (Nagata et al., 2006). 
2.16.1 Solutions 
2% BSA  
2%  BSA was diluted in PBS. 
Lysenin 
1μg/ml lysenin was prepared in 2%  SA. 
2.16.2 Protocol for lysenin treatment of cell cultures 
Fixed cell cultures were blocked with 2% BSA for 30-60 minutes, then incubate with 
lysenin for one hour. Cultures were then co-immunostained for lysenin and another 
antibody, as described in section 2.14.2. 
Antibody  





monoclonal rat anti-BrdU antibody (BU1/75 (ICR1)) 
Abcam (ab6326) 
IF 1/500 
monoclonal mouse anti-MyoD antibody (5.8A) 
Dako (M3512) 
IF 1/100 
monoclonal mouse anti-myosin heavy chain (MyHC) 
antibody 







monoclonal mouse anti-Pax7 antibody 
DSHB (PAX7) 
IF 1/100 
monoclonal mouse anti-®-tubulin antibody (DM 1A) Sigma 
(T9026) 
WB 1/5000 
monoclonal mouse anti-cyclinA antibody (CY- A1) 
Sigma (C4710) 
WB 1/2500 
polyclonal rabbit anti-lysenin antibody (020- 521031) 
Peptide Institute, Inc. (14802-v) 
IF 1/2000 
polyclonal rabbit anti-GFP antibody 
Molecular Probes, Invitrogen (A11122) 
IF 1/500 





polyclonal rabbit anti-p27 (C19) antibody 
Santa Cruz Biotechnology, Inc. (sc-528) 
IF 1/250 
polyclonal rabbit anti-p21 (M19) antibody 
Santa Cruz Biotechnology, Inc. (sc-471) 
IF 1/250 
monoclonal rat anti-Notch1 antibody 
DSHB (bTAN20) 
IF 1/100 
polyclonal goat anti-mouse Notch1 (M20) antibody  
Santa Cruz Biotechnology, Inc. (sc-6015) 
WB 1/200 
polyclonal rabbit anti-activated mouse Notch1 antibody 
Abcam (Ab8925) 
WB 1/200 
polyclonal goat anti-mouse Notch2 (M20) antibody  
Santa Cruz Biotechnology, Inc. (sc-7423) 
WB 1/200 
polyclonal goat anti-mouse Notch3 (M20) antibody 
Santa Cruz Biotechnology, Inc. (sc-7424) 
WB 1/200 
polyclonal goat anti-Jagged1 (C20) antibody 
Santa Cruz Biotechnology, Inc. (sc-6011) 
WB 1/200 
polyclonal goat anti-Dll4 (C20) antibody 
Santa Cruz Biotechnology, Inc. (sc-18640)  
WB 1/200 
 















Biotinylated rabbit anti-goat antibody 





HRP-conjugated goat anti-mouse antibody 
Dako (P0447) 
WB 1/3000 
HRP-conjugated swine anti-rabbit antibody 
Dako (P0217) 
WB 1/3000 
Alexa Fluor® 488-conjugated goat anti-rat antibody 
Molecular Probes, Invitrogen (A11006) 
IF 1/400 
Alexa Fluor® 594-conjugated goat anti-rat antibody 
Molecular Probes, Invitrogen (A11007) 
IF 1/400 
Alexa Fluor® 594-conjugated goat anti-mouse antibody 
Molecular Probes, Invitrogen (A11005) 
IF 1/400 
Alexa Fluor ®488-conjugated goat anti-mouse antibody 
Molecular Probes, Invitrogen (A11001) 
IF 1/400 
Alexa Fluor® 488-conjugated goat anti-rabbit antibody  




Alexa Fluor® 594-conjugated goat anti-rabbit antibody 
Molecular Probes, Invitrogen (A11012) 
IF 1/400 
Alexa Fluor® 594-conjugated donkey anti-mouse 
antibody  
Molecular Probes, Invitrogen (A21203) 
IF 1/400 
Alexa Fluor® 488-conjugated donkey anti-mouse 
antibody  
Molecular Probes, Invitrogen (A21202) 
IF 1/400 
Alexa Fluor 488-conjugated donkey anti-goat antibody  
Molecular Probes, Invitrogen (A11055) 
IF 1/400 
Alexa Fluor® 594-conjugated donkey anti-goat antibody  
Molecular Probes, Invitrogen (A11058) 
IF 1/400 
Alexa Fluor® 594-conjugated donkey anti-rabbit antibody  
Molecular Probes, Invitrogen (A21207) 
IF 1/400 
Alexa Fluor® 488-conjugated donkey anti-rabbit antibody  
Molecular Probes, Invitrogen (A21206) 
IF 1/400 
 
Table 2.2 Secondary and tertiary antibodies used for immunofluorescence (IF) and 
Western blotting (WB) 
 
2.17 RNA isolation from C2C12 cell cultures 
C2C12 cell cultures were grown in either T75cm2 tissue culture flasks or 10cm2 petri 
dishes in preparation for RNA isolation. RNA was extracted from proliferating 
myoblasts, differentiated cultures and separated myotube and reserve cell samples 
(sections 2.2 and 2.5) for RT-PCR and Quantitative RT-PCR analysis. One millilitre of 
TRIzol® reagent was added to each T75cm2 flask 10cm2 Petri dishes and the cells 
were scraped, triturated and transferred to an RNase-free Eppendorf tube. Samples 
were stored at -80°C. Total RNA was isolated using TRIzol® reagent (Invitrogen) 




2.18 RT-PCR (reverse transcription-PCR) analysis of C2C12 cell culture 
transcripts 
2.18.1 One step RT-PCR (Qiagen) 
Total RNA (from myoblasts, unseparated differentiated cultures, myotubes or 
reserve cells; section 2.2.2) were used to analysed RT-PCRs using a One-Step kit 
(Qiagen) with appropriate primers ( 
Table 2.3), according to the manufacturer’s protocol. 
2.18.2 Quantitative RT- PCR 
Two micrograms of total RNA (from myoblasts, unseparated differentiated cultures, 
myotubes or reserve cells; section 2.12.3) were reverse transcribed in 40µl 
reactions, using Superscript reverse transcriptase with an oligo dT12-18 primer 
(both Invitrogen), according to the manufacturer’s instructions. 
Real-time RT-PCR was performed by means of the Rotor-Gene 6000 Real-time PCR 
system (Corbett Life Science). In each reaction, one micro litre of the resultant cDNA 
was diluted 20-fold with nuclease-free water and amplified using the Quantace 
SYBR Green QPCR Master mix, 300nM of each primer according to the protocol 
provided by the manufacturer. 
After initial denaturation for 10 minutes at 95°C, thermal cycling was performed for 
40 cycles of with steps of 95°C for 15 seconds, and annealing/extension at 60°C for 
1 min with the fluorescence being read at the end of each cycle. 
The analysis was performed with rotor-gene 6000 series software, version 1.7.4. 
The obtained values were within the linear range of a standard curve and were 
normalised to yield the same amount of glyceraldehyde phosphate dehydrogenase 




2.18.3 Sample preparation and running the gel 
A 1.5% agarose gel was prepared in a large tank. RT-PCR products were combined 
with 10X DNA loading buffer, so that a final buffer concentration of 1X was 
obtained, and loaded onto the gel with a molecular weight marker. At this point an 
image of the gel was taken in order to determine the location of the molecular 
weight marker bands, which were used to confirm the size of the target transcripts. 
 
Gene Forward and  










5' GCTGGTGAAAAGGACCTCTC 3' 





GAPDH 5' CCTCGTCCCGTAGACAAAAT 3’ 
5' AATCTCCACTTTGCCACTGC 3’ 
55 102 40b 
CD34 2 5' CCAGGGTATCTGCCTGGAAC 3' 
5' GCTGGAGTTTGCTGGGAAGT 3' 
55 218 20a 
40b 
MyoD 2 5' CGGCGGCAGAATGGCTACGA 3' 
5’ GAGGGGCGGCGTCGGGAGAC 3' 




5' TTGCTCAGCTCCCTCAACCA 3' 
5' TGGGCTGGGTGTTAGCCTTA 3' 
59 445 28a 
 
Notch11 5' TGGACGCCGCTGTGAGTCA 3' 
5' TGGGCCCGAGATGCATGTA 3' 
59 202 20a 
40b 
Notch21 5' GTGCCTGAATGCTGGAACG 3' 
5' CTGCCGCCTTACAGGACAC 3' 
57 227 20a 
40b 
Notch31 5' CCTGGATGCTGGGGCGGACAC 3' 
5' CGGCATGGCTGGCGATGAGCT 3' 




5' ACCTACGGCAGTGCTGTCAC 3' 
5' ATGGAGGGCTTCAATGATCA 3' 




5' GCTCAAAAACACAAACCAGA 3' 
5' CAAATGGCTGATATTCGACA 3' 
54 225 25a 
40b 
Jagged11 5' CGAGAGCAACCCCTGTAAAA 3' 
5' CTTCGTCACACTGGCTGTCA 3' 
55 236 20a 
40b 
Jagged21 5' AGCCTGACCAATACCTCTG 3' 
5' GCACACTCATCAATGTCGA 3' 
56 190 20a 
40b 
Numb1 5' GCGTAAACAGAAGCGGGAGA 3' 
5' GAGAGGTGGGAGAGGATGGG 3' 
56 233 20a 
40b 
Hes1 5’ GGTGCTGATAACAGCGGAAT 3’ 
5’ TGGAATCCTTCACGCAAAA 3’ 
59 145 40b 
Hes2 5’ TGGAGTCCAGAGCAAGTTGA 3’ 
5’ AGCAGCGGCTTTAGGTTCTT 3’ 
58 106 40b 
Hes5 5’ CTCGCTAATCGCCTCCAG 3’ 
5’ CAGCTTCAGCTGCTCTATGC 3’ 
58 113 40b 
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Hes7 5’ CGGAGGAGCAATGGTCAC 3’ 
5’ ATCTCCGCTTTCTCCAGCTT 3’ 
59 110 40b 
Hey1 5’ GGGAAAGGGATGGTTGAGTT 3’ 
5’ GGGTGAGCTCTCTTCATGGT 3’ 
58 114 40b 
Hey2 5’ GTTCCGCTAGGCGACAGTAG 3’ 
5’ CCACGTCGATGGTCTCGT 3’ 
58 100 40b 
HeyL 5’ CATCGATGTGGGTCAAGAGA 3’ 
5’ CAATCGTCGCAATTCAGAAA 3’ 
58 120 40b 
 
Table 2.3 PCR primer sets 
 
All PCR primers were obtained from Sigma (Genosys) and were designed using 
Primer3 Input (version 0.4.0), except: 1 (Dr Josephine Sales), 2 (Beauchamp et al., 
2000). a One step RT-PCR, b Quantitative RT-PCR. 
2.18.4 Analysis of RNA concentration, integrity and purity 
Total RNA was isolated from proliferating myoblasts, differentiated myotubes and 
undifferentiated reserve cells, using TRIzol® reagent (Invitrogen), as described in 
section 2.12.3. In order to confirm the integrity of the RNA, one micro litre of each 
sample was run on a 1.4% agarose gel. The RNA was then quantified using a 
spectrophotometer and the optical density of the samples was recorded at 
wavelengths of "230, "260 and "280. The "260 reading was used to determine the 
total RNA concentration, which was greater than 11ng/μl per sample, meeting the 
SuperArray instruction requirements. The "260:"280 ratio was greater than two 
showing that there was no protein contamination. The "260: "230 ratio was 
calculated to be greater than 1.7, which confirms that there was no salt or 
guanidine contamination. 
 
2.19 Analysis of C2C12 cell culture proteins 
2.19.1 Solutions 
10% SDS  was prepared in sterile dH2O and diluted to make other solutions. 
Protein extraction buffer 
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Described in section 2.4.1. 
RIPA buffer 
150mM NaCl, 1% Igepal (CA-630); 0.5%  deoxycholate (DOC); 0.1%  SDS 50mM Tris,; 
1X protease inhibitor cocktail (for general use; Sigma). This was prepared in sterile 
dH2O and kept on ice.  
Resolving gel 
25% of 1.5M Tris-HCl (pH8.8), 0.1%  SDS and 10%  acrylamide/bis acrylamide. This 
stock solution was prepared in sterile dH2O and stored at 4⁰C for up to one month. 
0.05%  ammonium persulphate (APS) and 0.05%  TEMED (N, N, N’, N’-
tetramethylethylenediamine) were added immediately prior to pouring the gel. 
Stacking gel 
25% of 0.5M TrisHCl (pH6.8), 1% SDS, 4% acrylamide/bis acrylamide, 0.05% of APS 
and 0.1% of TEMED. 
Water-saturated butanol 
One millilitre of dH2O was added to 5ml n-butanol (BDH) and the solution was 
shaken vigorously. 
5X sample buffer 
12.5% of 0.5M TrisHCl (pH6.8 ), 10%  glycerol; 2%  SDS; 5%  β-mercaptoethanol  and 
0.05%  bromophenol blue. This was prepared in sterile dH2O. 
5X running buffer 
15g Trizma Base 72g glycine 5g SDS This was prepared to give a final volume of one 
litre in dH2O, kept as a stock solution at room temperature, and diluted to 1X with 
dH2O prior to use. 
Transfer buffer 
3g Trizma Base and 14.4g of glycine. This was freshly prepared with dH2O to a 
volume of 800ml, 200ml methanol was added, and it was pre-cooled to 4°C. 
10X TBS (Tris-buffered saline) 
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25ml of 1M TrisHCl (pH7.5); 8g NaCl ;0.2g KCl. This was prepared to give a final 
volume of 100ml in dH2O, kept as a stock solution at room temperature and diluted 
as appropriate for use. 
TBS-T 
0.2% Tween-20  
1X TBS  
This was prepared in dH2O. 
Blocking solution 
5%  Marvel milk (Cadbury)  
This was prepared in TBS-T. 
Stripping buffer 
100mM β-mercaptoethanol 
2% SDS  
62.5mM of TrisHCl 
This was freshly prepared in dH2O prior to use. 
 
2.19.2 Protein extraction and quantification 
Protein was extracted from proliferating myoblasts (cultured for 24 hours), 
unseparated differentiated cultures, myotubes and reserve cells (sections 2.2 and 
2.5). Cultures or samples were rinsed with DMEM and between 300μl and 1ml of 
ice- cold protein extraction buffer or RIPA buffer was added. Cells were scraped 
with a sterile scraper (Sarstedt) if required, triturated, transferred to an Eppendorf 
tube and stored at -80°C so that they could be processed when needed. Samples 
were thawed on ice and Bradford reagent (Bio-Rad) was used to determine the 
protein concentration as per the manufacturer’s instructions.  SA standards were 
used to create a curve to quantify protein. 
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2.19.3 Western blot analysis of protein samples 
2.19.3.1 SDS-polyacrylamide gel electrophoresis 
For protein separation, SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed using a Bio-Rad Mini-PR TEAN® Cell Kit as per the manufacturer’s 
instructions. Spacer and short glass plates were cleaned using sterile dH2O and 
methanol and clamped together in a casting frame so there was a 0.75mm space 
between them. The gel cassette assembly was secured using a casting stand before 
gel casting. Resolving gel was poured into the space between the plates until it was 
75%-full and a layer of water-saturated butanol was poured on the top. It took the 
resolving gel roughly 45 minutes to polymerize. The butanol was subsequently 
removed and the gel surface was rinsed with dH2O. Stacking gel was poured above 
the resolving gel until the cassette was full and a comb was placed on top. The gel 
polymerised after approximately 30 minutes. Then the combs were removed. 
Samples were prepared in dH2O so that they contained an equal quantity of protein, 
between 10 and 25µg, and their final volumes were equal. A final 1X concentration 
was obtained by adding 5X sample buffer.  When investigating intracellular 
proteins, the samples were denatured by applying heat (100⁰C) for a duration of 
three minutes. 
Two gel cassettes were inserted into the electrode assembly, with a central 
chamber between them, and then placed in a mini-tank. The central chamber was 
filled with 1X running buffer and a smaller quantity was added to the external 
chambers. Samples were loaded into the wells beside molecular weight markers 
and electrophoresed at 90 volts until the markers reached the bottom of the 
resolving gel. 
However, separation of NotchICD protein was achieved by using NuPage 4-12% 
gradient Bis-Tris pre-cast polyacrylamide gels (Invitrogen) in a XCELL II Mini gel 
apparatus (Novex) with 1 x Nupage MES SDS running buffer (Invitrogen) according 
to manufacturer’s instructions. Samples were mixed with 4x NuPage Sample Buffer 
(Invitrogen) containing β-mercaptoethanol before boiling for five minutes. The 
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Novex® Sharp Pre-Stained Protein Standard (Invitrogen) was used as a molecular 
weight marker. 
2.19.3.2 Western blotting and hybridization 
Gels were blotted onto nitrocellulose membranes (Hybond ECL, GE LifeSciences) 
after electrophoresis by using the Mini Trans-Blot Electrophoretic Transfer Cell (Bio-
Rad) or XCell II  lot Module (Invitrogen), according to the manufacturer’s 
instructions. Transfer took place at 120mA for approximately 2 hours. The pre-cast 
NuPage gels were transfered at 20 V constant voltage for 40 minutes. 
Membranes were rinsed in dH2O and air-dried. An orbital shaker was used during 
all washing, blocking and hybridisation stages. Each wash cycle took ten minutes. 
Membranes were washed three times in TBS-T and then incubated in blocking 
solution for one hour to prevent non-specific antibody-binding. Primary antibodies ( 
Table 2.1) were diluted in blocking solution, applied to the membranes and 
incubated at 4⁰C overnight. Membranes were washed three times with blocking 
solution. Secondary antibodies ( 
Table 2.2) were diluted in blocking solution and applied to membranes for one hour 
at room temperature, followed by tertiary antibodies if required ( 
Table 2.2). Membranes were washed once with diluted 250mM NaCl in TBS-T, twice 
with TBS-T and then once more for at least an hour with TBS-T. The ECL kit (Pierce) 
was used to detect immunoblotted proteins as per the manufacturer’s protocol and 
BIOMAX film (Kodak). 
 
2.19.3.3 Stripping Western blots 
To detect expression of a second protein, membranes could be stripped once and 
re-probed. The membrane was submerged in stripping buffer and incubated at 50⁰C 
for 30 minutes, with occasional agitation. It was washed twice in TBS-T and then 
exposed using the ECL Plus# kit with Hyperfilm to confirm that antibodies were 
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removed. The membrane was incubated for one hour in blocking solution and 
immunodetection continued as described in section 2.19.3.2. 
 
2.20 Statistical analysis 
Data was analysed using SPSS 17.0 Integrated Student Version and graphs were 
drawn using Microsoft Excel (version 14.0.0). Independent-samples t-tests were 
carried out to determine statistical significance. 
 
2.21 Solution recipes 
10X TBE (Tris-borate/EDTA) buffer  
89mM Tris  
89mM boric acid  
3mM EDTA  
This was prepared in dH2O, adjusted to pH8.3 and diluted with dH2O to make 1X 
TBE buffer. 
0.2M sodium phosphate buffer 
0.12M Na2HPO4  
0.8M NaH2PO4  
This was prepared in dH2O, adjusted to pH7 and treated to make it RNase-free. It 
was diluted as appropriate to produce other solutions. 
10mM sodium phosphate buffer 
0.2M sodium phosphate buffer was diluted as appropriate with RNase-free dH2O. 
20X SSC buffer 
3M NaCl 0.3M Na3citrate.2H2O This was prepared in dH2O, adjusted to pH7 and 





10%  SDS was diluted in sterile dH2O and was a constituent of several buffers. 
2%  SDS 
10%  SDS was diluted in RNase-free dH2O so it was at a final concentration of 2% . 
RNA loading buffer 
50%  glycerol  
5%  20X SSC buffer  
0.1%  bromophenol blue  
This was prepared in RNase-free dH2O and autoclaved. 
10X DNA loading buffer 
50%  glycerol  
0.25%  bromophenol blue  
This was prepared in dH2  and sterilised using a 0.2μM filter (Sartorius). 
10X TE (Tris-EDTA) buffer 
100mM Tris  
10mM EDTA  
This was prepared in dH2O, adjusted to pH7.6 and autoclaved. It was diluted in 
sterile dH2O to make 1X TE buffer. 
1M acetic acid 
17.4M glacial acetic acid was diluted to the appropriate concentration using sterile 
dH2O. 
Methylene blue solution 
0.2%  methylene blue  
0.4M sodium acetate 0.4M acetic acid  
This was prepared in sterile dH2O. 
Stripping buffer 
5%  SDS was prepared by diluting 10%  SDS in sterile dH2O. 
DEPC (diethyl pyrocarbonate)-treated water  
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1 ml DEPC  
1 litre dH2O water  
Mixed overnight then autoclaved. 
Agarose 
0.5 g UltraPure agarose (Invitrogen)  
50 ml 1 x TBE buffer Boiled until agarose is dissolved. 
1 μl 10 mg/ml ethidium bromide per 50 ml Agarose. 
Matrigel  
1ml Matrigel  
9ml DMEM  
Bottom of plate is covered, excess is removed. Plate kept at 37⁰C to allow Matrigel 
to set. 
MOPS (10 x) Solution  
3-[N-Morpholino]propane-sulfonic acid)  
41.8% MOPS powder  
50 mM sodium acetate  
10 mM EDTA 
PBS (Phosphate Buffered Saline) 
1 PBS tablet (Oxoid)  
100 ml dH2O 
Protein loading buffer  
3 parts 4 x NuPage sample buffer  
1 part b-mercaptoethanol 
TBS (Tris buffered saline) 
50 ml 1 M Tris  
30 ml 5 M Sodium chloride  
Made up to 1 l with MilliQ water 
TBS-T (Tris buffered saline + Tween-20) 
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999 ml TBS  
1 ml Tween-20 
1M dithiothreitol (DTT) 
1.542 g dithiothreitol  
Distilled water to 10 ml  
Disburse into 500 ml aliquots and store at -20⁰C 
5 M NaCl Stock  
292.2 g NaCl  
Distilled water to 1 litre  





Chapter 3: Expression of Notch receptors and ligands during 
differentiation of C2C12 cultures 
 
3.1 Introduction 
C2C12 cell culture and differentiation 
The aim of the experiments in this chapter was to investigate expression of Notch 
signalling pathway components during myogenesis in C2C12 cell line. Phase-
contrast images of the stages analysed during myogenesis are shown in Figure 3.1 
C2C12 cultures were maintained as proliferating myoblasts in growth medium for 
24 hours, then switched to differentiation medium and induced to undergo 
differentiation into multinucleated myotubes as described in material and methods, 
section 2.2.4. C2C12 cultures were isolated for examination from day 0 after the 
induction of differentiation, over a total period of 5 days. Fusion of myoblasts into 
myotubes was first observed after day 2 and continued over the next three days. 
Many large, multinucleated myotubes were observed after 5 days in culture (Figure 
3.1). 
Significantly, when C2C12 cell cultures are induced to differentiate, not all of the 
myoblasts differentiate; a proportion exits the cell cycle and persists as reversibly 
quiescent, mononucleated MyoD-ve, reserve cells (Yoshida et al., 1998), 
comparable to the way that some satellite cell progeny withdraw from 
differentiation when maintained on the surface of individual myofibres in 
suspension (Zammit et al., 2004). Reserve cells express Myf-5 and CD34 
(Beauchamp et al., 2000) and retain the ability to be reactivated, after which they 
proliferate and can then be induced to differentiate, leading again to a new mixed 
population of myotubes and reserve cells (Kitzmann et al., 1998; Lindon et al., 1998; 
Yoshida et al., 1998). These characteristics make reserve cells a useful model of 
quiescent satellite cells. This system is therefore a potentially useful in vitro model 
of satellite cells and may be used as a model of both myogenic differentiation and 
satellite cell specification. 
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Since Notch signalling is implicated in determining cell fate in a range of developing 
and adult tissues including skeletal muscle (reviewed in Artavanis-Tsakonas et al., 
1999), differences in the expression and/or distribution of Notch pathway 
components in C2C12 cultures may result in the specification of distinct fates. To 
further investigate the expression of components in differentiated cultures, 
undifferentiated reserve cells and differentiated myotubes were separated by 
partial trypsinisation to investigate the expression of Notch pathway components in 
cells that had adopted these alternate fates. 
 
Figure 3.1 Phase-contrast images showing the morphology of proliferating and 
differentiated C2C12 cells.  
a. Proliferating myoblasts (Day 0) were maintained in a growth medium. 
Differentiation was induced by serum-reduction and cultures were allowed to 
differentiate for 5 days. During the first 24 hours after differentiation was induced 
the cells underwent at least one further round of division and then withdrew from 
cell cycle (a). After 2 days morphological differentiation (i.e. myotubes formation) 
was first visible (arrow in c). Many large, multinucleated myotubes were visible by 
day 5 (arrows in d). ( ar: 20μM.) 
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3.2 Analysis of Notch receptor and ligand transcript expression during 
myogenesis in C2C12 cultures 
To investigate expression of Notch signalling components during myogenic 
differentiation, cultures of C2C12 myoblasts were switched to low serum medium 
and allowed to differentiate for 5 days. Cultures were harvested at 24-hour 
intervals and total RNA was extracted for analysis by reverse transcription-
polymerase chain reaction (RT-PCR). 
Figure 3.2 shows that the expression of MyoD was present in proliferating 
myoblasts throughout differentiation. Myogenin was almost undetectable in 
proliferating myoblasts but increased once differentiation had begun, coinciding 
with myotubes formation from Day 2 onwards. Notch1, Notch2 and Notch3 
transcripts were all present in proliferating myoblasts (albeit at relatively low 
levels). The Notch receptor transcripts were all up-regulated after 24 hours of 
differentiation and remained at similar levels for the subsequent 4 days. Notch4 
receptor was not detected in any of the samples (data not shown). 
 
Figure 3.2 also shows that Delta-like1 (DL1) transcript was expressed at a low level 
in proliferating myoblasts, but was upregulated when differentiation was induced. 
Delta-like 4 (DL4) was not detected in proliferating cultures, but was upregulated 1 
day after differentiation was induced. Delta-like 3 (DL3) was absent from C2C12 
cells (data not shown). Jagged1 and Jagged2 transcripts were expressed in 





       
Figure 3.2 RT-PCR analysis of Notch receptor and ligand expression during 
differentiation of C2C12 cultures. 
Total RNA was extracted from replicate C2C12 cultures immediately before inducing 
differentiation (Day 0) and at 24 hour intervals after induction (Day 1- Day 5). (A) 
RT-PCR analyses of Notch receptors (Notch1-4) and ligands (Dll1, 3 and 4; Jagged 1 
and 2). Notch4 and Dll3 were not detectable in any of the samples (data not 
shown). Expression of the myogenic regulatory factors MyoD and Myogenin are 
shown as markers of differentiation; Hypoxanthine guanine phosphoribosyl 
transferase (HPRT) is presented as an RT-PCR control. Reaction products were run 
on 1.5% agarose gels and visualized with ethidium bromide with the corresponding 
product sizes shown on the right. Primer sequences, RT-PCR conditions and cycle 
numbers are provided in the Materials and Methods (section 2.18). ( ) 1μg of each 
total RNA sample run on a 1.2% agarose gel and visualised with ethidium bromide 




3.3 Analysis of Notch receptor and ligand protein expression during 
myogenesis in C2C12 cultures 
To examine the expression of Notch signalling components at the protein level, 
whole cell lysates were prepared from myoblasts and cultures differentiated for up 
to 5 days. Protein was extracted at 24 hour intervals and analysed by Western 
blotting (see 2.19). 
Notch receptor antibodies used for Western blot analysis of the Notch receptors 
were specifically directed against the intracellular domain (ICD) of the protein. The 
membrane-bound form of each receptor has a higher molecular weight (around 
230kDa) than the cleaved (about 120kDa), active (around 100kDa), intracellular 
forms that translocates to the nucleus, since upon cleavage a small portion of the 
receptor is lost extracellularly (Okochi et al., 2002). Since the ICD-specific antibodies 
will detect the receptor before and after cleavage it is, therefore, possible to 
determine the activation status from the size of the bands detected (i.e. an active 
band will be approximately 10kDa smaller than the inactive membrane-bound 
form). Error! Reference source not found. shows that the expression of skeletal 
uscle-specific myosin heavy chain (MyHC) was progressively up-regulated with time, 
thereby confirming the kinetics of myogenic differentiation. When protein extracts 
from proliferating myoblasts were probed with antibodies specific to Notch1, 
Notch2 or Notch3 respectively, two predominant bands were detected. In each 
case, as stated above, the larger molecular weight band corresponds to the 
membrane-tethered, inactive form of the receptor, while the smaller molecular 
weight band is the activated, cleaved form.  These results show that proliferating 
myoblasts contained the membrane-bound and activated forms of Notch1, Notch2 
and Notch3, although Notch3 was present at much lower levels than the other two 
receptors. The level of expression of Notch1 was maintained throughout 
differentiation: Figure 3.3 shows that cleaved, active Notch1 was expressed 
throughout myogenic differentiation, but was slightly up-regulated after 48 hours 
(Day 3). In contrast, the active form of Notch2 was highly expressed in myoblasts, 
but decreased during early differentiation and was no longer detectable by day 3. 
Notch3 transcript was barely detected at Day 0 and Western blot analysis showed 
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that the full-length (inactive) Notch3 protein was predominant until Day 2/3 of 
differentiation. Although expression of the active form was upregulated at the 
initiation of differentiation, it became more prominant at Day 3, coincident with 
myotube formation. In all cases, Western blot data were consistent with the 
observed transcript expression (Figure 3.2). 
Notch receptor ligand, Dll1 gradually increased from Day0 to Day5. Interestingly, 
Dll4 was undetectable in proliferating cultures (Day 0), but was up-regulated 
between Day 2 and Day 3 as myotubes began to form. Jagged1 protein was highly 
expressed in proliferating myoblasts and throughout differentiation. Jagged1 
expression increased as differentiation proceeded. A correlation is found between 
protein and transcript expression of Jagged1 and Dll4 (Figure 3.2), as Jagged1 was 






Figure 3.3 Western blot analysis of Notch receptor and ligand expression during 
differentiation of C2C12 cultures 
Protein was extracted from C2C12 cultures immediately before inducing 
differentiation (Day 0) and at intervals after induction (Day 1- Day 5). Western blot 
analyses the expression of Notch receptors (Notch1-3), ligands (Dll1, Dll4 and 
Jagged 1) and Numb. Notch receptor and ligand expressions and activities were 
activated and detected after initiation of myotubes formation. Myosin heavy chain 
(MyHC) and -Tubulin expression were used as differentiation and loading control 
respectively. n=3 
 
3.4 Analysis of Notch receptor and ligand transcript expression in 
separated myotubes and reserve cells 
Data presented in sections 3.2 and 3.4 shows that Notch signalling components are 
expressed in differentiated cultures, which contain both differentiated myotubes 
and quiescent reserve cells (Yoshida et al., 1998). To investigate the distribution of 
Notch signalling components in differentiated cultures, C2C12 cultures were 
allowed to differentiate for 5 days and then separated by a modified method of 
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partial trypsinisation originally described by Carnac et al. (1992), which selectively 
detaches the myotubes releasing them in suspension whilst the reserve cells remain 
attached. This technique was modified to include three additional washes using PBS 
(see Materials and Methonds section 2.5) 
3.4.1 Separation of myotube and reserve cell fractions in differentiated C2C12 
cultures 
The phase contrast pictures shown in Figure 3.4 show the culture before and after 
the removal and collection of the myotubes with the reserve cells (d) remained 
attached. After 5 days of differentiation, cultures were separated into myotube and 
reserve cell fractions by partial trypsinisation. Briefly, cultures were rinsed with PBS 
and then incubated in 0.01% trypsin (Sigma) in PBS until the detachment of 
myotubes from the subscribe was observed. The detached myotubes were retained 
and the adherent cells rinsed again with PBS and then subjected to a series of 3 
one-minute incubations in 0.01% trypsin (with intervening PBS washes) to remove 
residual myoblasts and myocytes (as described in Materials and Methods). Total 
RNA was isolated from each fraction (myotubes, washings and remaining reserve 
cells) and the purity of the fractions was confirmed by RT-PCR (Figure 3.5 and Figure 
3.6).  
Expression of CD34, myogenin and MyoD were used as markers of reserve cells, 
differentiated cells and myoblasts/early myotubes, respectively (Zammit et al., 
2006). CD34 is a transmembrane sialomucin, expressed by haematopoietic stem 
cells (HSC) and progenitors and quiescent satellite cells (Beauchamp et al., 2000). 
CD34 is involved in the maintenance of quiescence and coexpression of CD34, Myf5 
and M-cadherin defines the majority of quiescent satellite cells (Beauchamp et al., 
2000). The satellite cell compartment is heterogeneous, as not all cells express 
these markers, which may result in divergent cell fates (Beauchamp et al., 2000). 
Thus CD34 is both a marker of satellite cells and of a population of muscle-derived 
stem cells.  
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MyoD, Myogenin and MRF are transcription factors markers that facilitate terminal 
differentiation of myoblasts into myocytes (Cornelison and Wold, 1997; Megeney et 
al., 1996; Yablonka-Reuveni and Rivera, 1994). 
The results showed that CD34 was exclusively expressed in the reserve cell fraction 





Figure 3.4 C2C12 myotube and reserve cell separation 
C2C12 myoblasts were grown for 24 hours and then induced to differentiation.  
(a). Unseparated culture after 5 days of differentiation. During the initial brief 
trypsinisation, the myotubes detach (b) leaving undifferentiated single cells and 
myocytes (c). A further three washes with trypsin were used to remove the 







Figure 3.5 Validation of the partial trypsination protocol 
C2C12 myoblasts were differentiated for 5 days. Total RNA was extracted from 
unseparated differentiated C2C12 cultures (U), myotubes (MT), washings (2, 3) and 
reserve cells (RC) by partial trypsinisation. RT-PCR analyses the efficiency of the 
modified partial trypsination protocol. CD34, MyoD and Myogenin were used to 
demonstrate efficient purification of the myotube (MT) and reserve cell (RC) 
fractions. HPRT is presented as an RT-PCR control. Reaction products were run on 
1.5% agarose gels and visualized with ethidium bromide with the corresponding 
product sizes shown on the right. Primer sequences, RT-PCR conditions and cycle 
numbers are provided in the Materials and Methods (section 2.18). n=3 
 
According to Figure 3.5, RT-PCR of total RNA from unseparated cultures, myotube, 
reserve cell fractions and two intermediate washes showed that the myotube 
fraction contained MyoD and myogenin transcripts, whilst the reserve cell fraction 
expressed only CD34, both consistent with the expected phenotypes. Cells detached 
by intermediate washes expressed MyoD and/or myogenin, presumably myoblasts 
and differentiated mononucleated myocytes. Therefore separation was successful 
in highly enriching each cell-type with no contamination between fractions.  
3.4.2 Distribution of Notch receptor and ligand transcript expression in 
differentiated C2C12 cultures 
Having validated the cell separation method, the distribution of Notch receptors 
and ligands between myotubes and reserve cells was investigated. Notch1 
transcript was expressed in both myotubes and reserve cells, but was highly 
enriched in the myotubes fraction, whilst Notch 2 and Notch 3 were highly 
expressed in reserve cells only. Dll1 expression was relatively low in reserve cells 
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but high in myotubes. Dll4 was exclusively expressed in myotubes fraction only 
whereas Jagged1 transcripts were highly expressed in reserve cells only.   
RT-PCR analysis of unseparated cultures, myotube and reserve cell RNA is shown in 
Figure 3.6. The analysis revealed the expected enrichment of MyoD in myotubes, is 
consistent with up-regulation of MyoD expression during myotube formation 
(Kitzmann et al., 1998). CD34, predicted from (Beauchamp et al., 2000), was highly 




Figure 3.6 RT-PCR analysis of Notch receptor and ligand expression in separated 
myotubes and reserve cells 
C2C12 myoblasts were differentiated for 5 days. Total RNA was extracted from 
unseparated differentiated C2C12 cultures (Total), myotubes (MT) and reserve cells 
(RC) by partial trypsinisation. (A). RT-PCR analyses of Notch receptors (Notch1-3) 
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and ligands (Dll1, Dll4 and Jagged 1). MyoD, Myogenin and CD34 were used to 
demonstrate efficient purification of the two fractions. HPRT is presented as an RT-
PCR control. Reaction products were run on 1.5% agarose gels and visualized with 
ethidium bromide with the corresponding product sizes shown on the right. Primer 
sequences, RT-PCR conditions and cycle numbers are provided in the Materials and 
Methods (section 2.18). ( ) 1μg of each total RNA sample run on a 1.2% agarose gel 
and visualised with ethidium bromide to confirm sample integrity. n=3 
 
3.4.3 Distribution of Notch receptor and ligand protein expression in 
differentiated C2C12 cultures 
 
Figure 3.7 Western blot analysis of distribution of Notch receptors and ligands in 
separated myotubes and reserve cells 
C2C12 myoblasts were differentiated for 5 days. Protein was extracted from 
unseparated differentiated C2C12 cultures (Total), myotubes (MT) and reserve cells 
(RC) by partial trypsinisation. Western blot analyses the expression of Notch 
receptors (Notch1-3), ligands (Dll1, Dll4 and Jagged 1). Notch receptor and ligand 
expressions and activities were activated and detected in myotubes or reserve cells 
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fraction. Myosin heavy chain (MyHC) and -Tubulin expression were used as 
differentiation and loading control respectively. n=3 
 
Protein extracts from myotubes and reserve cells were analysed by Western 
blotting (Figure 3.7). Using antibodies directed against of Notch1, Notch2 or Notch3 
ICDs, allowing the determination of their activated status.  
Figure 3.7 shows a very faint band of activated Notch1 was detected in the reserve 
cells whereas high levels of activated Notch1 were detected in the myotubes. When 
blots were probed with antibodies specific for Notch2 or Notch3 ICD, two bands 
were detected in the reserve cell fraction only. In both cases, the larger molecular 
weight band corresponds to the membrane-bound inactive form of the receptor, 
while the smaller molecular weight band is the activated, cleaved form of the 
receptor. Reserve cells contained the membrane-bound and activated forms of 
Notch2 and Notch3. Transcript Figure 3.6 shows only Notch1 in myotubes fraction, 
no Notch2 or Notch3. This is completely consistent with the protein data. 
Western blot analysis showed that Dll1 was expressed at a low level in reserve cells 
was highly expressed in myotubes, consistent with observed the expression of its 
transcript reflecting the expression of its transcript (Figure 3.6A). The observed 
expression of Dll4 and Jagged1 proteins were also consistent with transcript 
expression with Dll4 was expressed only in the myotube fraction whilst Jagged1 
protein was highly expressed in reserve cells only. This shows that following 
differentiation, Dll4 and Dll1 are expressed by myotubes, whereas Jagged1 is 
restricted to the reserve cell fraction. 
 
3.5 Discussion 
The aim of the experiments performed during this thesis was to decipher the role of 
the Notch signalling pathway and of the different receptors and ligands during 
myogenic differentiation using C2C12 cultures. The results demonstrated that 
myogenic differentiation is accompanied by changes in the expression profiles of 
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the Notch components, and that differential expression of receptors and ligands in 
were present at different stages of differentiation in the cellular model tested, i.e. 
C2C12.This is consistent with Notch signalling playing a role in the cell fate decisions 
during myogenesis, as initially hypothesized. 
3.5.1 Proliferating myoblasts 
Notch receptor expression was analysed both at the transcript and protein level. 
Notch1, Notch2 and Notch3 (but not Notch4) were expressed in proliferating 
myoblasts, although the level of Notch3 expressed was very low compared with 
Notch1 and Notch2.  Therefore, whilst un-cleaved Notch3 was present in 
proliferating (and differentiating, see below) muscle cells, activated Notch3 was 
present from Day 1 only. 
 
Since active Notch1 and Notch2 are expressed in proliferating myoblasts it suggests 
that they may play a role in maintaining a proliferative state as previously shown 
both in development and during adult tissue regeneration (Conboy et al., 2003; 
Conboy and Rando, 2002; Schuster-Gossler et al., 2007; Vasyutina et al., 2007). 
Active Notch3 is undetectable during proliferation; it is thought to perform 
functions distinct from Notch1 and Notch2 (Beatus et al., 1999; Beatus et al., 2001). 
Although the active Notch3 ICD can bind to RBPJK, it is a poor transcriptional 
activator (Kadesch, 2000); indeed Notch3 can act as a transcriptional repressor by 
competing with the Notch1 ICD and blocking Notch1 ICD’s ability to bind to a 
common co-activator, PCAF present in limited amount or by competing with Notch1 
ICD and preventing it from binding to RBPJK and activating target genes (Beatus et 
al., 1999). Furthermore, the Notch2 ICD may be inhibited by Notch3 (Beres et al., 
2006). Although, conversely Notch2 ICD may negatively regulate Notch1 and 




 myoblasts myotubes reserve cells 
Notch1 + + +/- 
Notch2 + - - 
Notch3 - - + 
Delta-like1 + + - 
Delta-like 4 - + - 
Jagged 1 + - + 
Table 3.1 Expression levels of Notch receptors and ligands in myoblasts, myotubes 
and reserve cells fraction 
 
The activation of the various Notch receptors in proliferating myoblasts requires 
interaction with ligands on the surface of adjacent cells (Parks et al., 2000; Conboy 
and Rando, 2002; Ross and Kadesch, 2004). Both RT-PCR and Western blot analysis 
showed that Dll1 was expressed by proliferating myoblasts. In contrast, Dll4 was 
undetectable in proliferating cultures by RT-PCR and Western blot in proliferating 
myoblasts. RT-PCR showed that Jagged1 and Jagged2 transcripts were expressed at 
a high level in proliferating myoblasts. In addition, Western blot analysis confirmed 
the elevated expression of Jagged1 in myoblasts. It is likely, therefore, that Dll1 and 
Jagged1 (and probably Jagged2) expressed on the cell surface activates 
transmembrane Notch receptors (Notch1 and Notch2) on adjacent myoblasts, 
which signal via the RBPJK-dependent pathway to transactivate target genes. It has 
also been shown that activated Notch can autonomously induce Jagged1 activity 
(Ross and Kadesch, 2004), such that active Notch receptors and Jagged1 can be 
expressed simultaneously within a cell. Induced Jagged1 has no autocrine effect on 
Notch signalling, but can promote signalling in adjacent naive cells (Ross and 
Kadesch, 2004). Therefore, proliferating myoblasts may exist as a homogeneous 
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population where all cells express Jagged1, and possibly Jagged2 together with 
active Notch receptors. 
 
3.5.2 Expression of Notch receptors and ligands during muscle cell 
differentiation. 
The induction of differentiation in C2C12 cultures led to changes in the expression 
levels of the Notch receptors and ligands analysed. These changes were most 
apparent between 24 and 48 hours, coincident with the onset of morphological 
differentiation. This suggests that Notch signalling may potentially be involved in 
cell fate decisions made at this time: specifically  concerning the decisions of the 
cells to become myotubes or maintained as reserve cells. This is directly connected 
to the initial hypothesis: Notch signalling is involved in the decision that leads to the 
generation of precursors, i.e. satellite cells, and in the process that leads to their 
proper location in the niche between basal lamina and differentiated muscle fibres. 
 
Expression of activated Notch1 remained relatively constant throughout myogenic 
differentiation, although it was noticeably upregulated after 48 hours. In 
differentiated cultures, membrane-bound and active Notch1 were present at a 
highly elevated level in myotubes, with much lower level of expression in reserve 
cells. Previous studies (Kitzmann et. al., 2006; Sun et. al., 2008) have reported active 
Notch1 in quiescent reserve cells, but this is probably due to the separation 
technique used. The original method used to separate myotubes and reserve cells 
as described by Carnac and co-workers (Carnac et. al., 1992) was modified by the 
addition of controlled washes to obtain purer reserve cell fractions (Figure 3.5). RT-
PCR analysis of cells removed by these washes showed them to express MyoD 
and/or Myogenin, suggesting that they are either myoblast or differentiated 
mononucleated myocytes: such contaminating cell types express Notch1 and would 
therefore provide a false positive result. 
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Active Notch2 was expressed initially but then began to disappear 48 hours after 
differentiation was induced. However, expression of the membrane-tethered form 
of Notch2 was maintained exclusively in reserve cells. The apparent disappearance 
of Notch2 from unseparated differentiated cultures may be explained because the 
reserve cells contribute only a small proportion of the total protein in a 
differentiated culture (myotubes contain a large amount of contractile proteins), so 
the signal is diluted and hence is not detected. In contrast, Notch1 was expressed in 
both fractions and was, therefore, detectable. 
Active Notch3 was detectable sooner after the initiation of differentiation, reaching 
a maximum after 48-72 hours during myotube formation and was localised entirely 
in reserve cells. Notch3 (active/inactive form) was detected in unseparated cultures 
throughout myogenic differentiation, even though it was only expressed in the 
reserve cells. This suggests a particularly high level of Notch3 expression in reserve 
cells (compared with Notch2), indicating Notch3 could potentially be the dominant 
Notch receptor in these cells. 
Since active Notch1 (very low level), Notch2 and particularly Notch3 are expressed 
in reserve cells it is possible that Notch signalling plays a role in reserve cell 
specification. 
Active Notch1 may inhibit differentiation of a subset of cells (Nofziger et al., 1999; 
Shawber et al., 1996), ensuring that they are maintained as reserve cells. The 
marked up-regulation of Notch3 when cell fate decision is being made and its 
maintenance in the reserve cells strongly suggests that Notch3 plays a crucial role in 
the specification and maintenance of the stem cell phenotype within a 
differentiating culture. High expression of the active Notch3 ICD may prevent the 
Notch1 (Beatus et al., 1999) and Notch2 ICDs (Beres et al., 2006) from binding to 
RBPJK and/or a common coactivator, preventing transactivation of their 
downstream target genes and any unbound active Notch3 ICD may bind to RBPJK, 
and act as a weak transcriptional activator or possibly even a repressor of a specific 
cohort of target genes (Beatus et al., 1999; Kadesch, 2000). The outcomes of the 
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interacting regulatory mechanisms could result in the expression of a particular set 
of target genes and hence specify the maintenance of reserve cells. 
Activation of the Notch receptors in reserve cells would require interaction between 
transmembrane Notch receptors with ligands on the surface of adjacent cells 
(reviewed in Artavanis-Tsakonas et al., 1999), or autonomous activation by Dtx 
proteins (Kishi et al., 2001). Both Dll1 and Dll4 expression are up-regulated upon the 
induction of differentiation. Dll1 was expressed in both myotubes (more 
abundantly) and reserve cells, but Dll4 was expressed exclusively in myotubes. 
Dll4 was undetectable in proliferating cultures (Day 0), but was up-regulated 
between Day 2 and Day 3 as myotubes began to form. The pattern of Dll4 
expression during myogenesis is coincidentally consistent with Notch 3 receptor. 
In contrast, Jagged1 and Jagged2 were expressed throughout differentiation. 
However, Western blot analysis demonstrated a gradual increase in Jagged1 protein 
expression, in contrasts to the increasing expression of the Delta-like ligands. 
Following differentiation, Jagged1 was expressed in reserve cells presumably at a 
high level, since it was observed in unseparated cultures where the signal is diluted 
by the presence of myotube proteins. Therefore, it is possible that transmembrane 
Jagged1 on reserve cells could activate transmembrane Notch receptors on 
adjacent cells, which signal via the RBPJK-dependent pathway to transactivate 
target genes that specify those cells as reserve cells. Hence, Jagged1 recruit more 
reserve cells. 
Numb could prevent NICD from translocation to the nucleus by interacting with the 
membrane-tethered form of Notch, thus inhibiting Notch signalling (McGill and 
McGlade, 2003). Specifically ubiquitin-mediated degradation and receptor 
endocytosis have been proposed as potential mechanisms for Numb-dependent 
Notch downregulation (Berdnik et al., 2002; McGill and McGlade, 2003). 
Notch/Numb signalling pathways may regulate myogenic cell fate decisions (Conboy 
and Rando, 2002; Halevy et al., 2004). It is well-established that Notch signalling 
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inhibits MyoD expression and therefore differentiation (Kopan et al., 1994). This is 
consistent with the hypothesis that inhibition of Notch1 signalling as mediated by 
an up-regulation of the antagonist, Numb, may allow exit from a progenitor stage 
into differentiation, whilst constitutively high levels of Notch1 signalling maintain 
cells in the intermediate progenitor stage. It has therefore been suggested that the 
balance between Notch1 and Numb may control cellular homeostatic and cell fate 
decision. (Conboy and Rando, 2002). 
Western blot analysis revealed that the inhibitory molecule Numb is expressed in 
proliferating myoblasts and was maintained throughout differentiation for 5 days. 
Notch1 is targeted by all four mammalian Numb isoforms ((65, 66, 71 and 72kDa 
(Dho et al., 1999)), Notch2 is variably repressed and Notch3 is not a target of any of 
the Numb proteins (Beres et al., 2006). Hence, in proliferating myoblasts, Numb 
could inhibit signalling of Notch1 and Notch2. 
Results presented in this chapter have revealed the differential expression of Notch 
receptors and ligands during and myogenic differentiation and the differences in 
expression profiles in cells that adopt different fates. These changes were mostly 
observed after 24 to 48 hours, coincident with the onset of morphological 
differentiation, which suggests that the expression levels of the Notch signalling 
components may be involved in determining cell fate. Different receptor/ligand 
profiles are expressed in proliferating myoblasts, differentiated myotubes and 
undifferentiated reserve cells. These differences may underlie the distinct 
outcomes: regulating both the proliferation of muscle precursors through 
interaction with other myoblasts and, through interaction with differentiated cells, 
the specification of reserve cells. Most significantly, active Notch3 was expressed 
exclusively in the reserve cell fraction but was completely absent from the myotube 
fraction. The marked upregulation of Notch3 when the cell fate decision is being 
made and is maintenance in the reserve cells strongly suggests that Notch3 may 
play a crucial role in the specification and maintenance of the stem cell phenotype 
within a differentiating culture. Furthermore, the Notch ligand, Dll4 is up-regulated 
at approximately the same time as Notch3 during skeletal muscle cell 
differentiation, which leads to the hypothesis that the appearance of differentiated 
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cells during muscle regeneration may direct other as yet “undecided” cells into a 




Figure 3.8 Possible model for Notch3 receptor function during myogenic 
differentiation. 
Notch3 is activated after differentiation is induced in proliferating myoblast cultures 
(Notch3–ve, Notch1+ve, Notch2+ve, Dll1+). Cell fate is determined by the presence 
or absence of Notch3 activation by its ligand. In the presence of ligand in the 
adjacent nascent cells (possibly Dll4), Notch3 is activated and the cell is specified as 
a reserve cell. 
 
Based on the results obtained, a simple model of the role of Notch3 in the 
specification of reserve cells is speculated as shown in Figure 3.8. After 
differentiation is induced in the activated myoblasts (Notch3–ve, Notch1+ve, 
Notch2+ve, Dll1+ve and Jagged1+), Notch3 is activated. Unfused single cells in 
differentiated cultures could either remain in the cell cycle or exit to become an 
undifferentiated reserve cell. For Notch3 to have an effect on myoblast fate 
decisions, it must interact with a Notch ligand. One possible explanation is that such 
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a ligand may be expressed on newly formed myotubes that can interact with 
remaining undifferentiated cells: one possible candidate is DL4. 
 
Chapter 4: The effects of shRNA-mediated knockdown of 




Results presented in Chapter 3 show that Notch3 becomes up-regulated and active 
when skeletal muscle precursor cells are induced to differentiate and is 
subsequently maintained exclusively in reserve cells and not in myotubes. Thus, 
Notch3 is active when the decision is made either to commit to differentiation or to 
adopt a quiescent reserve cell fate. However, this is not enough to ascertain that 
Notch3 plays an active role in this decision, and functional studies must be carried 
out to further investigate the original hypothesis on the role of Notch3 in the 
establishment of quiescent satellite cells in their niche. The aim of this chapter was 
to investigate whether Notch3 activity is required for reserve cell specification by 
investigating the effects of inhibiting expression on the behaviour and 
differentiation of skeletal muscle precursor cells. The hypothesis was that if Notch3 
is required, reduced levels of expression and therefore activity should promote 
differentiation and enhance myotube formation. 
 
4.2 shRNA-mediated knockdown of Notch3 expression 
Four SureSilencing™ shRNA/GFP plasmids designed to knockdown the expression of 
mouse Notch3 (P1-P4) and a control plasmid encoding an irrelevant scrambled 
sequence (P5), were obtained from SA Biosciences (sequences provided in Materials 
and Methods, section 2.8.20). To determine which plasmid was the most effective, 
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stably-transfected C2C12 cultures were generated by co-transfection with one of 
the above plasmids, together with a Neomycin resistance plasmid (pC1Neo) 
followed by selection in G418 (Materials and Methods, section 2.9.4). Cultures were 
allowed to differentiate for 48 hours to allow maximal Notch3 expression and then 
total RNA and protein were extracted for analysis by RT-PCR and Western blotting, 
respectively (Figure 4.1A and B). The results show that transfection with P3 
markedly reduced the levels of both Notch3 transcript and protein, whereas P1, P2 
and P4 had no significant effect compared with the control plasmid, P5. 
Importantly, Western blotting analysis showed the expression of the related Notch1 
receptor was unaffected by the shRNA sequence encoded by P3 (Figure 4.1C). The 
G418-selected, uncloned cultures expressing P3 were therefore chosen for further 






Figure 4.1 shRNA-mediated knockdown of Notch3 expression in C2C12 cultures 
Proliferating C2C12 myoblasts were co-transfected with SureSilencing™ shRNA/GFP 
plasmids containing either potential shRNA knockdown sequences (P1-P4) or an 
irrelevant scrambled control sequence (P5), together with the Neomycin-resistance 
plasmid, pC1Neo. After selection with G418, cultures were transferred to 
differentiation medium for 48 hours to induce maximal levels of endogenous 
Notch3 expression as observed in untransfected C2C12 cells. (A) RT-PCR analysis of 
Notch3 transcript expression (HPRT) is shown as a control. (B) Western blot analysis 
of Notch3 protein levels. The membrane was probed with an antibody raised 
against the Notch3 ICD (M-20; Santa Cruz). (C) Western blot analysis of Notch1 
protein levels in cultures transfected with P3 or P5, using an antibody raised against 
the activated Notch1CD (Abcam). - Tubulin was used as a loading control for 
Western blot analyses: the sizes of the RT-PCR products and protein bands were 
determined by the use of appropriate markers and are indicated on the left. n=3 
 
4.3 Effects of Notch3 knockdown on the behaviour of C2C12 cultures 
4.3.1 Proliferation of C2C12 myoblasts 
The effects of Notch3 knockdown on myoblast proliferation were assessed using 
C2C12 cultures stably expressing either the P3 (knockdown) or P5 (shRNA control) 
plasmids, compared with untransfected C2C12 myoblasts. Myoblast cultures were 
seeded in 96 well plates at a density of 1000 cells/well and after 24 hours, the 
number of cells was determined using a colorimetric assay (Materials and Methods, 
section 2.4). The results shown in Figure 4.2 show that knockdown of Notch3 had 
no effect on myoblast proliferation, consistent with the fact that Notch3 is present 




Figure 4.2 Effects of shRNA-mediated knockdown of Notch3 on C2C12 myoblast 
proliferation. 
Proliferating C2C12 myoblasts, either untransfected, transfected with P3 
(knockdown) or with P5 (control shRNA) were seeded at the same density (1000 
cells/well) in 96 well plates and cultured for 24 hours as proliferating myoblasts in 
growth medium containing high levels of serum. (A) Representative phase contrast 
images of proliferating cultures (scale bar = 20µm). (B) Histogram showing cell 
number as determined using the CellTiter 96 Aqueous One Solution colorimetric cell 
proliferation assay (Promega). Each column shows the mean of three wells (± 1 SD) 
and when compared using a Student’s t-test, there were no significant differences 




4.3.2 Differentiation of C2C12 cultures 
To investigate the effects of shRNA-mediated inhibition of Notch3 on myogenic 
differentiation, C2C12 cells transfected with either P3 (knockdown) or P5 (shRNA 
control) were transferred to and maintained in low serum-containing differentiation 
medium (Materials and Methods, section 2.2.4, section 2.9.4)). Although inhibition 
of Notch3 expression had no effect on proliferation in growth medium, it appeared 
that after 48 hours in differentiation medium, P3-transfected cultures contained 
more cells than untransfected or P5-transfected cultures, an observation that was 
confirmed using the cell proliferation assay (Figure 4.3). In untransfected cultures, 
Notch3 activity is upregulated by 48 hours after differentiation is induced (Chapter 
3.3), during which time the myoblasts withdraw from the cell cycle and initiate a 
program of myogenic differentiation. Cultures in which Notch3 expression was 
inhibited by shRNA proliferated normally in growth medium, but when induced to 
differentiate, the absence of Notch3 appeared to increase or prolong proliferation 






Figure 4.3 Effects of shRNA-mediated knockdown of Notch3 on cell proliferation in 
C2C12 cultures induced to differentiate 
C2C12 myoblasts, either untransfected, transfected with P3 (Notch3 knockdown 
shRNA) or with P5 (control shRNA) were seeded at the same density (1000 
cells/well) in 96 well plates, cultured for 24 hours in growth medium and then for a 
further 48 hours in differentiation medium containing low levels of serum. (A) 
Representative phase contrast images of cultures (scale bar = 20µm). (B) Histogram 
showing cell number determined using the CellTiter 96 Aqueous One Solution 
colorimetric cell proliferation assay (Promega). Each column shows the mean of 
three wells (± 1 SD) and when compared using a Student’s t-test, cultures 
transfected with P3 contained significantly more cells than either those transfected 
P5 plasmid (p=0.025) or untransfected controls (p=0.021). 
 
When skeletal muscle cultures are induced to differentiate, levels of the myogenic 
regulatory factor MyoD increase in cells destined to differentiate whereas those 
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that adopt the reserve cell fate become MyoD-ve (Yoshida et al 1998). To 
investigate the effect of Notch3 inhibition on MyoD expression, C2C12 cultures 
transfected with either P3 (knockdown) or P5 (shRNA control) were seeded into 8-
well chamber slides (1000 cells/well), cultured for 24 hours in growth medium and 
then for a further 48 hours in differentiation medium. The cultures were then fixed 
and co-immunostained for MyoD and GFP (Materials and Methods, section 2.14.2). 
Figure 4.4 shows that in the absence of Notch3 (P3), the percentage of cells 
expressing MyoD was significantly increased (p=0.0001) compared with control 
cultures, indicating that Notch3 inhibits MyoD expression. 
 
Figure 4.4 Effects of shRNA-mediated knockdown of Notch3 on MyoD expression 
in C2C12 cultures after 48 hours of differentiation. 
C2C12 myoblasts expressing the shRNA plasmids P3 (Notch3 knockdown) or P5 
(control) were seeded into 8-well chamber slides, cultured in growth medium for 24 
hours and then induced to differentiate. After 48 hours, cultures were fixed and co-
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immunostained for anti-MyoD antibody (Dako 5.8A); red) and anti-GFP antibody (A 
Molecular Probes; green) and counterstained with the nuclear stain, DAPI, to reveal 
all nuclei. (A) Histogram showing the mean percentage of GFP+ve cells expressing 
MyoD. For each column, three separate cultures were analysed (at least 200 
cells/culture) and the mean value is shown ± 1SD. When compared using a 
Student’s t-test, the percentage of GFP+/MyoD+ve cells was statistically greater in 
the P3-transfected cultures compared with the control (p<0.0001). (B) 
Representative fluorescent microscopy images showing cultures stained for MyoD 
(a, e) and GFP (b, f); also shown are overlaid images (c, g) and DAPI staining of the 
same cultures (scale bar = 20µm). 
 
To investigate the effects of Notch3 knockdown on later stages of myogenic 
differentiation, P3-transfected (knockdown), P5-transfected (shRNA control) and 
untransfected C2C12 cultures were established as above and maintained for several 
days in differentiation medium. After 4 days, all cultures contained large numbers 
of differentiated, multinucleated myotubes, the number and size of which 
continued to increase during the following 2 days (Figure 4.5). Even after 4 days of 
differentiation, the Notch3 knockdown cultures appeared to contain relatively more 
myotubes and fewer mononucleated single cells than either control cultures (Figure 




Figure 4.5 Effects of Notch3 knockdown on the morphology of differentiated 
C2C12 cultures. 
Untransfected C2C12 myoblasts and myoblasts transfected with shRNA plasmids P3 
(Notch3 knockdown) or P5 (shRNA control) were cultured in growth medium for 24 
hours and then induced to differentiate. Phase contrast images of cultures were 
captured after 4 days (A) and 6 days (B) in differentiation medium (scale bar = 
20µm). n=5 
 
To further investigate the effect of Notch3 knockdown on differentiation, P3-
transfected (knockdown) and P5-transfected (shRNA control) myoblasts were 
seeded into 8-well chamber slides (1000 cells/chamber), cultured for 24 hours in 
growth medium and then switched to differentiation medium. After 5 days, the 
cultures were fixed and co-immunostained with antibodies against skeletal muscle 
myosin heavy chain (MyHC) and GFP and counterstained with DAPI to reveal the 
nuclei (Figure 4.6A). To determine the fusion index (i.e. the proportion of cells that 
had differentiated), the percentage of total nuclei present in MyHC+ve cells, both 
multinucleated myotubes and mononucleated myocytes, were counted. The mean 
percentage of nuclei in MyHC+ cells was significantly higher in the Notch3 
knockdown cultures (P3) compared with the shRNA control (P5) (p=0.002) (Figure 
4.6B). Conversely, the mean percentage of GFP+ve undifferentiated cells (MyHC-ve) 
was significantly lower in knockdown cultures compared with shRNA controls 
(p=0.0004) (Figure 4.6C). As mentioned previously, the presence of GFP-ve cells in 
the G418-selected cultures was assumed to be due to the silencing or elimination of 
the shRNA plasmid in cells that had retained the Neomycin-resistance plasmid. 
Therefore, the decreased proportion of GFP+ve cells in the undifferentiated 
population in the P3-transfected cultures suggests that a large proportion of the 
cells that had not differentiated were not expressing the shRNA sequence and 




Figure 4.6 Effects of shRNA-mediated knockdown of Notch3 on the differentiation 
of C2C12 cultures. 
(A) C2C12 myoblasts transfected with shRNA Notch3 knockdown plasmid (P3) or an 
shRNA control plasmid (P5) were allowed to differentiate for 5 days, fixed and co-
immunostained with antibodies against skeletal muscle myosin heavy chain (MyHC) 
a marker of differentiation (MF20; red) and GFP (Molecular Probes; green): DAPI 
was used as a counterstain to reveal all nuclei (blue) (scale bar = 20µm). Histograms 
showng (B) the mean percentage of nuclei in differentiated (MyHC+ve) cells and (C) 
the mean percentage of undifferentiated cells (MyHC-ve) expressing GFP. For (A) 
and (B), 3 replicate cultures were analysed and at least 200 cells were counted per 
culture. The mean percentage of the 3 cultures are shown (± 1 SEM) and were 
compared using a Student’s t-test: ** denotes a significant difference in the mean 
percentage of nuclei in MyHC+ve cells (p=0.002); *** indicates a significant 




4.3.3 Apoptosis of C2C12 cultures 
The results presented above show that shRNA-mediated knockdown of Notch3 
expression in differentiating C2C12 cultures results in an increase in the proportion 
of cells expressing MyoD followed by an increase in the proportion of cells that 
differentiate and a decrease in the proportion that persist as undifferentiated 
reserve cells. 
It has been shown that when C2C12 cultures are induced to differentiate, the 
myoblasts can adopt one of three fates: whilst the majority undergo terminal 
differentiation to form myotubes, the remainder either persist as undifferentiated, 
quiescent reserve cells, or undergo apoptosis (Cao et al., 2003). Results presented 
above show that knockdown of Notch3 did not affect myoblast proliferation: 
indeed, proliferation appeared to be prolonged or increased during the period 
immediately after differentiation was induced. It is therefore unlikely that the 
reduction in the number of undifferentiated single cells observed in differentiated 
Notch3 knockdown cultures is due to an effect on proliferation. However, another 
possible reason for this reduction could be an increase in the level of apoptosis 
amongst undifferentiated cells as it has been previously suggested that Notch3 
signaling may be a critical determinant of cell survival (Wang et al., 2002, Konishi et 
al 2010, Nwabo Kamdje et al., 2011). 
To investigate potential effects on apoptosis, cultures of untransfected, P3-
transfected (knockdown) and P5-transfected (shRNA control) C2C12 myoblasts 
were seeded in 96-well plates at the same density (1000 cells/well), maintained in 
growth medium for 24 hours and then transferred to differentiation medium. After 
48 hours, Caspase 3/7 activity was measured using the Caspase3/7-Glo assay kit 
(Promega: Materials and Methods, section 2.4.2). A 48 hour time point was chosen 
as this is when Notch3 activity is highest following the induction of differentiation 
(Chapter 3, section 3.3). Caspases are a group of cysteine proteases that are the 
central effectors of apoptosis (Fesik and Shi, 2001), such that the level of caspase 
3/7 activity is an accepted indicator of the level of apoptosis. 
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After 48 hours of differentiation, the mean level of caspase 3/7 activity was 
significantly higher in Notch3 knockdown cultures (P3) compared with either shRNA 
control (P5) or untransfected cultures (Figure 4.7). 
 
Figure 4.7 Effect of shRNA-mediated knockdown of Notch3 expression on 
apoptosis in differentiating C2C12 cultures 
Untransfected (C2C12), P3-transfected (shRNA-mediated Notch3 knockdown) and 
P5-transfected (shRNA control) C2C12 cultures were seeded into 96-well plates, 
maintained in growth medium for 24 hours and then induced to differentiate. After 
48 hours in differentiation medium, caspase 3/7 activity was measured using a 
Caspase3/7-Glo assay kit (Promega). Each column shows the mean activity from 
three wells, ± 1 SD, which were compared using a Student’s t-test. * Denotes a 
significant difference in the mean caspase 3/7 activity in Notch3 knockdown 
cultures compared with shRNA control cultures (P5) (p=0.000012): *** denotes a 
significant difference compared with untransfected cells (C2C12) (p=0.00001). 
 
These data show that the levels of caspase 3/7 activity in the shRNA –mediated 
Notch3 knockdown cultures were approximately 3.5 times greater than in either of 
the controls, suggesting that once differentiation is induced, Notch3 activity is 
required to prevent apoptosis, presumably of cells that have yet to differentiate or 




4.4 Effects of Notch3 knockdown and overexpression on the behaviour of 
mouse primary skeletal muscle cultures 
Previous results in this chapter were obtained using the mouse skeletal muscle cell 
line C2C12 which can be propagated indefinitely and therefore selected for stable 
expression following transfection. However, this abnormal proliferative capacity, 
together with the ability to form tumours in vivo (Morgan et al., 2002), mean that 
results obtained with this line require further validation, particularly as Notch3 has 
also been implicated in tumourigenesis in other systems (Bellavia et al., 2002; Dang 
et al., 2006; Park et al., 2006; Yamaguchi et l., 2008; Serafin et al, 2011). 
In order to further investigate the effects of Notch3 on the behaviour of skeletal 
muscle cell precursors, the shRNA Notch3 knockdown (P3) and shRNA control P5) 
plasmids described above were used to transiently transfect cultures of primary 
skeletal muscle cultures derived from mouse satellite cells. In the following 
experiments, single myofibres were obtained by collagenase-digestion of 8 week-
old, C57BL/10 (i.e. strain) mouse EDL muscles and the satellite cells isolated by 
trypsinisation as described in Materials and Methods (section 2.7.2 and 2.7.3). The 
pooled satellite cells were cultured for 72 hours, and the satellite cell-derived 
myoblasts were then seeded into Matrigel-coated, 8-well chamber slides at 3000 
cells/chamber. Cultures were transfected 24 hours after plating (Materials and 
Methods, section 2.9) and after a further 24 hours, cultures were induced to 
differentiate and were maintained for 48 hours prior to fixation and analysis. 
(Materials and Methods, section 2.2). In addition to shRNA-mediated knockdown of 
Notch3, the effects of overexpression of constitutively-active Notch3ICD were 
investigated by transfection with pMSCV-Notch3ICD-IRES-eGFP (pNotch3/MIG) 
compared with the empty control vector, pMSCV-IRES-eGFP (pMIG) (Materials and 
Methods, section 2.8). Both of these vectors were modified from the retroviral 
backbone pMSCV-puro (Clontech) as described in Zammit et al (2006) and although 
originally designed for retroviral packaging, were used as plasmids. 
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4.4.1 Effects of shRNA-mediated knockdown and overexpression of Notch3 on 
mouse primary skeletal muscle culture differentiation 
To test the effects of modulating Notch3 activity on the ability of primary skeletal 
muscle myoblasts to differentiate, proliferating cultures of satellite cell-derived 
myoblasts were established as above and transfected with plasmids encoding either 
the shRNA Notch3 knockdown sequence (P3), the shRNA control sequence (p5), 
Notch3ICD (pNotch3/MIG) or the corresponding control, pMIG mig. After 48 hours 
of differentiation, cultures were co-immunostained for skeletal muscle MyHC and 
GFP and counterstained with DAPI. To determine the extent of differentiation, the 
mean percentages of total nuclei present in MyHC+ve cells (myotubes or 
mononucleated myocytes) were counted. Figure 4.8B shows that the mean 
percentages of nuclei in differentiated cells were similar following transfection with 
the control plasmids (P5 and pMIG). However, knockdown of Notch3 activity (P3) 
resulted in a significant increase in the fusion index (p0.0001) compared with the 
shRNA control (P5), whereas expression of active Notch3ICD significantly inhibited 
differentiation compared with the pMIG control (p=0.002). When the 
undifferentiated, MyHC-ve cell populations were examined, there was a 
significantly lower mean percentage of GFP+ve cells in the Notch3 knockdown 
cultures compared with the shRNA control and a significantly higher mean 
proportion of GFP+ve cells in the Notch3ICD transfected cultures compared with 
the pMIG control (in both cases, p=0.0003). All of these findings are consistent with 
the effects of shRNA-mediated knockdown of Notch3 activity on the differentiation 
of C2C12 cultures (Section 4.3.2), and suggest that in the knockdown cultures, a 
higher proportion of the remaining cells had formed or become incorporated into 
myotubes and that of those that did not differentiate, most had not been 
transfected and were presumably, Notch3+ve. Where NotchICD was overexpressed, 
differentiation was inhibited and the undifferentiated population was 




Figure 4.8 Effects of modulating Notch3 activity on the differentiated of mouse 
primary skeletal muscle cultures 
Cultures of primary mouse satellite cell-derived myoblasts were established, 
transfected with either P3 (shRNA Notch3 knockdown), P5 (shRNA control), 
pNotch3/MIG (constitively-active Notch3ICD) or pMIG (control) and allowed to 
differentiate for 48 hours. (A) Fluorescence microscopy images of representative 
cultures fixed and co-immunostained for the expression of skeletal muscle MyHC 
(MF20 (DSHB); red) and GFP (Molecular Probes; green), counterstained with DAPI 
(blue) to reveal all nuclei. Scale bar = 20µm. (B) Histogram showing the mean 
percentages of nuclei in differentiated (MyHC+ve) cells. (C) Histogram showing the 
mean percentages of GFP+ve (i.e. transfected) undifferentiated, MyHC-ve cells. In 
MyHC/GFP /Dapi MyHC/GFP /Dapi MyHC/GFP /Dapi MyHC/GFP /Dapi 
Dapi Dapi Dapi Dapi 
GFP GFP GFP GFP 
MyHC MyHC MyHC MyHC 
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both (B) and (C), each column represents the mean of three cultures (at least 200 
nuclei from each). 
 
The fluorescence microscopy images shown in Figure 4.8A suggest that the 
myotubes formed in the Notch3 knockdown cultures were much larger than in 
either of the control cultures. To further investigate this observation, myotube size 
was determined by measuring the average width of a random sample of GFP+ve 
myotubes. Briefly, mouse primary skeletal muscle cultures were prepared, 
transfected, allowed to differentiate for 48 hours and co-immunostained for MyHC 
and GFP, all as described above. Five random areas were selected from 8-well 
chambers and mean the widths of individual myotubes (10 per field) were 
calculated from 10 measurements taken along the length of the cell. The data are 
presented in Figure 4.9 and confirm that the mean width of the myotubes in the 
shRNA-mediated Notch3 knockdown cultures (P3) was significantly greater than in 
the shRNA controls (P5) (p=0.000014). Conversely, the Notch3ICD-transfected 
cultures were less well-differentiated (Figure 4.8) and the average myotube width 
was smaller than in the pMIG-transfected controls. 
 
 
Figure 4.9 Effects of modulating Notch3 activity on myotube width in 




Cultures of primary mouse satellite cell-derived myoblasts were established, 
transfected with either P3 (shRNA Notch3 knockdown), P5 (shRNA control), 
pNotch3/MIG (constitively-active Notch3ICD) or pMIG (control) and allowed to 
differentiate for 48 hours. After co-immunostaining for skeletal muscle MyHC and 
GFP, the mean width of individual GFP+ve myotubes was calculated from 10 
measurements taken along the length of the cell. For each condition, 3 cultures 
were analysed, involving measurement of 10 myotubes from each of 5 randomly 
selected fields.  
 
The results presented in Figure 4.9 confirm the subjective observation that 
therefore inhibition of Notch3 activity increases myoblast fusion and promotes 
myotube hypertrophy in primary skeletal. 
4.4.2 Effects of shRNA-mediated knockdown and overexpression of Notch3 on 
MyoD expression in differentiated mouse primary skeletal muscle 
cultures 
To investigate the effects of modulating Notch3 activity on MyoD expression, 
mouse primary skeletal muscle cultures were prepared as described above and 
transfected with either P3 (shRNA knockdown), P5 (shRNA control), 
pNotch3ICD/MIG (Notch3ICD) or pMIG (Control). After 24 hours of differentiation, 
the cultures were fixed and co-immunostained for MyoD and GFP. 
Figure 4.10 shows that when the GFP+ve populations were analysed (i.e 
transfected), the mean percentage of MyoD+ve cells was significantly higher in the 
P3-transfected (shRNA knockdown) compared with the P5-transfected (shRNA 
control) controls (p=0.00001). Conversely, cultures transfected with constitutively 
active Notch3ICD (pNotch3/MIG) contained a significantly lower mean percentage 
of MyoD+ve cells (P=0.0000001) than those transfected with the relevant control 
(pMIG). These results show that as in C2C12 cultures, (Figure 4.4), knockdown of 
Notch3 activity results in increased MyoD expression and further, that 




Figure 4.10 Effects of modulating Notch3 activity on MyoD expression in 
differentiated mouse primary skeletal muscle cultures 
Cultures of primary mouse satellite cell-derived myoblasts were established, 
transfected with either P3 (shRNA Notch3 knockdown), P5 (shRNA control), 
pNotch3/MIG (constitutively-active Notch3ICD) or pMIG (control) and allowed to 
differentiate for 48 hours. (A) Fluorescence microscopy images of representative 
cultures fixed and co-immunostained for the expression of MyoD (Dako 5.8A; red) 
and GFP (Molecular Probes; green), counterstained with DAPI (blue) to reveal all 
nuclei. Scale bar = 20µm. (B) Histogram showing the mean percentages of 
transfected cells (i.e. GFP+ve) expressing MyoD. For each column, three cultures 
were analysed and at least 200 cells were counted from each. 
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4.4.3 Effects of shRNA-mediated knockdown and overexpression of Notch3 on 
Pax7 expression in differentiated mouse primary skeletal muscle cultures 
Pax7 is a paired box transcription factor that is expressed by quiescent satellite 
cells, maintained during proliferation and down-regulated during myogenesis such 
that in a differentiated culture, Pax7 marks cells that have adopted an 
undifferentiated, reserve cell fate (Zammit et al., 2004, 2006; Halevy et al., 2004; 
Nagata et al., 2006). Although the C2C12 cell line used in earlier studies expressed 
little (if any) Pax7, primary skeletal muscle cultures established, transfected and 
differentiated as described above were co-immunostained for Pax7 and GFP to 
directly investigate the effects of modulating Notch3 activity on the number of 
single cells (Figure 4.9). The results clearly show that shRNA-mediated inhibition of 
Notch3 activity (P3) resulted in a significant decrease in the number of Pax7+ve cells 
compared with cultures transfected with the shRNA-control (P5) (p=0.00004): in 
contrast, a significantly greater percentage of cells expressing Pax7 were present in 
cultures transfected with constitutively-active Notch3ICD (pNotch3/MIG) compared 
with the relevant control plasmid, pMIG (p=0.0007). These data are consistent with 
and extend the findings presented in Figure 4.8 by showing that in the absence of 
normal levels of Notch3 activity, few (if any) myoblasts are able to adopt and 
maintain the Pax7+ve/MyoD-ve phenotype characteristic of a reserve cell fate 
(Nagata et al., 2006), whereas overexpression of Notch3 activity inhibits MyoD 






Figure 4.11 Effect of modulating Notch3 activity on Pax7 expression in 
differentiated primary skeletal muscle cultures. 
Cultures of primary mouse satellite cell-derived myoblasts were established, 
transfected with either P3 (shRNA Notch3 knockdown), P5 (shRNA control), 
pNotch3/MIG (constitutively-active Notch3ICD) or pMIG (control) and allowed to 
differentiate for 48 hours. (A) Fluorescence microscopy images of representative 
cultures fixed and co-immunostained for the expression of Pax7 (DSHB; red) and 
GFP (Molecular Probes; green), counterstained with DAPI (blue) to reveal all nuclei. 
Scale bar = 20µm. (B) Histogram showing the mean percentages of transfected cells 
(i.e. GFP+ve) expressing Pax7. For each column, three cultures were analysed and at 
least 200 cells were counted from each. 
Pax7/GFP /Dapi Pax7/GFP /Dapi Pax7/GFP /Dapi Pax7/GFP /Dapi 














In chapter 3, inactive Notch3 was present during proliferation, whereas active 
Notch 3 was first detected at the time when the decision to become a myotube or 
reserve cell is being made. By Western blot analysis, active Notch 3 was found to be 
highly expressed by reserve cells, but was completely absent from the myotube 
fraction. These findings strongly suggest that Notch3 may play a crucial role in the 
specification and maintenance of the stem cell phenotype within a differentiating 
culture. 
The hypothesis was that if Notch3 is required for self-renewal of the stem cell 
compartment, reduced levels of expression and therefore activity should promote 
differentiation and enhance myotube formation. Since Notch3 was expressed in 
myogenic cultures at the onset of differentiation and maintained in those cells that 
adopted a quiescent reserve cell fate, a lack of Notch3 would reduce the number of 
reserve cells in a differentiated culture. The shRNA was used to knockdown 
expression of Notch3 in C2C12 and primary cultures, immediately prior to initiating 
differentiation. 
Reduced expression of Notch3 by shRNA plasmid had no apparent effect on C2C12 
myoblast proliferation as demonstrated by proliferation assay. This is consistent 
with the fact active Notch3 is not present in proliferating cultures. 
When the density of cultures reaches confluency, the repression of Notch3 
appeared to cause a decrease in the size of C2C12 cells. From the phase contrast 
images, the morphology of cells in Notch3 knockdown cultures  appear rounder and 
smaller. As Notch3 alters the actin cytoskeletal dynamics in VSMC, so there is an 
increase in actin fibres and steady-state levels of polymerised actin (Domenga et al., 
2004). It is possible in C2C12 cells Notch3 may increase cell-size by altering actin 
dynamics, which may enhance cell motility and migration (Chakravarti et al., 2005). 
Therefore by inhibiting Notch3 expression the size of cells decreased. 
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MyoD is one of the four myogenic regulatory factors (MRFs) that are essential for 
myogenensis. MyoD is undetectable in the majority of quiescent satellite cells 
(Grounds et al., 1992). As satellite cells become activated in response to injury, they 
will express MyoD (Cooper et al., 1999). At earlier time-points following induction of 
differentiation, MyoD expression appeared to be elevated in cultures with reduced 
Notch3 expression. These observations are consistent with the hypothesis that loss 
of Notch3 leads to a decrease in the number of reserve cells such that almost all 
myogenic precursors that would have remained undifferentiated, instead, commit 
to differentiation. This suggests that Notch3 may inhibit myogenic differentiation by 
diminishing MyoD, hypothetically facilitated through either the RBP-JK-dependent 
or RBP-JK-independent pathway (Kopan et al., 1994; Shawber et al., 1996; Kuroda et 
al., 1999; Nofziger et al., 1999). 
Repressed Notch3 accelerated the myotubes formation during differentiation. 
When differentiation was induced, the cultures, in which expression of Notch3 was 
reduced or absent, appeared to contain a greater number of larger myotubes 
compared to control and untransfected cultures. The myogenic differentiation 
process was significantly sped up in Notch3 knockdown C2C12 cultures. As a result, 
these cultures have a massive decrease in the number of undifferentiated reserve 
cells. 
Wang et al. (2002) postulated that Notch3 signalling might be a critical determinant 
of VSMC survival. Notch3 may play an anti-apoptosis role. An apoptosis assay 
confirmed that loss of Notch3 leads to 3.5 times higher rate of apoptosis indicated 
by increased in Caspase 3/7 activity. Nevertheless, even with the higher rate of 
apoptosis, the lost of Notch3 still resulted in an increased fusion index characterised 
by higher average numbers of nuclei in myotubes. 
Work by Cao and colleagues (2003) revealed that p27 appears to be involved in the 
regulation of myogenic differentiation, as it is highly upregulated when C2C12 
myoblast differentiation is induced. p27 is found highly expressed in reserve cells, it 
induces and maintains a quiescent state in cells (Miskimins et al., 2001; Olashaw 
and Pledger, 2002). Since Notch3 highly upregulated p27 expression, which induces 
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cells to enter a quiescent state, it is plausible that suppressed Notch3 also 
suppressed level of p27 hence leading to loss of quiescent reserve cells population 
during myogenesis. On the other hand, in the apoptosis assay activity of Caspase3/7 
was elevated in Notch3 knockdown cultures. This is consistent with the increased 
caspase3/7 activity coupled with the down-regulation of p27 in nuclei (Hashimoto 
et al. 2008). 
In the primary cultures section, satellite cell-derived myoblasts were used to 
compare the Notch3 knockdown effect observed in C2C12 cells. Notch3 knockdown 
had no significant effect on proliferating primary myoblasts, but when 
differentiation was induced, Notch3 knockdown primary cultures produced changes 
that were similar to those observed when Notch3 was knocked down in C2C12. Cell 
population increased and in differentiated cultures the MyoD+ cells increased 
significantly. These results again consistent with the fact active Notch3 is not 
present in proliferating C2C12 cultures in the earlier findings. 
When differentiation was induced, the effect of Notch3 on differentiation becomes 
apparent. Notch3 knockdown cultures significantly accelerated the myogenic 
differentiation process. As expected, knockdown Notch3 cultures had more MyoD+ 
cells after differentiation was induced consistent with the C2C12 results. 
Knockdown Notch3 upregulates MyoD expression, reflecting that Notch3 may 
inhibit myogenic differentiation by downregulating MyoD, presumably facilitated 
via either the RBP-JK-dependent or RBP-J-independent pathway (Kopan et al., 1994; 
Shawber et al., 1996; Kuroda et al., 1999; Nofziger et al., 1999). Active Notch3 was 
found expressed in reserve cells exclusively; reserve cells are in fact known to 
downregulate their expression of MyoD (Yoshida et al., 1998). It is possible that 
upon the induction of differentiation, a lack of Notch3 in the cultures upregulates 
MyoD expression and enhances differentiation, as a consequence loss of reserve 
cells population in Notch3 knockdown cultures. 
Knockdown Notch3 in both C2C12 and primary cultures studies suggested that 
Notch3 inhibits differentiation. Since Notch3 also down-regulates Caspase 3/7 and 
highly upregulates p27, which induces cells to enter a quiescent state, it is likely 
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that endogenous Notch3 expression predominates in reserve cells, inhibiting their 
differentiation and ensuring that the cells become quiescent. 
As mentioned earlier section, high levels of active Notch3 in reserve cells caused 
downregulation of MyoD expression and inhibition of differentiation as well as 
upregulation of p27 expression, which causes the cells to reversibly withdraw from 
the cell cycle and become quiescent. This is consistent with the high-level 
expression of the cdk inhibitor p27 observed in Notch3-expressing cells, which 
should induce cells to enter G0 phase (Cao et al., 2003). 
Notch inhibition by its antagonist numb causes proliferating myoblasts to commit to 
terminal differentiation (Conboy and Rando, 2002). The inhibition of notch by 
overexpressing numb or by use of a -secretase inhibitor resulted in an enhanced 
fusion index of the myoblasts and increased differentiation (Kitzmann et al., 2006). 
In differentiated cultures, repressed Notch3 showed a large increase in the number 
of nuclei in differentiated cells, as well as an increase in the width of myotubes. This 
is consistence to the results inNotch3 knockdown C2 cell line. The fusion index in 
the Notch3 knockdown cultures was 2 fold higher than controls. By estimate the 
width of myotube, suppressed Notch3 expression resulted 4 fold wider than 
controls. This suggested that suppressed Notch3 leading to myotubes hypertrophy. 
Cultures of differentiated Notch3 knockdown clones have larger myotubes and 
fewer reserve cells again consistence with C2C12 Notch3 knockdown results. This 
observation has led to the hypothesis that inhibition of Notch3 enabling the 
recruitment of more reserve cells into the differentiation pathway leads to 
hypertrophy. 
Analysis of the myotube and reserve cell populations in chapter 3 revealed that in 
C2C12 cells the level of Notch3 was significantly higher exclusively in the reserve cell 
population. This same pattern of expression was preserved in the Notch3 
overexpression clones in primary cultures. Expression levels of Pax7+ cells increased 
approximately 25% more than controls in the differentiated cultures. Figure 4.11 
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proposed that overexpression of Notch3 keep a population of myoblasts in a slowly 
proliferating non-dividing state that is capable of giving rise to Pax7+ reserve cells. 
Constitutively active Notch3 increased the number of Pax7+ cells, which 
withdrawed from cell cycle and become quiescent, and decrease the number of 
cells that express MyoD and differentiate. Thus endogenously active Notch3 may 
inhibit the differentiation of a subset of progeny by preventing MyoD expression, 
ensuring that they remain undifferentiated and quiescent and hence maintain their 
expression of Pax7. This is consistent with their effects during C2C12 differentiation, 
where Notch3 inhibit differentiation and reduce MyoD expression. 
Differentiated primary cultures formed a heterogeneous population of 
differentiated myotubes and undifferentiated reserve cells, comparable with 
differentiated C2C12 cell cultures. Overexpressed constitutively active Notch3 was 
capable of inhibiting myogenic differentiation and resulted in downregulation of 
both MyoD and MyHC. 
In proliferating primary myoblasts, constitutively active Notch3 completely 
downregulated MyoD expression and completed inhibited differentiation when it 
was induced. It is possible that upon the induction of differentiation, endogenous 
Notch3 remains active in a subset of cells, where it downregulates MyoD expression 
and inhibits differentiation, to ensure that those reserve cells remain 
undifferentiated. Reserve cells are in fact known to downregulate their expression 
of MyoD (Yoshida et al., 1998). Suggesting that in reserve cells where active Notch3 
is highly expressed, it may act as the predominant receptor to inhibit myogenic 
differentiation. 
Together, the results obtained from both Notch3 knockdown and overexpression in 
C2C12 or primary cultures suggests Notch3 may play an important role in the 
specification of cells that are maintained in a quiescent stem cell state and may 
therefore be involved in replenishment of the satellite cell pool. 
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For Notch3 to have an effect on myoblast fate decisions, it must interact with a 
Notch ligand. One possible explanation is that such a ligand may be expressed on 
newly formed myotubes that can interact with remaining undifferentiated cells: one 
possible candidate is DL4. When the expression of Notch ligands was investigated in 
the culture system used above, DL1 1 was expressed throughout differentiation and 
in differentiated cultures and was present in both myotube and reserve cell 
fractions. In contrast, DL4 is not expressed until myotubes started to form 
differentiated cultures, DL4 is only expressed by differentiated cells and not in the 
reserve cell fraction, the opposite pattern to Notch3. Previously, DL4 was found to 
be expressed in arterial endothelium (Shutter et al., 2000), but has not been 

















The aims of the experiments presented in this chapter were to investigate which of 
these Notch DSL ligands could be responsible for maintaining Notch3 activity and 
therefore the quiescent, undifferentiated reserve cell phenotype.  
When a skeletal muscle culture is induced to differentiate, myoblasts either 
withdraw permanently from the cell cycle and initiate terminal myogenesis, enter a 
reversible quiescent state (Kitzmann et al., 1998; Yoshida et al., 1998) or undergo 
apoptosis (Dee et al., 2002). Results presented in the previous chapters implicate 
Notch3 activity in determining myoblast cell fate. Specifically, in the absence of 
Notch3 activity, the vast majority of myoblasts differentiate whilst few adopt the 
reverse cell fate. This alteration of the normal balance of cell fates is accompanied 
by an increase in apoptosis, although it has yet to be determined whether this 
reflects a requirement for Notch3 in the survival of nascent reserve cells or is due to 
a failure to specify reserve cell fate. In a differentiated culture, Notch3 activity is 
restricted to the reserve cell population and overexpression of Notch3 inhibits 
differentiation markedly increasing the proportion of reserve cells. 
Notch receptor activation requires interaction with DSL ligands (Introduction, 
sections 1.12 and 1.13). Since Notch3 is active in reserve cells present in 
differentiated cultures of the clonally-derived cell line C2C12, the DSL ligand(s) 
responsible must be expressed within the culture. Results presented in Chapter 3 
show that DL1 1, Jagged 1 and Jagged 2 are present on proliferating myoblasts and 
that following differentiation, DL1 1 and DL4 are expressed by myotubes whilst 




5.2 Regulation of Notch3 and Notch1 receptor activity during C2C12 
reserve cell activation 
Previous studies have shown that reserve cells can be isolated from differentiated 
skeletal muscle cultures and activated to enter the cell cycle by exposure to 
mitogen-rich growth medium (Yoshida et al., 1998). If Notch3 activity is responsible 
for maintaining the reserve cell phenotype, this implies that this must be overcome, 
inhibited or lost during the activation process. 
To investigate Notch3 expression during activation, C2C12 myoblasts were seeded 
into 10cm-diameter Petri dishes at 5x105cells/dish and after 24 hours in growth 
medium, were transferred to differentiation medium (Materials and Methods, 
section 2.2.4). After 4 days of differentiation, reserve cells were isolated by partial 
trypsinisation as described in the Materials and Methods (section 2.5.2), pooled, 
replated and reactivated by culturing in serum-rich growth medium. 
5.2.1 Time course of C2C12 reserve cell activation 
To investigate the timing of re-entry into the cell cycle following transfer to growth 
medium, reserve cells were seeded into 8-well chamber slides at 2500 
cells/chamber. After 1, 3, 6, 12 and 24 hours, cultures (three per time point) were 
pulsed with BrdU for 1 hour, washed, fixed and then immunostained for BrdU-
incorporation to determine the percentage of cells that had entered S-phase during 
the pulse. Figure 5.1 shows that only approximately 7% of the reserve cells 
incorporated BrdU during the first hour and that the vast majority of cells entered 





Figure 5.1 Time course of C2C12 reserve cell activation determined by BrdU 
incorporation 
Quiescent reserve cells were isolated from C2C12 cultures after 4 days of 
differentiation and seeded into 8-well chamber slides at 2500 cells/chamber. After 1 
hour, 3 hours, 6 hours, 12 hours and 24 hours in growth medium, cultures were 
pulsed for 1 hour with BrdU, fixed and immunostained with an antibody against 
BrdU (BU1/75, Abcam) and counterstained with DAPI to reveal all nuclei. (A) 
Representative cultures 1 and 24 hours after transfer to growth medium, 
immunostained for BrdU (BU1/75; red) and counterstained with DAPI (blue) (scale 
bar = 10µm). (B) Histogram showing the mean percentages of cells that had 
incorporated BrdU during the pulse. Three cultures were analysed at each time 
point with at least 100 cells counted per culture: mean values are shown ± SEM. 
 
5.2.2 Changes in Notch3 and Notch1 expression during C2C12 reserve cell 
activation 
The above data show that once returned to serum-rich growth medium, C2C12 
reserve cells re-enter the cell cycle with the majority of cells entering S-phase after 
12-24 hours and experiments were therefore carried out to investigate the 
expression of Notch3 and Notch1 during this activation process. Reserve cells 
isolated from differentiated C2C12 cultures as described above, seeded into 10cm-
diameter Petri dishes at 105 cells/dish and maintained in growth medium. Individual 
cultures were taken after 0, 0.5, 0.75, 1.5, 3, 6, 12 and 24 hours of reactivation and 
total RNA and protein were extracted (Materials and Methods, sections 2.5.2.1 and 
0) for analysis by RT- PCR and Western blotting, respectively. Figure 5.2 shows RT-
PCR analysis of the expression of Notch3, Notch1 and MyoD transcripts during 
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activation. RT-PCR was carried out as described in the Materials and Methods 
(section 2.18) using the primers and conditions listed in section 2.18 ( 
Table 2.3). 
The results show that as expected, freshly isolated reserve cells (0 hours) expressed 
Notch3, a very low level of Notch1 and no MyoD transcript. However, between 0.75 
and 1.5 hours, Notch3 transcription was down-regulated, accompanied by an 
increase in the level of Notch1 and the appearance of MyoD mRNA. After 24 hours, 
by which time the cells had entered S-phase (Figure 5.1), Notch3 transcript was 
almost undetectable whilst both Notch1 and MyoD were clearly expressed. 
 
 
Figure 5.2 Expression of Notch3 and Notch1 transcripts during activation of C2C12 
reserve cells 
Quiescent C2C12 reserve cells were isolated and activated in serum-rich growth 
medium. Total RNA was extracted from cultures at the time points indicated and 
subjected to RT-PCR analysis for the presence of Notch3, Notch1 and MyoD 
transcripts. Reaction products were run on 1.5% agarose gels/TBE gels and stained 
with ethidium bromide. HPRT was used as a loading control and for the negative 
control reactions, RNA was replaced by water. Predicted product sizes are shown on 
the right and were consistent with appropriate DNA marker ladders. n=3 
 
Western blotting analysis of protein extracted from a series of cultures taken at the 
same time points during C2C12 reserve cell activation were consistent with the RT-
PCR results shown above and further, revealed changes in activities of the 
translated receptors (Figure 5.3). An antibody raised against the Notch3ICD was 
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used to distinguish between membrane-associated receptor (“inactive”) and 
“active” ICD released from the membrane by S2/S3 cleavage (Introduction, section 
1.13). The results show that during the first 1.5 hours, both active and inactive 
Notch3 was present although by 3 hours, active Notch3ICD could no longer be 
detected and there was evidence of the presence of unprocessed protein (i.e. pre-
S1 cleavage). In contrast, Notch1 was first detected after 1.5 hours using an 




Figure 5.3 Expression of Notch3 and Notch1 proteins during C2C12 reserve cell 
activation 
Quiescent C2C12 reserve cells were isolated and activated in serum-rich growth 
medium. Protein was extracted from cultures at the time points indicated, 
separated by SDS-PAGE on 10% acylamide gels and transferred onto nylon 
membrane. Notch3 was detected using an antibody raised against Notch3ICD (M-
20, Santa Cruz) and Notch1 with an antibody specific for the active ICD (Ab8925, 
Abcam). The blot was also probed for cyclinA (CY- A1, Sigma) as a marker of re-entry 
into the S-phase cell cycle and α-tubulin as a loading control (Sigma, DM1A). 
Molecular masses were estimated from appropriate SDS-PAGE markers and are 
shown on the right. For Notch3, “unprocessed” corresponds to the receptor before 
S1 cleavage, “inactive” to membrane-associated receptor and “active to the ICD 
released by S2/S3 cleavage (Introduction, section 1.13). n=3 
 
Results presented in Figure 5.2 and Figure 5.3 reveal a rapid switch in Notch 
receptor activity initiated approximately 1 hour after exposure to serum-rich 
medium. The data confirm that Notch3 is expressed and active in quiescent reserve 
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cells, whilst any Notch1 is inactive, consistent with the results presented in Chapter 
3 (section 3.3). By 1.5 hours however, Notch3 was shown to be down-regulated at 
the level of transcription and any remaining receptor was inactive: in contrast, 
transcription of Notch1 increased and the translated receptor was active. 
Significantly, these events were accompanied by increased expression of MyoD and 
re-entry into the cell cycle as determined by the presence of cyclinA. Again, these 
findings are consistent with earlier results suggesting that Notch3 activity inhibits 
both MyoD expression and proliferation (Chapter 4, section 4.4.2) and the known 
pro-proliferative effects of Notch1 activity on skeletal muscle precursors . 
 
5.3 Effects of exposure to specific DSL ligands on C2C12 reserve cell 
activation 
In mammals, Notch signalling can be mediated by interactions between any of four 
receptors and five DSL ligands (Introduction, section 1.12). Evidence suggests that 
different receptor/ligand combinations can result in different outcomes including 
divergent cell fates reported in myeloid (Neves et al., 2006), T-cell (Amsen et al., 
2004; Lehar et al., 2005; Rutz et al., 2005) and prosensory precursor cells (Brooker 
et al., 2006). To identify which DSL ligand(s) could be responsible for maintaining 
Notch3 activity in reserve cells within a differentiated culture, co-culture 
experiments were carried to investigate the effects of individual DSL ligands on 
reserve cell reactivation. 
5.3.1 Generation of 3T3 fibroblast lines expressing individual DSL ligands 
Full-length cDNAs encoding murine Delta-like 1 and 4 ((de La Coste et al., 2005) and 
Jagged1 (Lehar et al., 2005) were each cloned into the neomycin-resistance gene-
containing expression plasmid, pC1-Neo (Promega) (Materials and Methods, section 
2.12). Individual 3T3 fibroblast cultures were transfected with these plasmids and 
selected with G418 for 2 weeks (Materials and Methods, section 2.9.4). To confirm 
expression of the relevant ligands, total RNA was extracted from stable, uncloned 
cultures and analysed by RT-PCR (Materials and Methods, section 2.18). Details of 






Figure 5.4 RT-PCR analysis of DSL ligand expression in transfected 3T3 fibroblast 
cultures 
G418-resistant cultures of mouse 3T3 fibroblasts were generated by transfection 
with a neomycin-resistance plasmid (pC1-Neo) containing full-length cDNA 
encoding either DL1 1, DL4 or Jagged1(3T3/DL1, 3T3/DL4 and 3T3/Jag1, 
respectively). Total RNA was isolated and subjected to RT-PCR analysis for the 
expression of the three DSL ligands. Reaction products were run on 1.5% 
agarose/T E gels and stained with ethidium bromide. “Cont.” refers to 
untransfected control 3T3 fibroblasts cells, the “+ve Control” was total mouse 
embryo and HPRT was used as a control for the starting amount of total RNA. 
Predicted product sizes are shown on the right and were consistent with 
appropriate DNA marker ladders. n=3 
 
Figure 5.4 shows that following selection, each of the 3T3 cultures expressed the 
transfected cDNA. Importantly, untransfected 3T3 fibroblasts did not contain 
detectable levels of transcript for any of the three DSL ligands examined and the 
results confirm that each of the transfected cultures expressed only one ligand, 
consistent with the transfected cDNA. 
5.3.2 Effects of exposure to individual DSL ligands on C2C12 reserve cell 
activation 
To investigate the effects of individual DSL ligands on the activation of reserve cells, 
C2C12 reserve cells were isolated and then co-cultured in growth medium with the 
3T3 fibroblast lines described above. GFP+ve reserve cells were used in order to 
distinguish them from the fibroblasts in the co-cultures. C2C12 myoblasts were 
transfected with the GFP reporter plasmid pmaxFP-Green-n (Lonza) and selected 
with G418 to produce stable, GFP+ve cultures (Materials and Methods, section 
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2.9.4). Cultures of GFP+ve myoblasts were allowed to differentiate for 5 days and 
the reserve cells were isolated as described in the Materials and Methods (section 
2.5). Control, untransfected 3T3 fibroblasts and G418-selected cultures of 3T3 
fibroblasts expressing murine DL1, DL4 or Jagged1 (3T3, 3T3/DL1, 3T3/DL4 and 
3T3/Jag1, respectively) were seeded into 8-well chamber slides and grown to 
confluency. The medium was removed from the fibroblast cultures and replaced 
with a suspension of C2C12 reserve cells in growth medium: 4 x 103 reserve cells 
were added to each co-culture, giving an approximate reserve cell:fibroblast ratio of 
1:3. After 23 hours, co-cultures were pulsed with BrdU for 1 hour (Materials and 
Methods, section 2.15), washed, fixed and co-immunostained for GFP and BrdU to 
determine the proportion of reserve cells (identified by GFP expression) that had 




Figure 5.5 Effects of exposure to DSL ligands on re-entry of C2C12 reserve cells 
into the cell cycle. 
Quiescent GFP+ve reserve cells were isolated from C2C12 cultures after 5 days of 
differentiation and co-cultured in serum-rich growth medium with confluent 
cultures of 3T3 fibroblasts either untransfected (control), or expressing DL1, DL4 or 
Jagged1 (3T3/DL1, 3T3/DL4 or 3T3/Jag1, respectively). Co-cultures were carried out 
in 8-well chamber slides with a reserve cell:fibroblast ratio of approximately 1:3. 
After 23 hours, the co-cultures were pulsed for 1 hour with BrdU, fixed, co-
immunostained stained for GFP (Molecular probe; green) and BrdU (BU1/75; red) 
and counterstained with DAPI (blue) to reveal all nuclei. (A) Representative images 
of reserve cells co-cultured with untransfected 3T3 cells (a, b) and with fibroblasts 
expressing DL1 (c, d), DL4 (e, f) or Jagged1 (g, h). In a, b, g and h, arrows indicate 
GFP+ve/BrdU-ve reserve cells: in e and f, arrowheads indicate examples of 
GFP+ve/BrdU+ cells (scale bar = 20µm). (B) Histogram showing the mean 
percentage of GFP+ve cells that had incorporated BrdU during the 1 hour pulse. 
“RC” refers to reserve cells cultured alone and each column represents the mean of 
3 cultures ± SEM (at least 200 GFP+ve cells were counted per culture). The mean 
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values were compared using a Student’s t-test: *** denotes a statistically significant 
difference (p=0.0002) between reserve cells co-cultured with 3T3 cells expressing 
DL4 compared with cells co-cultured with control 3T3 fibroblasts. 
 
BrdU incorporation occurs during S-phase and therefore reflects the proportion of 
cells that had re-entered the cell cycle and were actively synthesizing DNA during 
the pulse: i.e. in the above experiments, cells that were no longer in quiescence. 
This was complemented by directly determining the number of cells that retained 
reserve cell status after 24 hours of co-culture by incubation with lysenin, an 
earthworm protein that binds specifically to sphingomyelin, present at high levels in 
the plasma membrane of quiescent satellite cells and reserve cells (Nagata et al., 
2006). GFP+ve C2C12 reserve cells were co-cultured for 24 hours with 3T3, 3T3/DL1, 
3T3/DL4 and 3T3/Jag1 fibroblasts as above, fixed and incubated with lysenin. The 
cultures were then co-immunostained for GFP and bound lysenin (Materials and 
Methods, section 2.16) to determine the proportion of reserve cells that remained 
quiescent after 24 hours in growth medium. 
After 24 hours in serum-rich growth medium, co-cultures were pulsed with BrdU for 
1 hour to establish the proportion of GFP+ve cells that had initiated proliferation 
(Figure 5.5), or immunostained for lysenin-binding to determine the identify GFP+ve 






Figure 5.6 Effects of exposure to DSL ligands on maintaining C2C12 reserve cell 
quiescence 
Quiescent GFP+ve reserve cells were isolated from C2C12 cultures after 5 days of 
differentiation and co-cultured in serum-rich growth medium with confluent 
cultures of 3T3 fibroblasts either untransfected (control), or expressing DL1, DL4 or 
Jagged1 (3T3/DL1, 3T3/DL4 or 3T3/Jag1, respectively). Co-cultures were carried out 
in 8-well chamber slides with a reserve cell:fibroblast ratio of approximately 1:3. 
After 24 hours, the co-cultures were fixed, incubated with lysenin and then co-
immunostained for bound lysenin (rabbit anti-lysenin polyclonal antibody, Peptide 
Institute Inc.; red) and GFP (Molecular Probes; green) and counterstained with DAPI 
(blue) to reveal all nuclei. (A) Representative images of reserve cells co-cultured 
with untransfected 3T3 cells (a, b) and with fibroblasts expressing DL1 (c, d), DL4 (e, 
f) or Jagged1 (g, h). In a-d, g and h, arrows indicate GFP+ve/lysenin+ve reserve cells: 
in e and f, arrowheads indicate examples of GFP+ve/lysenin-ve cells (scale bar = 
20µm). (B) Histogram showing the mean percentage of GFP+ve cells that bound 
lysenin. “RC” refers to reserve cells cultured alone and each column represents the 
mean of 3 cultures ± SEM (at least 200 GFP+ve cells were counted per culture). The 
mean values were compared to the control co-cultures (with untransfected 3T3 
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cells) using a Student’s t-test: statistical differences are indicated by asterisks and p 
values. 
 
Results presented in Figure 5.5 and Figure 5.6 show that when cultured alone, 85% 
of reserve cells were in S-phase during the BrdU pulse 23-24 hours after transfer to 
serum-rich growth medium, with 14% still in quiescence (as determined by lysenin 
binding) after 24 hours, consistent with data presented in Figure 5.1. Co-culture 
with control, untransfected 3T3 fibroblasts resulted in a small increase in the 
proportion of reactivated reserve cells, with 91% BrdU+ve and only 3% lysenin+ve 
cells after 24 hours. When compared with the control co-cultures, the presence of 
fibroblasts expressing either Jagged1 or DL1 had no effect on reserve cell activation, 
although the latter did result in a small but significant increase (from a mean of 3% 
to a mean of 14%) in the proportion of lysenin+ve cells present after 24 hours. In 
contrast, co-culture with 3T3 fibroblasts expressing DL4 inhibited reserve cell 
reactivation with only 15% entering S-phase and 82% remaining lysenin+ve after 24 
hours. Thus, using both BrdU incorporation as a negative marker and lysenin 
binding as a positive indicator of reserve cell quiescence, these results show that 
exposure to DL4, but not DL1 or Jagged1, is sufficient to prevent C2C12 reserve cells 
from exiting the quiescent state and re-entering the cell cycle for at least 24 hours 
after stimulation with serum-rich medium. 
 
5.4 Effects of exposure to specific DSL ligands on Notch3 and Notch1 
regulation during C2C12 reserve cell activation 
Data presented in Chapter 4 implicate Notch3 activity in maintaining the quiescent 
reserve cell phenotype, which is consistent with results presented above (section 
5.2.2) showing that when reserve cells are activated by transfer to serum-rich 
medium, Notch3 transcription is rapidly down-regulated and any remaining 
receptor becomes inactive prior to up-regulation of MyoD expression and entry into 
the cell cycle. That co-culture with fibroblasts expressing DL4 (but not DL1 or 
Jagged1) is sufficient to maintain the reserve cell phenotype in conditions that 
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normal promote activation, suggests that this ligand may interact specifically with 
Notch3 in this context. To test this hypothesis, the expression and regulation of 
Notch3 and Notch1 were investigated following co-culture with DSL ligand-
expressing 3T3 fibroblasts. 
Confluent cultures of control 3T3 fibroblasts, 3T3/DL1, 3T3/DL4 and 3T3/Jag1 
fibroblasts were established in 10cm-diameter Petri dishes. Quiescent GFP+ve 
reserve cells were isolated and 2 x 105 cells were added to each fibroblast culture in 
a total volume of 10ml of growth medium, to give an approximate reserve 
cell:fibroblast ratio of 1:3. After 24 hours, total RNA and protein were extracted 
from replicate co-cultures (Materials and Methods, section 2.17 and 2.18) for 
analysis by RT-PCR and Western blotting, respectively. 
Figure 5.7A shows RT-PCR analysis for the presence of Notch3, Notch1 and MyoD 
transcripts in reserve cell/3T3 fibroblast co-cultures. The results show that after 24 
hours in growth medium, cultures of reserve cells and co-cultures of reserve cells 
with either control fibroblasts or fibroblasts expressing DL1 or Jagged1, contained 
similar low levels of Notch3 and apparently much higher levels of Notch1 transcript: 
in all cases, MyoD transcript was clearly present. Furthermore, Western blot 
analysis with anti-Notch3 antibody produced a single band corresponding to the 
membrane-associated form, suggesting that the remaining receptor was inactive: in 
contrast, probing with an anti-Notch1 antibody identified two bands, revealing the 
presence of both the membrane-associated and S2/S3-cleaved active ICD (Figure 
5.6B). These results are consistent with the switch in Notch receptor activity shown 
in Figure 5.2 and Figure 5.3, suggesting that after 24 hours, the reserve cells had 
become activated reserve cell when cultured alone or in co-culture. Significantly, 
when quiescent reserve cells were co-cultured with 3T3 fibroblasts expressing DL4, 
Notch3 was maintained, both at the level of transcript and receptor activation, 
revealed by the detection of a lower molecular mass band corresponding to the 
presence of cleaved, active ICD (Figure 5.7). Furthermore, the increase in the level 
of Notch1 transcript observed in the other co-cultures was inhibited, active 







Figure 5.7 Effects of specific DSL ligands on Notch1 and Notch3 regulation during 
C2C12 reserve cell activation 
Quiescent reserve cells were isolated from C2C12 cultures after 5 days of 
differentiation and co-cultured in serum-rich growth medium with confluent 
cultures of 3T3 fibroblasts either untransfected (control), or expressing DL1, DL4 or 
Jagged1 (3T3/DL1, 3T3/DL4 or 3T3/Jag1, respectively) with a reserve cell:fibroblast 
ratio of approximately 1:3. (A) RT-PCR analysis of total RNA extracted after 24 hours 
of co-culture for the presence of Notch3, Notch1 and MyoD transcripts. Reaction 
products were run on 1.5% agarose gels/TBE gels and stained with ethidium 
bromide. HPRT was used as a loading control. The predicted product sizes are 
shown on the right and were consistent with appropriate DNA marker ladders. (B) 
Western blot analysis of protein extracts prepared after 24 hours of co-culture. The 
membrane was probed for Notch3 (M-20; Santa Cruz) and Notch1 using antibodies 
raised against the ICD (M-20; Santa Cruz). In both cases, the upper band (“Inactive”) 
corresponds to membrane-associated receptor; the lower band (“Active”) to the 
active ICD released from the membrane by S2/S3 cleavage. α-tubulin was used as a 
loading control and approximate molecular masses estimated from a molecular 
mass ladder are shown on the right. In both (A) and ( ), “3T3” refers to cultures of 
untransfected 3T3 fibroblasts cultured alone and “RC” to cultures of C2C12 reserve 




Together, these results show that exposure to DL4 inhibits the activation of 
quiescent reserve cells and subsequent entry into the cell cycle. This is associated 
with maintained Notch3 activity and suppression of Notch1 activity and MyoD up-
regulation that normally accompany activation.  
 
5.5 Discussion 
The general hypothesis of this thesis is that Notch signalling is involved in the 
generation of satellite cells in the proper location. The aims of this chapter were to 
investigate which of Notch DSL ligands is responsible for maintaining Notch3 activity 
in quiescent cells. Previous studies have shown that activation of the Notch1 
receptor promotes proliferation and prevents differentiation of skeletal muscle 
precursor cells, both during development and adult tissue regeneration (Conboy & 
Rando, 2002; Conboy et al., 2003). Results presented in the preceding two chapters 
show that reserve cells, a minority population that remains in state of 
undifferentiated quiescence within a differentiating skeletal muscle culture, express 
active Notch3. Furthermore, Notch3 activity is required for cells to adopt this fate as 
without it, cultures differentiate normally but contain few, if any reserve cells. If 
Notch 3 is required to establish and maintain a quiescent reserve cell phenotype 
and Notch1 is drives proliferation, this would predict that there must be some form 
of reciprocal regulation of the activities of the two receptors when cells are 
stimulated to exit the quiescent state and re-enter the cell cycle. The experiments 
presented in this chapter were therefore designed to investigate the expression and 
activities of Notch3 and Notch1 during the reactivation of reserve cells. 
Reserve cells were purified by partial trypsinisation of fully differentiated C2C12 
cultures and as observed previously, were found to express active Notch3 receptor 
(as demonstrated by the presence of cleaved Notch3 ICD), but no detectable 
Notch1 protein. In order to investigate Notch regulation during the transition from 
quiescence to proliferation, isolated reserve cells were transferred to serum-rich 
growth medium to stimulate entry into the cell cycle. Although the majority of 
reserve cells re-entered S-phase after 12-24 hours, the predicted reciprocal 
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regulation of Notch3 and Notch1 transcription were apparent as early as 90 minutes 
after exposure to growth medium. At the mRNA level, Notch3 was markedly down-
regulated 45-90 minutes post-stimulation and was virtually undetectable by 12 
hours: in contrast, Notch1 transcript was upregulated during the 45-90 minute 
period and maintained throughout re-entry into the cell cycle. Western blotting 
confirmed this switch but also showed that although Notch3 protein remained, 
there was no evidence of activity (i.e. cleaved ICD) after 3 hours, coincident with the 
appearance of Notch1 receptor activity. Significantly, this switch in Notch receptor 
activities has occurred immediately appearance of MyoD transcript and the increase 
in expression of cyclin A associated with cell cycle progression. 
The canonical Notch signalling pathway involves interaction between a Notch 
receptor expressed by the signal-receiving cell and a DSL ligand on a signalling cell, 
the outcome of which in terms of the behaviour or fate of the signal-receiving cells 
depends upon both ligand and context (Rutz et al., 2005; de La Coste & Freitas, 
2006). Data presented in an earlier chapter showed that in the context of the model 
system used here, DL1 is expressed by myoblasts and differentiated myotubes, 
Jagged1 and Jagged2 by myoblasts and reserve cells and DL4 is present on nascent 
myotubes (DL3 was not detected at any stage during differentiation). Based on the 
assumption that any one of these ligands could be responsible for Notch3 activity in 
reserve cells, experiments were carried out to investigate the effects of exposure to 
each of these ligands in a cellular context. Using a co-culture system in which 
quiescent reserve cells were cultured with 3T3 fibroblasts (which do not express any 
endogenous DSL ligands) transfected and selected to stably express individual 
ligands, it was possible to test the effects of the presence of each on reserve cell 
activation. This approach was chosen as previous studies have shown that soluble, 
as opposed to membrane-bound ligands can act in a dominant negative manner 
(Hukriede et al., 1997; Sun & Artavanis-Tsakonas, 1996; Sun & Artavanis-Tsakonas, 
1997) and that ligand stabilisation is essential for Notch activation (Varnum-Finney 
et al., 2000). 
Co-culture with 3T3 fibroblasts expressing either DL1 or Jagged1 had no effect on 
reserve cell activation compared with cells cultured with control untransfected 
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fibroblasts. This not only suggests that these ligands are unable to activate Notch3 
when presented by another cell type, but also that cell autonomous interactions or 
reserve cell-reserve cell interactions involving the endogenous ligands do not 
maintain quiescence. In marked contrast, exposure to DL4 maintained Notch3 
activity, prevented upregulation of MyoD expression and inhibited cells from re-
entering the cell cycle, even after 24 hours in serum-rich growth medium. 
These findings suggest that DL4 may be responsible for the activation of Notch3 in 
reserve cells and suggest a mechanism for their recruitment and maintenance. 
Results presented in previous chapters show that Notch3 is upregulated at the 
onset of differentiation and that DL4 is only expressed by newly-formed myotubes. 
Notch3/DL4 interaction can therefore only occur when myotubes first appear in the 
culture and can interact with Notch3+ve myoblasts, resulting in the Notch3 activity-
mediated establishment and maintenance of quiescent state in a spatially limited 
population of undifferentiated myoblasts. Previous studies (reviewed in Hoffmann 
and Iruela-Arispe, 2007) of blood vessel development and maintenance have also 
suggested the importance of Notch3/DL4 interaction in specifying and maintaining 





Chapter 6: Analysis of Notch3 target genes activities in 
skeletal muscle cultures 
 
6.1 Introduction 
Results presented in previous chapters suggest that the activation of Notch3 by the 
ligand DL4 may be responsible for the establishment and maintenance of the 
quiescent, undifferentiated reserve cells during the differentiation of skeletal 
muscle cultures, an in vitro model of the recruitment of satellite cells during 
regeneration. 
The canonical Notch signalling pathway involves intranuclear interaction between 
NICD and the DNA-binding protein R PJκ and in turn results in the transcription of 
target genes, the best characterised of which are members of the Hes (hairy and 
enhancer of split) and Hey (hairy/enhancer-of-split related with YRPW motif) gene 
families (reviewed in Iso et al., 2003b; Introduction Section 1.16). 
Experiments described in this chapter were designed to investigate the effects of 
Notch3 activity in terms of activation and repression of the Hes and Hey genes, in 
the context of mouse skeletal muscle myoblasts.  
The aims of this chapter were to characterise the profile of target genes expressed 
in reserve cells and to determine how this is related to the up-regulation of Notch3 
activity in that population. Experiments were then carried out to investigate 
whether overexpression of individual Hes genes can compensate for the lack of 
Notch3 signalling in cultures of shRNA Notch3 knockdown cells, to determine 
whether the observed ability of Notch3 to reduce apoptosis and promote the 
sequestration of reserve cells during differentiation can be ascribed to the 




6.2 Quantitative RT-PCR analysis of Notch signalling pathway target genes 
in differentiated C2C12 cultures 
Results presented in previous chapters show that the expression of Notch receptors 
and DSL ligands change as C2C12 cultures undergo differentiation and that the main 
stages of the myogenic lineage (proliferating myoblasts, differentiated myotubes 
and quiescent reserve cells) are associated with distinct expression profiles. To 
investigate the expression of the canonical Notch signalling pathway target genes 
(Hey1, Hey2, HeyL and Hes1, Hes5, Hes7 (reviewed in Iso et al., 2003b)) in these 
phenotypically-distinct populations as determined by their particular 
receptor/ligand combination, quantitative RT-PCR analysis was carried out using 
RNA extracted from C2C12 myoblasts, myotubes and reserve cells.  
C2C12 myoblasts were seeded into five 10 cm-diameter Petri dishes (5 x105 cells per 
dish) in growth medium. After 24 hours, total RNA was extracted from 2 dishes of 
proliferating myoblasts using Trizol (Section 2.17): the remaining cultures were 
transferred to and maintained in differentiation medium. After 5 days, total RNA 
was extracted from myotube and reserve cell fractions, isolated from the 
differentiated cultures as described in Section 2.5.2.1). Quantitative RT-PCR 
analyses were carried out as described in Section 2.18.2, using the primers and 







Figure 6.1 Expression of Notch receptors and canonical Notch signalling pathway 
target genes in proliferating myoblasts, myotubes and reserve cells 
Total RNA was extracted from C2C12 myoblasts (MB), myotubes (MT) and reserve 
cells (RC). MT and RC fractions were obtained by partial trypsinisation of cultures 
after 5 days of differentiation. Expression levels were determined by quantitative 
RT-PCR and are presented as the mean ± SD from three replicate samples, relative 
to the expression of 18S ribosomal RNA. CD34 (a) and MyoD (b) were used to 
confirm efficient purification of the two fractions. (c) shows the relative expression 
of the receptors Notch1, Notch2, and Notch3. (d) and (e) show the relative 




The relative levels of expression of CD34 and MyoD (Figure 6.1a, b) are consistent 
with those expected from populations of proliferating myoblasts, myotubes and 
reserve cells. CD34 is marker of reserve cells, is expressed at lower levels in 
proliferating cultures and is absent from myotubes (Beauchamp et al., 2000), 
whereas MyoD is expressed by proliferating myoblasts (although variable according 
to position in the cell cycle), up-regulated during myotube formation, but absent 
from reserve cells (Kitzmann et al., 1998, Yoshida et al., 1998). 
Figure 6.1c shows that Notch1 was highly expressed in proliferating myoblasts and 
although present, was detected at much lower levels following differentiation in 
both myotube and reserve cell fractions. Notch2 was expressed at similar levels in 
both myoblasts and reserve cells, but was down-regulated in differentiated 
myotubes. Notch3 was expressed by proliferating myoblasts but in differentiated 
cultures, was relatively highly expressed in reserve cells but down-regulated in 
myotubes. These data are consistent with the RT-PCR and Western blot results 
presented in Chapter 3 and together (assuming that each population is 
homogenous) suggest that proliferating myoblasts are Notch1++/Notch2++/Notch3+ 
whilst in differentiated cultures, myotubes are Notch1+/Notch2-/Notch3- whereas 
reserve cells are Notch1+/Notch2+/Notch3++. This suggests a role for Notch3 in 
generating reserve cells, which may represent quiescent stellite cells in the 
experimental system used here. Notch3 could then be implicated in the identity of 
quiescent satellite cells and in their future fate as muscle stem cells located in their 
niche. 
 
Quantitative RT-PCR analyses of the same RNA samples (Figure 6.1d, e) suggested 
that that the Notch target genes Hey1, Hes1, Hes5 and Hes7 are all highly expressed 
in proliferating myoblasts (Figure 6.1d, e). In differentiated cultures, cells that had 
adopted different fates expressed different combinations of Notch target genes 
compared with proliferating myoblasts. Differentiation to form myotubes was 
accompanied by a marked down-regulation of Hey1 and Hes1, whilst Hes5 and Hes7 
were still expressed, but at lower levels. In contrast, reserve cells continued to 
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express Hey1, Hes1, Hes5 and Hes7, again at lower levels, but also showed marked 
up-regulation of HeyL. In all of the C2C12 samples assayed, expression of Hey2 was 
extremely low, consistent with previous findings (Reviewed in Iso et al., 2003b). 
 
6.3 Effects of Notch1 and Notch3 activity on canonical Notch signalling 
pathway target gene expression 
Results presented in the previous section show that in differentiated C2C12 
cultures, cells that have undergone terminal myogenic differentiation express 
different combinations of Notch receptors and downstream canonical Notch 
signalling pathway targets. To investigate whether the expression of specific target 
genes could be related to the activity of particular Notch receptors, experiments 
were carried out to examine the effects of constitutively active Notch1ICD and 
Notch3ICD on target gene promoter activity using a series of luciferase reporter 
constructs. 
C2C12 and C57BL/10 mouse primary myoblasts were seeded at a density of 
1.5X103cells per well in 96-well white walled plates and co-transfected with one of 
the reporter plasmids together with β -galactosidase plasmid at a ratio of 10:1 
according to the Lipofectamine 2000 protocol (see section 2.9). Cultures were 
maintained for 1 day in growth medium post-transfection and then switched to 
differentiation medium for 24-48 hours prior to the assays. Reporter activity was 
assayed using the Dual-Light system (Applied  iosystems) and was normalised to β-
galactosidase activity to control for transfection efficiency variation among different 
wells according to the manufacturer's instructions (see Section 2.11). All reporter 
assays shown are based on data averaged from at least three independent 
transfections. 
6.3.1 Effects of Notch1ICD and Notch3ICD on Hey gene promoter activity 
Overexpression of Notch1ICD increased both Hey1 and Hey2 promoter activity in 
both C2C12 and primary myoblasts, consistent with previous findings (Nakagawa et 
al., 2000), whereas Notch3ICD had no effect on either Hey1 or Hey2 promoter 
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activity in either system (Figure 6.2a,b, d, e). In contrast, Notch1ICD slightly 
decreased HeyL promoter activity in both primary myoblasts and C2C12, whereas 
overexpression of Notch3ICD increased activity in both C2C12 and mouse primary 




Figure 6.2 Effects of overexpression of constitutively active Notch1 and Notch3 on 
Hey gene promoter activity in skeletal muscle myoblasts 
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C2C12 and C57BL/10 mouse primary proliferating myoblasts were transfected with 
Hey1 (a and d), Hey2 (b and e) or HeyL (c and f) promoter/ luciferase reporter 
constructs with or without plasmids encoding Notch1ICD or Notch3ICD. Beneath 
each histogram bar, + denotes the presence, - the absence of each plasmid. A 
plasmid encoding β-galactosidase (30ng) was included in all transfections and 
luciferase activity was divided by β-galactosidase activity to normalise for  
transfection efficiency. All relative luciferase activities are presented as mean values 
± SEM of at least three independent experiments, each performed in triplicate and 
when compared using a Student’s t-test. 
 
6.3.2 Effects of Notch1ICD and Notch3ICD on Hes gene promoter activity 
The effects of Notch1ICD and Notch3ICD on Hes1, Hes5 and Hes7 promoter activity 
were determined using luciferase reporter constructs in C2C12 and C57BL/10 
mouse primary myoblasts as described above for the Hey genes.  
As shown in Figure 6.3, overexpression of Notch1ICD transactivated each of three 
Hes genes promoters tested in both C2C12 and mouse primary myoblasts, as shown 
by increased levels of luciferase activity compared with cultures transfected with 
the equivalent promoter/luciferase reporter construct alone. Overexpression of 
Notch3ICD was also found to increase Hes5 and Hes7 promoter activity, although 
the extent of transactivation differed from that of the Notch1ICD. In both C2C12 
and mouse primary myoblasts, co-transfection with Notch1ICD resulted in much a 
greater increase in activity of both the Hes1 and Hes7 promoter constructs 
compared with co-transfection with the Notch3ICD (Figure 6.3a,d and Figure 6.3c,f, 
respectively). In marked contrast, the Notch3ICD was much more effective in 
transactivating the Hes5 promoter construct than Notch1ICD (Figure 6.3b,e). This is 
in accordance with the initial hypothesis that Notch signalling, i.e. here both Notch1 
and Notch3, are activated during muscle cell differentiation and trigger the activity 





Figure 6.3 Effects of overexpression of constitutively active Notch1 and Notch3 on 




C2C12 and C57BL/10 mouse primary myoblasts were transfected with Hes1 (a and 
d), Hes5 (b and e) or Hes7 (c and f) promoter/ luciferase reporter constructs with or 
without plasmids encoding Notch1ICD or Notch3ICD. Beneath each histogram bar, + 
denotes the presence, - the absence of each plasmid. A plasmid encoding β-
galactosidase (30 ng) was included in all transfections and luciferase activity was 
divided by β-galactosidase activity to normalise for transfection efficiency. All 
relative luciferase activities are presented as mean values ± SEM of at least three 
independent experiments, each performed in triplicate and when compared using a 
Student’s t-test. 
 
The data presented in Figure 6.2 and Figure 6.3 suggest that in the cellular context 
of mouse skeletal muscle myoblasts, Notch1 and Notch3 activities may have 
differing effects on the expression of the canonical Notch signalling pathway target 
genes. For Hey1, Hey2, Hes1, and co-transfection with constitutively active 
Notch1ICD increased promoter activity, whereas the Notch3ICD caused little or no 
transactivation. In contrast, the Notch3ICD was significantly a more powerful 
transactivator of the Hes5 promoter than the Notch1ICD and in the case of the HeyL 
promoter; Notch3ICD appeared to cause a limited increase in activity whilst 
Notch1ICD was significantly slightly repressive. 
 
6.4 Regulation of Notch3 activity in the regulation of canonical Notch 
signalling pathway target gene expression 
Comparing results from 6.2 and 6.3, significantly the most prominent variations in 
the levels of activation for each gene were those of Hes1, Hes5 and Hes7 in C2C12 
and primary myoblasts (Figure 6.2 and Figure 6.3). The up-regulation or the down-
regulation of these genes was found to be very similar between C2C12 and primary 
myoblasts. This suggests that the initial hypothesis of implication of several genes 
from the Notch family, i.e. here Notch1 and Notch3, in the generation of a cell fate 
during differenciation, may be justified through then activation of downstream 
targets? Therefore, the aims of this section were to further characterise the 
regulatory region of Hes in C2C12 cells and Notch3 knockdown cultures. 
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According to the results obtained in the previous chapter, Notch3 was implicated as 
a potentially important receptor in determining alternate cell fates upon the 
induction of differentiation in C2C12 cell cultures. When Notch3 in C2C12 cultures 
was inhibited, the size of the cells appeared to be smaller and rounder. In addition, 
MyoD expression appeared to be elevated in cultures with reduced Notch3 
expression during differentiation (during which Notch3 was normally up-regulated). 
Despite the higher rate of apoptosis, the loss of Notch3 still resulted in increased 
fusion index characterised by higher average number of nuclei in myotubes in 
C2C12 cultures. In section 6.3, Notch3 was found to greatly enhance the activation 
of Hes5 in C2C12, which expressed Notch3 intrinsically. Hence we are interested to 
find out what is the implication of the absence of Notch3 to the regulation of Hes 
family. We also analysed and compared the regulation of Hes using shRNA Notch3 
knockdown cultures. 
As shown in Figure 6.4, Notch1 ICD was increased the luciferase activity of Hes1, 
Hes5 in the shRNA Notch3 knockdown cultures; in particular, there was a 3-fold 
increase in both Hes1 and Hes5 activity, although the increase in Hes7 luciferase 
activity was only marginal when compared to those of Hes1 and Hes5. While 
Notch3 IC was able to increase the luciferase activity of all three Hes genes in C2C12 
cultures, it only managed to increase the activity of Hes1 and Hes5, but there was a 
significant reduction of the Hes7 activation. Furthermore, in C2C12, the increased 
activation of Hes5 due to Notch3 IC was significantly greater than the increased 
activation of Hes5 due to Notch1 IC, the activation of Hes5 in shRNA Notch3 




Figure 6.4 Effects of Notch1IC and Notch3IC on the Hes1, -5 and -7 promoter 
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Hes1, -5, -7 luciferase constructs were transfected into C2C12 myoblasts (a, b, c) or 
shRNA Notch3 knockdown culture (d, e, f) with or without Notch1 IC and Notch3IC 
constructs. β-Galactosidase was used to normalise for transfection efficiency. 
Luciferase activities shown with a standard error are the average of at least three 
independent experiments performed in triplicate, which were compared using a 
Student’s t-test. 
 
We next analysed the effects of Numb on Notch signalling in the myogenic cell line 
C2C12, in which differentiation to myotubes can be blocked by Notch signalling  
(Dahlqvist et al., 2003; Gustafsson et al., 2005). 
As Numb inhibits Notch1, it would be expected that the magnitude of the increase 
in luciferase activity for Hes genes due to Notch1 IC would reduce. Indeed, as shown 
in Figure 6.5, the increase in Hes1 luciferase activity was significantly lower in both 
C2C12 and shRNA Notch3 knockdown cells when Numb was transfected. However, 
contrary to what was expected, there were 2-fold increase in the luciferase activity 
of Hes5 and Hes7 when Numb was transfected with Notch1 IC in C2C12. The 
luciferase activity of Hes5 and Hes7 was consistently increased when Numb was 
transfected with Notch3 IC in both C2C12 and shRNA Notch3 knockdown cultures. 
Numb appears to consistently enhance the ability of Notch3 IC to up-regulate all 
three Hes genes in the context of shRNA Notch3 knockdown culture. Numb was also 
able to consistently to inhibit Notch1 IC’s ability to up-regulate all three Hes genes 
in the shRNA Notch3 knockdown culture, but it was only capable of inhibiting 
Notch1 IC ability to up-regulate Hes1 activation in C2C12. The intrinsic expression of 
Notch3 in the C2C12 may have contributed to the increase of Hes5 and Hes7 
activation when Numb was transfected, and this increase due to Numb-Notch3 
interaction may have compensate and masked the reduction of Hes5 and Hes7 




Figure 6.5 Effects of Numb on the Hes1, -5 and -7 activation in Notch 
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Hes1, -5, -7 luciferase constructs were transfected into C2C12 myoblasts (a, b, c) 
and shRNA Notch3 knockdown culture (d, e, f) with or without Notch1 IC and 
Notch3IC constructs, co-cultured with combinations of Notch- and Jagged-
expressing cells. β-Galactosidase was used to normalise for transfection efficiency. 
Luciferase activities shown with a standard error are the average of at least three 
independent experiments performed in triplicate which were compared using a 
Student’s t-test. 
 
6.5 Investigation of the role of Notch3 in the regulation of Hes genes 
during skeletal muscle differentiation in vitro 
The initial hypothesis of this experimental work was that Notch receptors may be 
directly involved in the decision that generates satellite cells in their proper niche. 
The aims of this section were to investigate the role of Notch3 in the regulation of 
Notch-responsive Hes gene activity and the potential involvement of these targets 
in controlling cell fate (i.e. differentiation to form myotubes or sequestration as 
reserve cells) during differentiation. 
Evidence presented in previous chapters implicates Notch3 activity in the 
establishment and maintenance of a quiescent, stem cell-like reserve cell 
phenotype during skeletal muscle differentiation in vitro (Chapter 4 and Chapter 5). 
Compared with proliferating myoblasts, reserve cells show reduced levels of 
expression of Hes1, Hes5 and Hes7 which may reflect different relative levels of 
Notch receptor expression (Figure 6.1).  
To examine the role of Notch3, quantitative RT-PCR was used to investigate the 
patterns of expression of Hes1, Hes5 and Hes7 during the early stages of 
differentiation were compared using wild-type C2C12 and the stable shRNA Notch3-
knockdown line described in Chapter 4. 
Replicate cultures of wild-type and shRNA Notch3-knockdown C2C12 myoblasts 
were seeded into 10 cm-diameter Petri dishes (5 x105 cells per dish) and maintained 
for 24 hours in growth medium, before switching to differentiation medium. At 24 
hour intervals, three cultures were harvested and total RNA was extracted as 
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described in section 2.17. Quantitative RT-PCR analyses were carried out as 
described in Section 2.5.2.1, using the primers and cycling parameters presented in  
Table 2.3. 
6.5.1 Comparison of the expression of Hes1 following the induction of 




Figure 6.6 Quantitative RT-PCR analysis of Hes1 expression during the onset of 
differentiation of wild-type and shRNA Notch3-knockdown C2C12 myogenic 
cultures 
Total RNA was extracted from replicate wild-type C2C12 cultures (Control, open 
bars) and shRNA Notch3 knockdown C2C12 cultures (Notch3 knockdown, shaded 
bars) at 24-hour intervals after the induction of differentiation was induced. Levels 
of Hes1 transcript were determined by quantitative RT-PCR and are presented as 
the mean ± SD from three replicate samples, relative to the expression of 18S 
ribosomal RNA. 
 
Results presented in Chapter 3 (section 3.3) show that in wild-type C2C12 cultures, 
Notch3 is up-regulated 24-48 hours after differentiation is induced. Figure 6.6 
shows that during this period, the level of Hes1 transcript initially decreased in wild-
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type C2C12 cells and then increased at 48 hours. However, in the shRNA Notch3 
knockdown cultures, the increase in expression at 48 hours was not observed. This 
is consistent with the observation that following differentiation, Hes1 was much 
more highly expressed in reserve cells than in myotubes (Figure 6.1) as the 
knockdown cultures contain few, if any, reserve cells. 
6.5.2 Comparison of the expression of Hes5 following the induction of 
myogenic differentiation in wild-type and shRNA Notch3-knockdown 
C2C12 cultures 
 
Figure 6.7 Quantitative RT-PCR analysis of Hes5 expression during the onset of 
differentiation of wild-type and shRNA Notch3-knockdown C2C12 myogenic 
cultures 
Total RNA was extracted from replicate wild-type C2C12 cultures (Control, open 
bars) and shRNA Notch3 knockdown C2C12 cultures (Notch3 knockdown, shaded 
bars) at 24-hour intervals after the induction of differentiation was induced. Levels 
of Hes5 transcript were determined by quantitative RT-PCR and are presented as 
the mean ± SD from three replicate samples, relative to the expression of 18S 
ribosomal RNA. 
 
During the onset of differentiation, the levels of Hes5 transcript were found to 
increase in both the wild-type and the shRNA Notch3 knockdown C2C12 cultures 
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(Figure 6.7). That the same pattern of expression was observed both in both cell 
lines suggests that this increase is independent of changes in Notch3 expression. 
6.5.3 Comparison of the expression of Hes7 following the induction of 




Figure 6.8 Quantitative RT-PCR analysis of Hes7 expression during the onset of 
differentiation of wild-type and shRNA Notch3-knockdown C2C12 myogenic 
cultures 
Total RNA was extracted from replicate wild-type C2C12 cultures (Control, open 
bars) and shRNA Notch3 knockdown C2C12 cultures (Notch3 knockdown, shaded 
bars) at 24-hour intervals after the induction of differentiation was induced. Levels 
of Hes7 transcript were determined by quantitative RT-PCR and are presented as 
the mean ± SD from three replicate samples, relative to the expression of 18S 
ribosomal RNA. 
 
Figure 6.8 shows that in wild-type C2C12 cultures, the level of Hes7 transcript was 
decreased 48 hours after differentiation was induced: in contrast, the level of 




6.6 The effects of overexpression of Hes genes on the differentiation of 
C2C12 and shRNA Notch3 knockdown C2C12 myogenic cultures 
 
Results presented in Chapter 5 suggest that Notch3 activity is involved in the 
determination of cell fate during myogenic differentiation: specifically, in 
establishment and maintenance of the quiescent, undifferentiated reserve cell 
population. In the absence of Notch3, the initial stages of differentiation are 
accompanied by increased levels of apoptosis and once fully differentiated, the 
cultures consisted of myotubes containing a higher average number of myonuclei 
and a markedly reduced number of reserve cells compared with wild-type cells. 
Data presented above (Figure 6.6 and Figure 6.8) show that during the first 48 hours 
after differentiation was induced, the time when Notch3 expression is up-regulated, 
the overall level of Hes1 transcript was maintained whereas Hes7 expression 
decreased compared with proliferating myoblasts. In the absence of Notch3, the 
level of Hes1 transcript was decreased whereas Hes7 expression was greater 
compared with the controls. 
It is possible that Notch3 promotes Hes1 and inhibits Hes7 expression and that 
inappropriate expression of one or both is incompatible with the reserve cell 
phenotype. Alternatively, the lack of Notch3 may prevent cells from adopting the 
reserve cell fate which normally results in the subsequent overall maintained levels 
of Hes1 and down-regulation of Hes7 in the cultures. To further investigate these 
possibilities, the behaviour of differentiating shRNA Notch3 knockdown and shRNA 
control C2C12 cultures were compared following transfection with expression 
vectors encoding Hes1, Hes5 or Hes7. 
6.6.1 Effects of Hes gene overexpression on myotube formation in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
If the lack of reserve cells observed in differentiated shRNA Notch3 knockdown 
cultures is due to the lack of Notch3 activity-mediated up-regulation of Hes activity, 
overexpression of the downstream target would be expected to reverse this effect 
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in knockdown cultures and possibly increase the number of reserve cells in 
Notch3+ve cultures. 
To investigate this possibility, shRNA Notch3 knockdown and shRNA control C2C12 
cultures were transfected with Hes1, Hes5 or Hes7 expression plasmids (section 2.8) 
using Lipofectamine 2000 (section 2.9.1) and seeded into Permanox 8-well Lab-Tek 
chamber slides at 103 cells/chamber in growth medium. After 24 hours, the medium 
was switched to differentiation medium and the cultures allowed to differentiate 
for 96 hours before they were fixed and stained for skeletal muscle myosin heavy 
chain (MyHC) expression, (as described in section 2.14). The numbers of nuclei in 
MyHC+ve cells were counted to determine the fusion index (i.e. the proportion of 
nuclei in differentiated cells). The expression of GFP+ve and MyHC-ve 
undifferentiated cells were counted to determine the percentage of 




6.6.1.1 Effects of transfection with Hes1 
 
 
Figure 6.9 Effects of Hes1 overexpression on myotube formation in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
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were transfected with a Hes1 expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-MyHC antibodies. Representative images 
of untransfected control (a-d), Hes1-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes1-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for MyHC (red; b, f, j and n) 
and GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three 
stains. (Scale bar = 20μM) To determine the number of nuclei in MyHC+ve cells or 
undifferentiated (MyHC-ve)/GFP+ve single cells, at least 200 nuclei were counted in 
randomly selected fields (q and r). The histogram bars represent the mean ± 1 SD of 
three replicate cultures which were compared using a Student’s t-test. 
 
Consistent with previous data (section 4.4), the percentage of nuclei in MyHC+ve 
cells was greater in the shRNA Notch3 knockdown compared to the control cultures 
(Figure 6.9) due to the reduction in the number of cells that adopt the 
undifferentiated reserve cell fate. When control cultures were transfected with the 
Hes1 expression plasmid, a slight increase but significant (p=0.0003) in the level of 
differentiation was observed whereas in the shRNA Notch3 cultures, the level 
decreased (p=0.05), reflecting the persistence of a larger number of 
undifferentiated, mononucleated cells. The effect of Hes1 expression was 
statistically significant when analysed using a Student’s t-test. 
When the undifferentiated, GFP+ve and MyHC-ve cell populations were examined, 
there was a significantly lower mean percentage of GFP+ve/MyHC-ve cells in both 
control cultures transfected with Hes1 (p=0.015) and shRNA Notch3 cultures 




6.6.1.2 Effects of transfection with Hes5 
 
 
Figure 6.10 Effects of Hes5 overexpression on the myotube formation in C2C12 
and shRNA Notch3 knockdown C2C12 myogenic cultures 
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Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes5 expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-MyHC antibodies. Representative images 
of untransfected control (a-d), Hes5-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes5-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for MyHC (red; b, f, j and n) 
and GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three 
stains. (Scale bar =20μM). To determine the number of nuclei in MyHC+ve cells or 
undifferentiated (MyHC-ve)/GFP+ve single cells, at least 200 nuclei were counted in 
randomly selected fields (q and r). The histogram bars represent the mean ± 1 SD of 
three replicate cultures which were compared using a Student’s t-test. 
 
Data presented in Figure 6.10 show that overexpression of Hes5 in shRNA Notch3 
knockdown C2C12 cells resulted in a slight but significantly increased in the fusion 
index (i.e. the number of nuclei in MyHC+ve cells) following differentiation, also 
transfection with the same plasmid produced a significant increase (p=0.03) in the 
fusion index of differentiated control C1C12 cells.  
When the undifferentiated GFP+ve/MyHC-ve cell populations were examined, there 
was a significantly lower mean percentage of GFP+ve/MyHC-ve cells in the shRNA 
control cultures compared with Hes5-transfected control (p=0.002). However 
shRNA Notch3 knockdown and Hes5-transfected shRNA Notch3 knockdown cultures 




6.6.1.3 Effects of transfection with Hes7 
 
 
Figure 6.11 Effects of Hes7 overexpression on myotube formation in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes7expression construct. Twenty-four hours post-
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transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-MyHC antibodies. Representative images 
of untransfected control (a-d), Hes7-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes7-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for MyHC (red; b, f, j and n) 
and GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three 
stains. (Scale bar = 20μM). To determine the number of nuclei in MyHC+ve cells or 
undifferentiated (MyHC-ve)/GFP+ve single cells, at least 200 nuclei were counted in 
randomly selected fields (q and r). The histogram bars represent the mean ± 1 SD of 
three replicate cultures, which were compared using a Student’s t-test. 
 
Figure 6.11 shows that transfection of shRNA Notch3 knockdown cultures with Hes7 
prior to the induction of differentiation resulted in a significant decrease in the 
percentage of nuclei in MyHC+ve cells compared with untransfected knockdown 
cultures (p=0.0001). However, the opposite was observed in control cultures where 
overexpression of Hes7 resulted in an increased fusion index (p=0.0003).  
Overexpression of Hes7 caused significantly reduced luciferase activity in both 
control and Notch3 knockdown cells. A possible explanation is that Hes7 activity has 
different effects on the behaviour of residual mononucleated cells in differentiated 
cultures. Hes7 activity may promote the differentiation of reserve cells (consistent 
with the inhibition of Hes7 promoter activity by overexpression of Notch3 (Figure 
6.4)) leading to an increase in the fusion indices of control cultures, but inhibit the 
differentiation of Notch3-ve myoblasts. 
6.6.2 Effects of Hes gene overexpression on MyoD expression in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
The initial hypothesis involved a potential role of Notch genes in the cell fate 
towards self-renewing of the stem cell compartment. Since Notch genes activate 
Hes genes, we wanted to investigate the relationship between Hes genes activation 
and MyoD expression, as a marker of activated satellite cells absent of the self-
renewing population. To investigate the effects of Hes genes on MyoD expression, 
shRNA Notch3 knockdown and shRNA control C2C12 cultures were transfected with 
Hes1, Hes5 or Hes7 expression plasmids (section 2.8) using Lipofectamine 2000 
(section 2.9.1) and seeded into Permanox 8-well Lab-Tek chamber slides at 103 
 185 
 
cells/chamber in growth medium. 24 Hours after transfection, the medium was 
switched to differentiation medium and the cultures allowed to differentiate for 96 
hours before they were fixed and stained for MyoD expression, as described in 
section 2.14). 
 






Figure 6.12 Effects of Hes1 overexpression on MyoD expression in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes1 expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-MyoD antibodies. Representative images 
of untransfected control (a-d), Hes1-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes1-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for MyoD (red; b, f, j and n) 
and GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three 
stains. (Scale bar = 20μM). To determine the percentage of MyoD+ve cells, at least 
200 nuclei were counted in randomly selected fields (q). The histogram bars 
represent the mean ± 1 SD of three replicate cultures were compared using a 
Student’s t-test. 
 
Figure 6.12 shows Hes1 overexpression resulted in a significant increase in the 
percentage of MyoD cells in the control cultures, whereas transfection of the 
Notch3 knockdown cultures with same plasmid resulted in a significant decrease 
MyoD expression to the same level as observed in the control, Notch3+ve cultures. 
This suggests that the expression of Hes1 results in an increase in the number of 
MyoD-ve cells, presumably reserve cells, within the differentiated cultures. 
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6.6.2.2 Effects of transfection with Hes5 
 
 
Figure 6.13 Effects of Hes5 overexpression on MyoD expression in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes5 expression construct. Twenty-four hours post-
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transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-MyoD antibodies. Representative images 
of untransfected control (a-d), Hes5-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes5-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for MyoD (red; b, f, j and n) 
and GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three 
stains. (Scale bar = 20μM). To determine the percentage of MyoD+ve cells, at least 
200 nuclei were counted in randomly selected fields (q). The histogram bars 
represent the mean ± 1 SD of three replicate cultures. 
 
Overexpression of Hes5 had no significant effect on MyoD expression in the control 
C2C12 cultures, but resulted in a significant decrease in the proportion of MyoD+ve 
cells in equivalent Notch3 knockdown cultures (Figure 6.13). As was observed with 
the Hes1, transfection with the Hes5 construct reduced the level of MyoD 
expression in the knockdown cultures to that observed in the control, Notch3+ve 
cells. There was no significant difference in MyoD expression in Hes5 transfected 
shRNA control cultures when compared with the shRNA control (Figure 6.14). 
However, there was a significant reduction (p=0.002 < 0.05) in the MyoD expression 
in the Hes5 transfected shRNA Notch3 knockdown cultures when compared with 
the shRNA Notch3 knockdown cultures. 
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6.6.2.3 Effects of transfection with Hes7 
 
 
Figure 6.14 Effects of Hes7 overexpression on MyoD expression in C2C12 and 
shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes7 expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
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co-immunostained with anti-GFP and anti-MyoD antibodies. Representative images 
of untransfected control (a-d), Hes7-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes7-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for MyoD (red; b, f, j and n) 
and GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three 
stains. (Scale bar = 20μM). To determine the percentage of MyoD+ve cells, at least 
200 nuclei were counted in randomly selected fields (q). The histogram bars 
represent the mean ± 1 SD of three replicate cultures. 
 
Figure 6.14 shows that transfection with Hes7 resulted in a slight but significant 
increase in the percentage of MyoD+ve cells in the control cultures (p=0.02), and a 
significant decrease in the percentage of MyD+ve cells in the shRNA Notch3 
knockdown cultures to similar levels to those observed in the untransfected 
controls (p=0.0001). 
 
6.6.3 Effects of Hes gene overexpression on cyclin dependent kinase inhibitors 
p21 and p27 expression in C2C12 and shRNA Notch3 knockdown C2C12 
myogenic cultures 
The main aim of this section was to investigate the effects of Hes gene expression 
on p21 and p27, involved during the differentiation of myogenic cultures, in C2C12 
and Notch3 knockdown cells. As Notch signalling has an effect on Hes gene 
expression, this further tests the hypothesis that Notch receptors have a direct 
effect on cell fate during differentiation. 
Results presented in Section 4.4 suggest Notch3 activity may be involved in the 
regulation of cell cycle progression. As transfection with a constitutively active form 
of Notch3 was found to inhibit myoblast proliferation, but enhance proliferation 
when differentiation was induced. It has previously been suggested that Notch 
signalling may regulate the cell cycle by inducing changes in the expression of the 
cdk inhibitors p21 and p27 (Cao et al., 2003). p21 and p27 appear to be involved in 
the regulation of myogenic differentiation, as they are highly upregulated when 
C2C12 myoblast differentiation is induced (Cao et al., 2003). 
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p21 expression is a prerequisite for irreversible cell cycle withdrawal that precedes 
differentiation (Cao et al., 2003), and it was not expressed in proliferating 
myoblasts. p27 induces and maintains a quiescent state in cells (Medema et al., 
2000; Miskimins et al., 2001; Olashaw and Pledger, 2002) and is normally expressed 
in reversibly quiescence cells (i.e. reserve cells). 
To study the effects of Hes gene expression on p21 and p27 during the 
differentiation of myogenic cultures, shRNA Notch3 knockdown and shRNA control 
C2C12 cultures were transfected with Hes1, Hes5 or Hes7 expression plasmids 
(section 2.8) using Lipofectamine 2000 (section 2.9.1) and seeded into Permanox 8-
well Lab-Tek chamber slides at 103 cells/chamber in growth medium. 24 Hours 
after transfection, the medium was switched to differentiation medium and the 
cultures allowed to differentiate for 96 hours before they were fixed and stained for 




6.6.3.1 Effects of transfection with Hes1 on p21 expression 
 
 
Figure 6.15 Effects of Hes1 overexpression on p21 expression in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes1expression construct. Twenty-four hours post-
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transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-p21 antibodies. Representative images of 
untransfected control (a-d), Hes1-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes1-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for p21 (red; b, f, j and n) and 
GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three stains. 
(Scale bar = 20μM). To determine the percentage of p21 cells, at least 200 nuclei 
were counted in randomly selected fields (q). The histogram bars represent the 
mean ± 1 SD of three replicate cultures. Statistical comparisons were carried out by 
Student’s t-test. 
 
Overexpression of Hes decreased the percentage of p21+ve cells in the 
differentiated control cultures. Hes1-transfected Notch3 knockdown cultures 
contained significantly fewer p21+ve cells compared with the equivalent 
untransfected control cultures (p=0.005). 





Figure 6.16 Effects of Hes1 overexpression on p27 expression in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes1expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-p27 antibodies. Representative images of 
untransfected control (a-d), Hes1-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes1-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for p27 (red; b, f, j and n) and 
GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three stains. 
(Scale bar = 20μM). To determine the percentage of undifferentiated p27+ve cells, 
at least 200 nuclei were counted in randomly selected fields (q). The histogram bars 
represent the mean ± 1 SD of three replicate cultures. Statistical comparisons were 
carried out by Student’s t-test. 
 
Figure 6.16 shows that the untransfected Notch3 knockdown cultures contained 
fewer p27+cells compared to the untransfected controls, consistent with the 
previously observed reduction in the number of reserve cells present following 
differentiation. Overexpression of Hes1 resulted in a significant increase in the 
proportion of p27+ve cells in the control cultures (p=0.0003). Counting p27+ cells in 
mononucleated cell excluding myotubes, then the mean percentage of p27+ cells of 
the Hes1 transfected shRNA Notch3 knockdown control cultures is significantly less 
than that of shRNA Notch3 knockdown control cultures (p=0.008). 
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6.6.3.3 Effects of transfection with Hes5 on p21 expression 
 
 
Figure 6.17 Effects of Hes5 overexpression on p21 expression in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes5expression construct. Twenty-four hours post-
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transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-p21 antibodies. Representative images of 
untransfected control (a-d), Hes5-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes5-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for p21 (red; b, f, j and n) and 
GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three stains. 
(Scale bar = 20μM) 
To determine the percentage of p21 cells, at least 200 nuclei were counted in 
randomly selected fields (q). The histogram bars represent the mean ± 1 SD of three 
replicate cultures. Statistical comparisons were carried out by Student’s t-test. 
 
Transfection with the Hes5 expression plasmid resulted in a significant increase in 
the percentage of p21+ve cells in the control cultures (p=0.03), but significantly 
decreased the proportion in the Notch3 knockdown cultures (p=0.02 (Figure 6.17)). 
 





Figure 6.18 Effects of Hes5 overexpression on p27 expression in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes5expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-p27 antibodies. Representative images of 
untransfected control (a-d), Hes5-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes5-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for p27 (red; b, f, j and n) and 
GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three stains. 
(Scale bar = 20μM). To determine the percentage of undifferentiated p27+ve cells, 
at least 200 nuclei were counted in randomly selected fields (q). The histogram bars 
represent the mean ± 1 SD of three replicate cultures. Statistical comparisons were 
carried out by Student’s t-test. 
 
As was observed with the Hes1 plasmid, overexpression of Hes5 in control cultures 
resulted in a significant increase in the percentage of p27+ve cells in the single cell 
population remaining after differentiation (Figure 6.18). However, in contrast to 
Hes1, overexpression of Hes5 also significantly increased the percentage of p27+ve 
single cells in the Notch3 knockdown cultures to greater levels than in the 
untransfected control cultures. This suggests that Hes5 may be involved in 
establishing a reversibly quiescent reserve cell phenotype and that during 
differentiation, Notch3 activity may promote Hes5 expression as shown by the 
effect of the Notch3ICD on Hes5 promoter activity (refer back to the promoter 
results (Figure 6.3)) 
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6.6.3.5 Effects of transfection with Hes7 on p21 expression 
 
 
Figure 6.19 Effects of Hes7 overexpression on p21 expression in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes7expression construct. Twenty-four hours post-
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transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-p21 antibodies. Representative images of 
untransfected control (a-d), Hes7-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes7-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for p21 (red; b, f, j and n) and 
GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three stains. 
(Scale bar = 20μM). To determine the percentage of p21 cells, at least 200 nuclei 
were counted in randomly selected fields (q). The histogram bars represent the 
mean ± 1 SD of three replicate cultures. Statistical comparisons were carried out by 
Student’s t-test. 
 
Figure 6.19 shows that overexpression of Hes7 in control cultures resulted in a 
significant increase in the percentage of cells positive for p21 (p=0.003). Together 
with the observed increases in the myotube formation and MyoD expression (Figure 
6.11 and Figure 6.14, respectively), this suggests that Hes7 may be associated with 
differentiation. However, Hes7 overexpression significantly decreased the 




6.6.3.6 Effects of transfection with Hes7 on p27 expression 
 
 
Figure 6.20 Effects of Hes7 overexpression on p27 expression in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
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were transfected with a Hes7expression construct. Twenty-four hours post-
transfection, the cultures were allowed to differentiate for 96 hours fixed and then 
co-immunostained with anti-GFP and anti-p27 antibodies. Representative images of 
untransfected control (a-d), Hes7-transfected control (e-h), untransfected Notch3 
knockdown (i-l) and Hes7-transfected Notch3 knockdown (m-p) are shown stained 
with DAPI to reveal all nuclei (blue; a, e, i and m) and for p27 (red; b, f, j and n) and 
GFP (green; c, g, k and o) expression. d, h, l and p are overlay images all three stains. 
(Scale bar = 20μM). To determine the percentage of undifferentiated p27+ve cells, 
at least 200 nuclei were counted in randomly selected fields (q). The histogram bars 
represent the mean ± 1 SD of three replicate cultures. Statistical comparisons were 
carried out by Student’s t-test. 
 
Data presented in Figure 6.20 show that in control cultures, overexpression of Hes7 
resulted in a significant decrease in the percentage of p27+ve cells amongst the 
undifferentiated single cell population (p=0.04). Together with the p21 data, this 
suggests that Hes7 may promote differentiation whilst reducing the number of 
residual, quiescent reserve cells. In the Notch3 knockdown cultures however, the 
findings were reversed as Hes7 significantly increased the percentage of p27+ve 
single cells whilst decreasing p21 expression (p=0.0007). 
 
6.6.4 Effect of Hes gene overexpression on apoptosis in C2C12 and shRNA 
Notch3 knockdown C2C12 myogenic cultures 
Previous studies have suggested that Notch3 activity may be a critical determinant 
of vascular smooth muscle cell survival (Wang et al., 2002). Consistent with this, is 
the observation that caspase3/7 activity, a marker of apoptosis (Fesik & Shi, 2001), 
was more than three times greater in shRNA Notch3 knockdown cultures compared 
with shRNA control than and wild-type C2C12 and cultures (section 4.3.3). 
Our results concerning down-expression of Notch3 raises the hypothesis that 
increased apoptosis caused by a lack of Notch3-mediated Hes expression may play a 
role in the consequences of Notch3 inhibition. To asses this hypothesis, shRNA 
Notch3 knockdown and shRNA control C2C12 cultures were transfected with either 
the Hes1, Hes5 or Hes7 expression plasmid (section 2.7), and then seeded in white-
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walled 96 well plates at 1500 cells/well maintained in growth medium for 24 hours 
and then transferred to differentiation medium. After 48 hours, caspase 3/7 
activities were measured using the Caspase3/7-Glo Assay Kit (Promega) as 
described in section 2.4.2. A 48 hour time point was chosen as this is when Notch3 
activity is highest following the induction of differentiation (Chapter 3, Section 3.3). 
Caspases are a group of cysteine proteases that are the central effectors of 
apoptosis (Fesik and Shi, 2001), such that the level of caspase 3/7 activity is an 
accepted indicator of the level of apoptosis. 
 
6.6.4.1 Effects of transfection with Hes1 on apoptosis 
 
 
Figure 6.21 Effects of Hes1 overexpression on apoptosis in differentiating C2C12 
and shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes1 expression plasmid and induced to differentiate for 48 
hours. Caspase 3/7 activities were measured and the results are presented as the 
mean value from three cultures ± 1 SD, which were compared using a Student’s t-
test. The columns represent untransfected cultures; the solid columns are cultures 




Data presented in Figure 6.7 confirm that after 48 in differentiation medium, 
Notch3 knockdown C2C12 cultures express greater levels of caspase 3/7 activity 
than control cultures, indicative of a greater level of apoptosis. Overexpression of 
Hes1, which is downstream of Notch signalling, failed to compensate for the lack of 
Notch3 in terms of preventing apoptosis and in the case of the control cells, even 
increased the level of caspase activity, thus suggesting that overexpression of 
known downstreal target genes cannot completely compensate for Notch3 
knockdown. 
Effects of transfection with Hes5 on apoptosis 
 
 
Figure 6.22 Effects of Hes5 overexpression on apoptosis in differentiating C2C12 
and shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes5 expression plasmid and induced to differentiate for 48 
hours. Caspase 3/7 activities were measured and the results are presented as the 
mean value from three cultures ± 1 SD. The columns represent untransfected 
cultures; the solid columns are cultures transfected to overexpress Hes5. Statistical 




Figure 6.22 shows that overexpression of Hes5 resulted in a significant increase in 
Caspase3/7 activity (and therefore apoptosis) in control cultures. In Notch3 
knockdown cultures, Hes5 transfection resulted in a significant reduction compared 
with the Notch3 knockdown control cultures, although the overall level was still 
considerably greater than in the non-knockdown cultures. 
 
6.6.5 Effects of transfection with Hes7 on apoptosis 
 
 
Figure 6.23 Effects of Hes7 overexpression on apoptosis in differentiating C2C12 
and shRNA Notch3 knockdown C2C12 myogenic cultures 
Stable lines of C2C12 myoblasts expressing either an irrelevant control shRNA/eGFP 
plasmid (Control) or shRNA Notch3 knockdown/eGFP plasmid (Notch3 knockdown) 
were transfected with a Hes7 expression plasmid and induced to differentiate for 48 
hours. Caspase 3/7 activities were measured and the results are presented as the 
mean value from three cultures ± 1 SD. The columns represent untransfected 
cultures; the solid columns are cultures transfected to overexpress Hes7. Statistical 
comparisons were carried out by Student’s t-test. 
 
Transfection of control C2C12 cultures with the Hes7 expression plasmid had no 
effect on Caspase3/7 activity when compared with the untransfected control 
cultures (Figure 6.23). When Notch3 knockdown cultures were transfected 
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however, expression of Hes7 resulted in a small but significant increase compared 






Control+Hes     
N3KD vs 
N3KD+ Hes   
  Hes1 Hes5 Hes7 Hes1 Hes5 Hes7 
Myotube formation      
MyoD Expression  −    
p21 −     
p27      
Apoptosis   − −  
 
Table 6.1 Summary of the effects of overexpression of Hes1, Hes5 and Hes7 in 
shRNA control and shRNA Notch3 cultures 
 
Our initlal hypothesis is that members of the Notch receptor family play a role in 
the cell fate and self-renewing during muscle cell differentiation. We observed a 
differential expression of Notch1 and Notch3, which is consistent with this 
hypothesis, although the activation of downstream targets needed to be confirmed 
through Hes gene family activation. Chapter 6 revealed that Notch target genes 
Hey1, Hes1, Hes5 and Hes7 are all highly expressed in proliferating myoblasts. 
Notch1 and Notch2 were expressed at high levels in myoblasts. Myotube fractions 
only express Notch1 but not Notch2 or Notch3. Differentiation to form myotubes 
was accompanied by a marked down-regulation of Hey1 and Hes1, whilst Hes5 and 
Hes7 were still expressed, but at lower levels. The down-regulation of Hey1/Hes1 
could be due to loss of Notch2 and or changes in Numb.  
Hey1, Hes1, Hes5 and Hes7 were expressed in reserve cell fractions at lower levels, 
but there was significantly up-regulation of HeyL. Reserve cells expressed high level 
of Notch3. The result presented here is consistent with the observed HeyL highly 
expressed in quiescent satellite cells (Notch3IC+) but not in activated/proliferating 
satellite cells (Notch1+) or myofibres (Fukada et al., 2011; Mourikis et al., 2012). 
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Hey1 is also expressed in quiescent satellite cells. However, in contrast to HeyL, a 
weak Hey1 signal was detected in activated/proliferating satellite cells (Fukada et 
al., 2011). 
As Numb inhibits Notch1 (Beres et al., 2011), it would be expected that the 
magnitude of the increase in luciferase activity for Hes genes due to Notch1 IC 
would be reduced. However, conflicting to what was expected in Hes1/Hey1, the 
luciferase activity of Hes5 and Hes7 were increased when Numb was transfected 
with Notch1 IC in C2C12. Numb was able to consistently reduced the luciferase 
activity of Hes1, Hes5 and Hes7 when transfected with Notch1 IC in shRNA.  
Numb appears to consistently enhance the ability of Notch3 IC to up-regulate all 
three Hes genes in the context of shRNA Notch3 knockdown cultures. Numb was 
also able to consistently inhibit Notch1 IC’s ability to up-regulate all three Hes genes 
in the shRNA Notch3 knockdown culture, but it was only capable of inhibiting 
Notch1 IC’s ability to up-regulate Hes1 activation in C2C12. Beres et al. (2011) 
reported Notch1 and Notch2 are inhibited by numb but not Notch3 activity. The 
intrinsic expression of Notch3 in the C2C12 may have contributed to the increase of 
Hes5 and Hes7 activation when Numb was transfected, and this increase due to 
Numb-Notch3 interaction may have compensated and masked the reduction of 
Hes5 and Hes7 activity resulting from the inhibition of Notch1 by Numb.  
Overexpression of Notch1ICD increased both Hey1 and Hey2 promoter activity in 
both C2C12, consistent with previous findings (Nakagawa et al., 2000), whereas 
Notch3ICD had no effect on either Hey1 or Hey2 promoter activity in either system. 
In contrast, Notch1ICD slightly decreased HeyL promoter activity, whereas 
overexpression of Notch3ICD increased activity in both C2C12 and mouse primary 
myoblasts. 
Hes1 transfected shRNA control cultures shows a slight increase in the level of 
differentiation and MyoD+ cells. While in the shRNA Notch3 cultures, the level of 
both MyHC+ and MyoD+ cells decreased, reflecting the persistence of a larger 
number of undifferentiated, mononucleated cells. Overexpression of Hes1 
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decreased the percentage of p21+ populations in the differentiated control 
cultures. Untransfected Notch3 knockdown cultures contained fewer p27+cells 
compared to the untransfected controls, consistent with the previously observed 
reduction in the number of reserve cells present following differentiation. 
Overexpression of Hes1 resulted in a significant increase in the proportion of 
p27+ve cells in the control cultures, but significantly decreased the percentage in 
the Notch3 knockdown cultures.   
Overexpression of Hes5 in shRNA Notch3 knockdown C2C12 cells resulted in a 
small, but significant increase in the fusion index following differentiation, while 
transfection with the same plasmid produced a significant larger increase in the 
fusion index of differentiated control C1C12 cells. shRNA control cultures show 
lower undifferentiated cells compared with Hes5-transfected control. But shRNA 
Notch3 knockdown and Hes5-transfected shRNA Notch3 knockdown cultures show 
no difference in percentage of undifferentiated cells. This is different from the 
previous finding (Beatus et al., 1999), in which Notch3 IC was found to repress Hes5 
in vitro and in vivo.  Different genes are active in different kinds of cells. Therefore 
this is very like due to the difference between the mouse muscle cell line being used 
in our study and the JEG cells and COS-7 cell line used by Beatus and coworkers.  
Furthermore, overexpression of Hes5 resulted in a significant increase in the 
percentage of p21+ and p27+ cells in the transfected control cultures, but 
significantly decreased the p21+ proportion in the Notch3 knockdown cultures. 
However, in contrast to Hes1, overexpression of Hes5 also significantly increased 
the percentage of p27+ve single cells in the Notch3 knockdown cultures to greater 
levels than in the untransfected control cultures. This suggests that Hes5 may be 
involved in establishing a reversibly quiescent reserve cell phenotype and that 
during differentiation. Notch3 activity may promote Hes5 expression as shown by 
the effect of the Notch3ICD on Hes5  
Hes7 transfected shRNA Notch3 knockdown cultures resulted in a significant 
decrease in MyHC+ve cells compared with untransfected knockdown cultures. The 
contrary was observed in control cultures where overexpression of Hes7 resulted in 
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an increased fusion index and MyoD+ cell populations.  When the undifferentiated 
cell populations were examined, there was a significantly lower GFP+ve/MyHC-ve 
cells in the both shRNA control and shRNA Notch3 knockdown cultures compared 
with both Hes7-transfected cultures. 
In control cultures, overexpression of Hes7 resulted in a significant decrease in the 
percentage of p27+ve cells amongst the undifferentiated single cell population. 
Together with the p21 data, this suggests that Hes7 may promote differentiation 
whilst reducing the number of residual, quiescent reserve cells.  In the Notch3 
knockdown cultures however, the findings were reversed as Hes7 significantly 
increased the percentage of p27+ve single cells whilst decreasing p21 expression. 
The findings in this chapter suggested Hes1 prevents differentiation, but is probably 
responding to Notch1/Notch2 rather than Notch3. As during differention, Numb 
upregulates and inhibits Notch1/2 expression and therefore prevents cells from 
undergoing differentiation. This means most cells remain proliferating (Notch1/2+), 
whereas Notch3 has no effect on Numb upregulated.  Hes7 appears to “favour” 
differentiation and may be inhibited by Notch3. Hes5 is probably the most 
interesting and may be related to Notch3 and reserve cells.   
The main challenge is that while both the shRNA control and the knockdown 
cultures express GFP marker, none of the Notch target gene plasmids have a marker 
(i.e. mCherry) to examine the transfection efficiency when they are transfected into 
shRNA (GFP+) cells. Target genes expressing mCherry or other markers except GFP 
would facilitate data quantification. Besides, the data is based on transient 






Chapter 7: General discussion and a potential model for the 
recruitment of satellite cells during skeletal muscle 
regeneration 
 
Myofibre homeostasis, growth and repair require adult satellite cells, which are 
distributed throughout the tissue, each within an individual niche consisting of an 
underlying myofibre membrane, surrounding extracellular matrix and overlying 
basal lamina. Normally quiescent, satellite cells become activated in response to 
exercise or damage and proliferate to generate a pool of precursors (myoblasts) 
that differentiate into new myonuclei within existing or nascent myofibres (Charge 
& Rudnicki, 2004; Kuang et al., 2008). In addition to producing differentiated cells, 
satellite cells also self-renew to maintain or replenish the stem cell compartment 
retain regenerative capacity (Collins et al., 2005; Montarras et al., 2005; Sacco et al., 
2008). The precise mechanism by which this occurs remains unclear, although 
numerous studies have implicated the Notch signalling pathway involved in 
determining cell fate behaviour and fate in a wide range of developing and adult 
tissues (Conboy & Rando, 2002; Conboy et al., 2005; Luo et al., 2005; Kitzmann et 
al., 2006). We hypothesize that Notch signalling is indeed involved in the decision 
concerning cell fate between differentiation and self-renewing, and that several 
members of the Notch family receptors may be involved in different stages of this 
decision. 
 
Since Notch1 role has been investigated in the generation of quiescent precursors, 
the aim of this project was to investigate the role of Notch3 activity in the 
regulation of adult skeletal muscle stem cell behaviour. Although Notch3 is known 
to be expressed by quiescent satellite cells (Fukada et al., 2007; Kuang et al., 2007; 
Mourikis et al., 2012) and a recent study has shown that skeletal muscle 
regeneration is compromised in mice lacking the receptor (Kitamoto & Hanaoka, 
2010), its precise function remains unclear. 
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Many of the studies presented in this thesis were carried out an in vitro model of 
satellite cell specification during regeneration. Cultures of the murine myogenic cell 
line C2C12 (Yaffe and Saxel, 1977; Blau et al., 1983) and primary satellite cell-
derived cultures were maintained as proliferating myoblasts in growth media 
containing high levels of serum and as required, were induced to differentiate by 
transferring to low serum-containing differentiation medium. After a few days, the 
cultures contained large numbers of differentiated, post-mitotic myotubes formed 
by myoblast fusion.  Significantly, not all of the myoblasts underwent differentiate 
with a proportion exiting the cell cycle and persisting as quiescent, undifferentiated 
precursors, termed “reserve cells” (Yoshida et al., 1998). These reserve cells share 
many phenotypic characteristics with quiescent satellite cells such as the presence 
of Pax7 and CD34, the lack of expression of MRFs and high levels of membrane 
sphingomyelin (demonstrated by the binding of lysenin) (Beauchamp et al., 2000; 
Nagata et al., 2006). Furthermore, quiescent reserve cells can be reactivated to 
enter the cell cycle by the addition of growth medium and their progeny again 
induced to differentiate, leading again to a new mixed population of myotubes and 
reserve cells (Kitzmann et al., 1998; Lindon et al., 1998; Yoshida et al., 1998). That 
apparently equivalent cells (C2C12 is a clonally-derived cell line) can adopt different 
fates within the same culture suggests that extrinsic factors can cause cells to adopt 
a satellite cell phenotype within in an environment where most cells undergo 
terminal differentiation. 
The model outlined above was used to investigate the expression of Notch 
receptors and ligands during myogenesis and reserve cell formation. Both Notch1 
and Notch2 were found to be expressed by proliferating myoblasts and were 
maintained throughout differentiation from myoblasts to myotubes. This is 
consistent with a role for Notch in driving the proliferation of myogenic precursor 
cells, during both development (Vasyutina et al., 2007) and postnatal regeneration 
(Conboy & Rando, 2002). In both cases, DL1 appears to be the prominent DSL ligand 
responsible for Notch activation (Conboy et al., 2005, Schuster-Gossler et al., 2007). 
Notch3 was also shown to be present in proliferating cultures and throughout 
differentiation although in contrast to both Notch1 and Notch2 where the active 
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form was present, the Notch3 present during proliferation was inactive and the 
active receptor was first detected at the onset of differentiation, the time when the 
cell fate decision (i.e. myotube or reserve cell) was being made. Significantly, 
analysis of cultures separated into differentiated myotubes and undifferentiated, 
quiescent reserve cell fractions, revealed that Notch1 was expressed in both 
fractions (although at much higher levels in myotubes), Notch2 was expressed in 
both, whereas Notch3 activity was entirely restricted to reserve cells. This further 
supports that validity of the reserve cell model as this expression profile matches 
that reported for quiescent satellite cells (Fukada et al., 2007; Kuang et al., 2007; 
Mourikis et al., 2012). 
The temporal expression and distribution of the receptor suggested that Notch3 may 
be involved in regulating satellite cell behaviour, possibly in the specification of the 
quiescent, undifferentiated phenotype investigate. In cultures where Notch3 activity 
was inhibited by shRNA-mediated knockdown, myoblast proliferation was unaffected 
consistent with the observation that Notch3 activity was undetectable prior to the 
initiation of differentiation. However, following differentiation, cultures in which 
the expression of Notch3 was reduced or absent contained a greater number of 
larger myotubes and a vastly reduced number of reserve cells compared with 
equivalent controls. These results suggest that Notch3 activity is required for cells 
to adopt the satellite cell-like, reserve cell phenotype. This hypothesis was further 
supported by the effects of overexpression of constitutively active Notch3 ICD 
which was found to inhibit myoblast proliferation, to increase the number of 
quiescent, undifferentiated Pax7+ve cells whilst inhibiting MyoD expression and 
differentiation. Again, these findings are consistent with Notch3 activity inhibiting 
the differentiation myogenic precursor cells by preventing MyoD expression, 
ensuring that they remain undifferentiated and quiescent and hence maintain of 
Pax7 expression. 
It is interesting to note that in contrast to the above findings many studies of other 
systems have concluded that Notch3 activity is associated with increased 
proliferation and disregulated activity has been linked to tumorigenicty in several 
contexts. For example, Notch3 has been implicated in neoplasia, including T cell 
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leukemogenesis (Bellavia et al., 2002) and several epithelial malignancies (Dang et 
al., 2000; Park et al., 2006; Dang et al., 2006). Although dispensable for normal 
embryonic growth (Krebs et al., 2003), Notch3 may have a role in regulating 
terminal differentiation (Lardelli et al., 1996; Apelqvist et al., 1999; Dang et al., 
2003) cell cycle progression (Campos et al., 2002) and apoptosis (Giovannini et al., 
2009; Wang et al., 2002). In the vascular system, Notch3 is involved in maintaining 
the phenotypic stability of adult arterial smooth muscle cells (Wang et al., 2008) 
and several defined mutations in the human Notch3 receptor result in cerebral 
autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) due to disruption of normal vascular smooth 
muscle identity and function (Chabriat et al., 2009).  
However, the outcome of signaling through a specific Notch receptor is both 
context and ligand dependent and can have different results in different situations 
(Rutz et al., 2005; de La Coste & Freitas et al., 2006; Benedito et al., 2009). The anti-
proliferative effect of Notch3 activity in skeletal muscle precursors was also 
supported by the observed changes in Notch receptor activity during reserve cell 
reactivation. When transferred to growth medium, reserve cells were shown to 
upregulate MyoD and re-enter the cell cycle. Significantly, this was preceded by a 
switch in Notch receptor activity: within 15 minutes Notch3 transcription was 
down-regulated and by 90 minutes the remaining receptor was inactive, whilst 
Notch1 transcription increased and receptor activity was detectable within the 
same timeframe, all prior to the increase in MyoD transcription.  
For Notch3 to have an effect on myoblast fate decisions, its activity must be 
triggered by interaction with an appropriate ligands. One possible explanation for 
the timing of Notch3 activation was that the relevant ligand was not present within 
the cultures prior to the initiation of differentiation. The temporal expression 
patterns of the DSL ligands during differentiation suggested DL4 as a potential 
candidate. In contrast to DL1which was expressed throughout differentiation, DL4 
was only expressed on newly formed myotubes that could potentially interact with 
remaining undifferentiated cells, DL4 activating Notch3 and imposing a quiescent, 
reserve cell phenotype. Although DL4 expression has not been previously reported 
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in skeletal muscle cells, it is expressed by arterial endothelium and is thought to 
instruct cell fate during vasculogenesis by interaction with Notch3 (Shutter et al., 
2000) . Indeed, when reserve cells were co-cultured with fibroblasts expressing a 
range of DSL ligands, only exposure to DL4 was able to maintain the reserve cell 
phenotype by preventing activation and re-entry into the cell cycle. 
Overall, the results presented in this thesis suggest that Notch3 activity resulting 
from a interaction with a specific DSL ligand DL4 is sufficient to impose and maintain 
an undifferentiated, stem cell-like phenotype in skeletal muscle myoblasts. One 
possible mechanism for the recruitment of satellite cells during regeneration is 
therefore that as myotubes form, their expression of DL4 activates Notch3 on 
neighbouring, as yet undifferentiated precursor cells and imposes a quiescent, 
undifferentiated phenotype. Thus, it could be that it is the restablishment of the 
satellite cell niche during regeneration that recruits a new cohort of stem cells from 
a homogeneous population of proliferating myoblasts.  
 
Figure 7.1 Model for a role of Notch3 in establishing a quiescent, undifferentiated 
phenotype in the context of myogenic differentiation  
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Notch3 becomes activated after differentiation is induced in proliferating myoblasts 
(Notch3–ve). Unfused single cells in differentiated cultures could either remain in 
the cell cycle or exit to become an undifferentiated reserve cell. Nascent myotubes 
expressing DL4 are sufficient to maintain active Notch3 in the quiescent cell 
population and inhibit re-entry into the cell cycle. Thereby recruiting them to 
replenish the stem cell compartment during the asynchronous process of muscle 
regeneration. 
Recent studies of the mouse spermatogenetic system have suggested that different 
mechanisms may operate to maintain the stem cell compartment under different 
conditions: during normal turnover the niche retains a stem cell population (actual 
stem cells) that self-renew and give rise to transit amplifying progenitors, whereas if 
the niche is emptied, progenitors (potential stem cells) can be recruited back to the 
niche to assume the function of self-renewal (Nakagawa et al., 2007). There is 
evidence to suggest that there may be similar flexibility in the skeletal muscle stem 
cell lineage as studies of isolated muscle fibre preparations have shown that 
proliferating satellite cell progeny, defined as committed progenitors by the 
expression of MyoD, retain the ability to withdraw from the cell cycle, down-
regulate MRF expression and reassume a Pax7+ve/MyoD-ve phenotype 
characteristic of a quiescent satellite cell (Zammit et al., 2004). In addition, 
transplanted myoblasts retain the ability to contribute to the satellite cell pool in 
vivo even after removal from the niche and extensive expansion in vitro (Cousins et 
al., 2004, Ehrhardt et al., 2007, Heslop et al., 2001). 
It has been proposed that the regenerative compartment of adult skeletal muscle is 
strictly hierarchical, based on a small population of true stem cells that express 
Pax7, but no MRFs (Kuang et al., 2007). In this model, the true stem cells undergo 
niche-orientated asymmetric cell divisions giving rise to a new stem cell and a 
daughter fated to generate progeny for differentiation. However, although such a 
system could operate during skeletal muscle turnover and growth, it is difficult to 
apply to situations where the satellite cell niche is compromised such as following 
free muscle transplantation where complete regeneration is still accompanied by 
recruitment of an appropriate satellite cell cohort (Schultz et al., 1984). Notch-
mediated stem cell recruitment during niche restoration provides an alternative 
mechanism that could operate following extensive damage and suggests that there 
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is more flexibility in the satellite cell lineage than implicit in a unidirectional stem 
cell to committed progenitor model. Indeed, this would be consistent with previous 
reports suggesting that differentiated muscle cells can establish and maintain 
quiescence in myoblasts that are otherwise capable of both proliferation and 
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